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ABSTRACT OF DISSERTATION 
 
 
 
 
METHODS DEVELOPMENT IN BIOLOGICAL MASS SPECTROMETRY: 
APPLICATIONS IN SMALL MOLECULE RESEARCH AND PROTEOMICS 
 
Technological developments have enabled mass spectrometry (MS) to evolve as 
one of the most versatile, sensitive and widely used analytical methods. Key areas of 
research in biological MS include the development of analyte-selective MS 
methodologies, along with the design of MS compatible separation technology. Analytes 
of interest range from small, biologically active molecules in disease progression 
research, to macromolecules such as proteins, in proteomics investigations. Advances in 
these areas are vital to maintaining the level of sophistication that has become the 
benchmark for MS analyses. 
Mass spectrometry has found a permanent station in disease progression studies, 
particularly in biomarker discovery. This is especially true for Alzheimer’s disease (AD), 
a condition marked by widespread lipid peroxidation (LPO) in the brain. The main 
hypothesis of the first part of this dissertation is that LPO produces aldehydes that can 
potentially be exploited as AD biomarkers. Design of novel LC-MS/MS methods for 
brain aldehyde analysis is described. The methods were applied towards aldehyde 
quantification in the hippocampus, superior and middle temporal gyrus and cerebellum of 
subjects with early AD (EAD), mild cognitive impairment (MCI) and age-matched 
controls. Results obtained indicated elevation of neurotoxic aldehydes in MCI and EAD 
brain and suggested that LPO occurred early in AD. Understanding AD progression has 
become important for developing diagnostic methods and treatments. 
Mass spectrometry is also the major analytical tool in proteomics, where gel 
electrophoresis is dominant in pre-MS separations. The main hypothesis of the latter part 
of this dissertation is that exposure of microbe fermenters including Clostridium 
thermocellum to an external stimulus, such as ethanol, can alter the membrane proteome. 
Design of novel doubled-SDS-PAGE (dSDS-PAGE) methods for membrane protein 
analysis is described, as these proteins are under-represented in standard 2D-PAGE. The 
newly developed Bicine-dSDS-PAGE offered superior separation over other methods and 
was applied towards analysis of wild type and ethanol-adapted C. thermocellum cell 
membranes. Significant differences in protein expression were observed. An 
understanding of ethanol adaptation will promote the design of more ethanol-tolerant 
strains. Such an outcome can have dramatic effects in the fuel industry as the trend 
towards more efficient fuel development gathers momentum. 
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INTRODUCTION 
 
Sir J. J. Thompson (1856-1940) made headlines in 1898 for discovering the 
electron and revolutionizing the sciences of physics and chemistry. For this, he was 
awarded the Nobel Prize in physics in 1906. The following year, he designed and built a 
parabola mass spectroscope to support his work on positive ray analysis, and as a 
consequence, became the father of mass spectrometry (1). Today, mass spectrometry 
(MS) has evolved into a microanalytical technique requiring only a few picomoles of 
sample to obtain molecular weight and structural information of the analyte under 
investigation (1). This analytical tool is being applied to a wide variety of research areas, 
including protein identification and structure determination (proteomics), drug 
metabolism, inherited metabolic diseases, the analysis of respiratory gases, viral 
identification, forensics, flavor and smell chemistry, organic fossils, atmospheric 
chemistry, petroleum and petrochemicals and many other specialized subjects (2). The 
ultrahigh detection sensitivity and unsurpassed molecular specificity have contributed to 
the prominence of mass spectrometry in analytical sciences.  
 Continuous innovation and improvement of instrumentation and techniques have 
made mass spectrometry one of the most versatile, sensitive and widely used analytical 
methods available today. Highly effective and novel approaches and paradigms have 
developed in this field that can tackle practical issues in the biochemical sciences, once 
beyond the scope of mass spectrometry. This has largely been brought about by 
overcoming the roadblocks of converting bioanalytes into gas-phase ions, concerns that 
have historically been the Achilles’ heel of mass spectral analysis of large biological 
compounds. As a consequence, the applications of this analytical methodology to 
biochemical fields have grown in astronomical proportions. A new branch of mass 
spectrometry called biological mass spectrometry was born. It actively deals with the 
analysis of organic materials derived from biological systems. The spectrometry is 
different from organic mass spectrometry in that organic molecules are analyzed from the 
standpoint of biological function and the life sciences.  
Recent developments in ionization methods, improvements in ion detection, 
increases in the mass range of instruments, and improved interfaces for separation 
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techniques are providing mass spectrometrists with the resources required to analyze a 
plethora of biologically active materials. Speedy advances in the biological sciences, 
particularly in the fields of molecular biology and biochemistry, have led to an increased 
demand for chemical and structural information on biologically active molecules, 
important areas where mass spectrometry outshines most other analytical tools. In the 
past 70 years, the applications of biological mass spectrometry have matured from trace 
analysis of species with masses below 50 Da to peptide sequencing and the analysis of 
100 kDa proteins. In 2002, Koichi Tanaka and John Fenn shared the Nobel Prize in 
chemistry for the development of soft desorption ionization methods in the mass 
spectrometric analyses of biological macromolecules, an achievement that clearly 
highlights the ascension of mass spectrometry into prominence as part of the analytical 
tools and technology available to biological scientists today. 
Key areas of research and investigation in biological mass spectrometry include 
the development of mass spectrometric methods for selective analysis of target analytes, 
along with the design of specialized separation technology that is amenable to 
interfacing, both online and offline, with mass spectrometry. Analytes of interest range 
from small, biologically active molecules in drug development and disease progression 
research to macromolecular structures, such as proteins, in proteomic studies. Continued 
advances in these areas are vital to maintaining and improving the level of sophisticated 
analyses that has become the benchmark for this important area of bioanalytical 
chemistry. 
 In the interest of target compound analysis, mass spectrometry has found a 
permanent station in one of the major goals of modern medicine: identification of 
biomarkers for the earliest possible stages of disease progression so that prompt clinical 
intervention can limit damage, reverse pathological change and ideally effect a complete 
cure. This is especially true in the case of Alzheimer’s disease (AD) research. AD is a 
debilitating neurological condition that plagues the elderly and is marked by widespread 
lipid peroxidation in the brain. Key compounds generated as a result of lipid peroxidation 
include biogenic aldehydes, such as C1-C6 aliphatic aldehydes and α,β-unsaturated 
aldehydes, including acrolein and 4-hydroxynonenal (4-HNE). The design of an LC-ESI-
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MS/MS methodology is described here that is ideally suited to identify and quantify such 
aldehydes in tissues. 
 The LC-MS method was successfully applied in the quantification of aldehyde 
concentrations in the hippocampus, superior and middle temporal gyrus (SMTG) and the 
cerebellum of subjects with early signs of AD (EAD), those with mild cognitive 
impairment (MCI), as well as and age-matched controls. This was the first study to report 
an in-depth comparison of aldehyde levels between these three types of individuals.  
Results obtained clearly indicated that HNE and acrolein are statistically significantly 
elevated in both MCI and EAD brain and suggested that oxidative stress occurs early in 
AD pathogenesis. Understanding the differences between MCI, EAD and normal subjects 
has becoming increasingly important in the interest of developing early diagnostic 
methods and treatments for AD. 
 The LC-ESI-MS/MS method for aldehyde analysis designed and described here 
makes use of standard LC separation science for small molecule separations. Another 
broad area of mass spectrometric applications is in the field of proteomics, where gel-
based techniques play a dominant role in pre-MS separations. While chromatography has 
found a niche in proteomics in such techniques as multi-dimensional protein 
identification technology (MudPIT), 2-dimensional polyacrylamide gel electrophoresis 
(2D-PAGE) is still very much the gold standard for protein separations. Nevertheless, 
standard 2D-PAGE is wrought with problems, such as under-representation of 
hydrophobic membrane proteins due to solubility issues, along with very basic proteins. 
As with any separation method, manipulation of the mobile phase and stationary phase of 
the 2D-PAGE system can tailor the experiment to the needs of the particular protein 
sample at hand. 
 Proteomic analysis of the cell membranes has emerged as a very important area of 
research due to the unique position of this organelle as the site of first cellular contact 
with the external environment. The cell membrane is the location of important 
biochemical processes intimately associated with cell viability both in eukaryotes and 
prokaryotes. Hence, it is no surprise that a major area of research is the development of 
better separation methods for membrane proteins that bypass or overcome many of the 
disadvantages encountered in 2D-PAGE. The cell membrane is involved in cellular 
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defense, signal transduction, partitioning of organelles and protection of the integrity of 
the genome and proteome. Since the membrane is the site of initial communication of the 
cell with the exterior, many physiological changes within a cell can be traced back to 
changes that occur in the cell membrane. For instance, studies have shown that microbe 
fermenters can be selectively conditioned to grow in elevated levels of ethanol due to 
fundamental changes that occur in the membrane proteome. These changes enable the 
organism to become ethanol-adapted and encourage the production of cellular ethanol. 
Clostridium thermocellum, a cellulolytic, thermophilic anaerobe, is a classic example of 
such an organism. Understanding these changes will enable a better appreciation of the 
mechanism of ethanol adaptation and promote the development of more ethanol-tolerant 
strains of this bacterium. This could have dramatic consequences in the fuel industry as 
the general trend towards cleaner and more efficient fuel development gathers 
momentum. 
 In the interest of developing better separation methods for membrane proteins, 
doubled SDS-PAGE (dSDS-PAGE) methods were designed for the analysis of wild type 
and ethanol-adapted C. thermocellum cell membranes. This analytical methodology 
features the separation of fully denatured and solubilized proteins in two dimensions and 
circumvents problems associated with other gel-based methods. Solubility issues often 
encountered with isoelectric focusing (IEF, the first dimension of standard 2D-PAGE 
experiments) are avoided and circumvented by performing a molecular weight based 
PAGE separation in the first dimension. This is followed by another PAGE experiment in 
the second dimension. Orthogonality in the two dimensions can be achieved by varying 
an assortment of gel electrophoresis parameters in one dimension with respect to the 
other.  
Optimization of membrane protein separation was achieved by exploring the 
parameter space of dSDS-PAGE.  The mobile phase (running buffer) and gel preparation 
techniques were manipulated to arrive at the best possible separation conditions for 
membrane proteins. Tricine-dSDS-PAGE and a newly developed Bicine-dSDS-PAGE 
were investigated and optimized in membrane proteome analysis. It was shown that 
Bicine-dSDS-PAGE offered considerable advantages over Tricine-dSDS-PAGE and the 
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standard Laemmli experiment (Glycine-dSDS-PAGE) in terms of protein spot resolution 
and abundance, amongst other factors. 
For the purposes of exploiting the advantages of the newly designed gel 
electrophoresis technique in understanding ethanol tolerance, a two-stage Bicine-dSDS-
PAGE separation was performed to bring different regions of the C. thermocellum 
membrane proteome into focus. The two-stage analysis offered increased spot detection 
and resolution over a single stage experiment. Furthermore, the two-stage Bicine-dSDS-
PAGE approach produced comparable results to a 3-stage Glycine-dSDS-PAGE analysis. 
The dSDS-PAGE investigations of the C. thermocellum proteome demonstrated 
significant differences in membrane protein expression patterns between the wild type 
and ethanol-adapted strains. No doubt, these results offered insight into the biochemical 
nature of ethanol adaptation. 
This dissertation focuses on experimental design and the development of better 
separation-based mass spectrometric experiments to selectively analyze target 
compounds. Combining the power of separation science and mass spectrometry offers 
considerable sophistication to the arsenal of analytical methods available to clinicians and 
scientists. Tailoring separation and the mass spectrometric experiment to the compounds 
of interest can dramatically improve analysis. Analytical chemistry is a very diverse field 
and considerable research and development is focused on methods development for target 
analytes. A solid understanding of the chemistry of target species can enable the design 
of elegant methodologies, producing optimum analytical results, as clearly demonstrated 
in the experiments described in this dissertation. 
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Chapter 1.1 
Introduction 
 
Alzheimer’s Disease Background 
 
Alzheimer's disease (AD) is a progressive neurological disorder of the elderly that 
gradually destroys neurons in the brain, particularly in regions critical to cognition, such 
as judgment and reasoning, memory, movement coordination and pattern recognition (1). 
Dr. Alois Alzheimer, a German psychiatrist and neuropathologist, identified the disease 
in 1906 (2). He noticed unusual changes in the brain tissue of a 51-year old woman who 
had died after a 4.5 year episode of progressive dementia. The tissue displayed abnormal 
clumps, now called amyloid or senile plaques (SPs), and tangled bundles of fibers, 
recognized as neurofibrillary tangles (NFTs). Such artifacts are not normally observed in 
patients suffering from other forms of dementia (2). The presence of SPs and NFTs in the 
hippocampus, amygdala, cerebral cortex and certain other brain regions are now 
considered to be the major histopathological hallmarks of AD. The illness afflicts some 
4.5 million Americans today (1). As people live longer, AD is becoming a major medical 
and social concern. Risk factors for AD include age, Down syndrome, family history, and 
the ApoE genotype. The ApoE gene codes for apolipoprotein E, a macromolecule 
involved in processing and transport of cholesterol. The gene has three major alleles: E2, 
E3 (most common), and E4. Individuals who inherit copies of the E4 allele show an 80% 
increased risk of developing AD by the age of 60-65. Not all individuals with AD have 
E4, and not everyone who has this allele will develop AD. It is unknown why E4 is 
related to AD development. However, studies have shown that the allele is linked to an 
increased number of SPs (3). 
The accepted clinical criteria for AD diagnosis include dementia ascertained by 
clinical examination and neuropsychological testing, deficiencies in two or more areas of 
cognition, progressive decline of memory and other cognitive functions, no disturbance 
in consciousness, onset of symptoms sometime between ages 40 and 90 and lack of 
differential diagnosis that could attest for the gradual deterioration of cognitive function 
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(2). AD diagnosis can only be established clearly by the post-mortem demonstration of 
increased numbers of NFTs and SPs as compared with appropriate age-matched controls 
(4). While AD has been diagnosed in younger patients, it remains overwhelmingly a 
disease of the elderly community. Approximately 5% of men and women between the 
ages of 65 to 74 have AD and nearly half of those aged 85 and older are believed to 
suffer from this neurological condition (1). It should be noted that AD is not a normal 
part of the aging process. To this day, the etiology and pathogenesis of AD remains 
elusive and it is resistant to many treatments. 
The mechanisms responsible for AD pathology are multifaceted and comprise of 
several factors including mitochondrial dysfunction, abnormal protein aggregation, 
inflammation and excitotoxicity and eventual death of neurons (2). Autopsy examinations 
of the AD brain reveal abnormal fibers that appear to be tangles of brain tissue filaments 
(NFTs) and cores of amyloid surrounded by degenerative nerve endings (SPs). The 
amyloid fibrils of SPs are mainly composed of aggregated forms of the 39-43 amino acid 
peptide defined as amyloid β-peptide Aβ(1-42). This peptide (Figure 1.1.1) is generated 
by the abnormal proteolysis of an integral membrane precursor protein (amyloid 
precursor protein or APP), and is found in SPs surrounded by dystrophic neurites (5). By 
nature, SPs are extracellular formations (~8 nm filaments) that substantially impede 
electrical signal transmission by neurons (6, 7). In contrast, NFTs are intracellular ~20 
nm cytoplasmic fibers comprised of bundles of paired helical filaments (PHF), the major 
component of which is the microtubule-associated protein tau (τ) (8-10). NFTs are 
thought to interfere with axonal transport in neurons (1). 
One theory on the pathogenesis of AD suggests that neurodegeneration is the 
result of oxidative damage to vulnerable cerebral tissue. In a situation of oxidative stress, 
the antioxidant cellular mechanisms are inadequate to tackle the production of free 
radical oxidant species. It is thought that the molecular mechanism underlying Aβ 
toxicity may result from free radical generation enabled by the peptide (11). Studies have 
shown that Aβ(1-42) promotes oxidative injury to neuronal proteins and lipids in vitro 
and mediates oxidative damage in AD brain (12, 13). Such damage can be inhibited by 
addition of antioxidants (14). Butterfield and co-workers (12) postulated that small, 
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Figure 1.1.1. Sequence of Aβ(1-42) with the R group of methionine residue 35 displayed. 
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soluble aggregates of APP-derived amyloid β-peptide insert into the neuronal and glial 
membrane bilayer and produce an array of oxygen-dependent free radicals that then cause 
lipid peroxidation and protein oxidation. Direct membrane damage results from Aβ-
associated free radicals, perhaps involving peptide-bound redox metal ions and the 
methionine residue at position 35. Indirect membrane damage arises by the action of lipid 
free radicals or various LPO products, including 4-hydroxy-2-nonenal (HNE) and 2-
propenal (acrolein). In addition, Aβ contains several histidine residues (at positions 6, 13 
and 14) and a tyrosine residue (at position 10) that have a remarkable ability to chelate 
metal ions, including iron and copper. It is thought that chelation of metals by the peptide 
can result in its aggregation (15, 16). These complexes, detected in SPs, have pro-oxidant 
properties. Furthermore, the chelation reduces transition metals to their highly active, low 
valency state, with a concurrent synthesis of free radicals and initiation of LPO (17). 
There also appears to exist a clear mechanistic relationship between τ and 
oxidative stress (18-20). Compared to normal subjects, τ in the AD brain has been 
demonstrated to undergo a host of varied modifications. These include 
hyperphosphorylation (21-23), ubiquitination (24-26) and oxidation (27, 28). In addition, 
τ can be proteolytically processed and aggregated into filaments (23, 29, 30). 
Hyperphosphorylation renders τ unable to bind to microtubules and it therefore fails to 
promote or maintain microtubule assembly (10, 30). Studies have indicated that oxidative 
stress activates several kinases such as ERK, p38 and JNK, which have been shown to be 
activated in AD (31-33) and are capable of phosphorylating τ (34). As with τ and Aβ, 
data have also linked oxidative damage to AD, such as accumulation of trace elements 
(i.e. iron) as free radical sources, increased protein and DNA oxidation, elevated 
antioxidant enzymes (i.e. superoxide dismutase), in situ detection of carbonyls and 
increased LPO (35). In particular, the products of LPO have recently received 
considerable interest as potential biomarkers for AD. 
 
Lipid Peroxidation Biomarkers for Alzheimer’s Disease 
 
Polyunsaturated fatty acids (PUFA), primarily of the ω-3 and ω-6 variety such as 
linoleic (ω-6), arachidonic (ω-6) and docosahexaenoic acid (ω-3), are the major 
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substrates for LPO in lipoproteins and cell membranes (17). In the process of LPO, lipid 
constituents of cellular membranes are attacked by free radicals, including hydroxyl, 
peroxynitrite and hypochlorite, that have sufficient reactivity to abstract a weakly bound 
hydrogen atom from a methylene carbon in their side-chains (36). As a result, a carbon-
centered radical is left in the fatty acid. The radical then proceeds to bind with oxygen 
yielding the peroxyl radical, which can then react with other fatty acids or proteins 
(Figure 1.1.2). These reactions result in cell damage and a cascading increase in the 
production of free radicals. It has been shown that transition metal ions, such as Cu2+ and 
Fe3+, are responsible in exacerbating oxidative damage by the production of highly 
reactive hydroxyl radicals through the Fenton reaction (17). 
 
Fe2+ + H2O2 ? Fe3+ + OH• + OH- (1.1.1) 
 
Removal of hydrogen bonds is facilitated by the presence of higher numbers of double 
bonds in the PUFAs. Compared to other organ systems, the brain contains a high lipid 
content, high levels of transition metals, high oxygen and energy consumption rate, large 
stores of polyunsaturated fatty acids and relatively poor defenses against lipid 
peroxidation (2).  
Neuronal membranes readily succumb to oxidative damage because the PUFA 
constituent of their phospholipids can easily react with free radicals from cell metabolism 
(37, 38). Normal metabolic processes generate free radicals through a variety of sources. 
These radicals react with the PUFA component of cell membranes, producing such 
compounds as hydroxylated fatty acids (HETEs), prostanoids and lipid aldehydes (37). 
Ordinarily, the brain is protected from this type of damage by a carefully controlled 
balance between pro-oxidant and antioxidant cellular mechanisms. Vitamins E and C, 
glutathione (GSH), albumin, bilirubin, ceruloplasmin, uric acid, along with several 
antioxidant enzymes, such as superoxide dismutase, glutathione peroxidase and catalase, 
provide protection from free radical damage. Antioxidant protection occurs through 
various methods within cells, including prevention of free radical formation, interception 
of radicals, oxidative damage repair, eradication of damaged molecules, as well as 
nonrepair-recognition of excessively damaged molecules to prevent mutations. A 
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Figure 1.1.2. Peroxidation of fatty acids.
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situation of oxidative stress arises from an imbalance in free radical production 
(particularly reactive oxygen species) and their removal by antioxidants (37).  
Increasing evidence supports a role for oxidative damage in the pathogenesis of 
AD. Several studies demonstrated increased protein oxidation (11, 39), DNA oxidation 
(40-43), decreased levels of PUFAs (4, 44), and increased LPO (45-48) in AD. There 
have been reports of increased levels of neurotoxic markers of LPO, including HNE and 
acrolein, in the AD brain (49, 50) and cerebrospinal fluid (CSF) (51). 
Immunohistochemical studies of the AD brain also showed different markers of oxidative 
stress in NFTs and SPs (52-56). It is evident from the literature that an appropriate 
biochemical indicator or product of LPO would serve well as a biomarker for AD. Hence, 
it is no surprise that a considerable amount of research is currently focused on the 
exploration of lipid peroxidation byproducts in their suitability as biomarkers for the 
disease. 
A major consequence of LPO is the widespread damage to membrane structure 
and integrity as a result of the production of fragmented fatty acyl chains, lipid-lipid 
cross-links, endocyclization to form a variety of fatty acid esters and lipid-protein cross-
links (57). In total, these processes combine to generate significant changes in the 
biophysical properties of membranes that can result in profound effects on the biological 
activity of membrane-bound proteins. Another important outcome of LPO is the 
generation of secondary, more stable LPO products, which can be categorized into those 
formed through a host rearrangement processes and mechanisms as well as those 
generated by fragmentation of oxygenated lipids (57). 
A small proportion of lipid hydroperoxy radicals go through internal cyclization 
reactions to produce endoperoxide intermediates. These species are then converted to 
various ringed isomers similar in structure to prostaglandins (57). Such compounds are 
called isoprostanes (IsoPs) when they are derived from arachidonic acid. Quantification 
of IsoPs rivals that of malondialdehyde, one of the most commonly used biomarkers of 
LP, in accuracy and precision (58). However, concern with exploiting these chemicals as 
indices for LP and AD stem from the lack of a thorough understanding of the link 
between them and oxidant stress processes (59).  
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Fragmentation of lipid hydroperoxides in LPO generates low molecular weight, 
water-soluble, electrophilic aldehydes and is commonly observed in several different 
types of neurodegenerative conditions, such as stroke and AD (57). Notable aldehydic 
products include malondialdehyde (MDA), acrolein, and HNE. MDA can be detected 
through the thiobarbituric acid-reactive substances (TBARS) assay. The sample to be 
tested is heated with TBARS at low pH. Absorbance of a pink chromogen is measured at 
532 nm (60). The test is popular because it is quite simple to perform and rather 
inexpensive (36). However, it has the disadvantage of being an unspecific index for LPO 
in complex biological fluids or in vivo. Furthermore, the results can often be misleading 
as many species, including sugars, amino acids and bilirubin, can interfere with the test 
(36, 60, 61).  
Saturated aliphatic aldehydes (C3-C10) are also generated in LPO through 
fragmentation mechanisms, along with the α,β-unsaturated aldehydes such as acrolein 
and HNE (62). Aliphatic aldehydes have no evident toxicity, but acrolein (CH2=CH-
CHO) and HNE (C5H11-CH(OH)-CH=CH-CHO) are neurotoxic and have been detected 
by immunohistochemistry in the AD brain, especially in NFTs and SPs (13, 63). 
Alkenals, such as HNE and acrolein are strong electrophiles that react in tissues by 
alkylating nucleophiles (Michael Addition and Schiff base formation), particularly 
sulfhydryl groups, amino groups (i.e., lysine), and the imidazole group of histidine (64). 
Such reactions can lead to the structural alteration and/or cross-linking of proteins, which 
in turn can cause impairment of protein function. Therefore, these LPO products are 
biologically very active and can cause substantial disruption of cell processes at the 
genetic and biochemical level. The mechanism of formation of these toxic aldehydes 
(Figures 1.1.3 – 1.1.5) has been described previously (38, 65). HNE, a product of ω-6 
PUFA peroxidation, is a relatively stable aldehyde that can diffuse into different 
subcellular compartments and interact with a host of cell proteins, including τ (30, 66) 
and histones (67). Increased production of HNE has been shown to indicate an increased 
level of oxidative stress, which may not always be evident using the more common 
marker malondialdehyde (MDA) (68). HNE is generated in response to oxidative insults 
and can induce neuronal apoptosis (69, 70). HNE has been linked to a host of adverse 
cellular effects, including growth inhibition, alterations in glutathione levels, inhibition  
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Figure 1.1.3. Initial stages of arachidonic acid peroxidation. R• represents a small free 
radical (such as OH•) and L• is a lipid radical.
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Figure 1.1.4. Peroxidation of arachidonic acid to generate 4-hydroxynonenal.
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Figure 1.1.5. Peroxidation of arachidonic acid to generate acrolein. L• is a lipid radical.
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of enzymes and calcium sequestration by microsomes, exhibition of chemotactic activity 
toward neutrophils, inhibition of protein and DNA synthesis, as well as induction of cell 
death (40, 71). It has been shown to play a major role in oxidative impairment of synaptic 
functions, leading to excitotoxic cascades (72-74) and to impair Na+/K+ ATPase activity 
(75, 76) as well as glucose and glutamate transport (76). Microtubule organization and 
neurite outgrowth are also vulnerable to HNE (77). 
Among the α,β-unsaturated aldehydes, including HNE, acrolein shows the 
highest reactivity towards nucleophiles, such as lysine (40, 78, 79). This aldehyde is 
produced in vivo during the iron-catalyzed oxidation of PUFAs, such as arachidonic and 
docosahexaenoic acids (80). It readily reacts with proteins and phospholipids and can 
inhibit many enzyme systems including glucose and glutamate transport and Na+/K+ 
ATPase activity (49, 78). Acrolein is also known to modify DNA bases with the 
formation of exocyclic adducts, leading to chromosomal aberrations, sister chromatid 
exchanges and point mutations (40, 81) and has recently been linked to abnormal tau 
protein phosphorylation (20). It is believed that acrolein may inactivate the reductase 
responsible for the reduction of vitamin E radicals and, coupled with the depletion of 
glutathione, causes further LPO and neuronal death (13, 80). 
Considering the array of cellular constituents that can react with acrolein and 
HNE, it is believed that a majority of these aldehydes exist in neurons bound to 
macromolecules, particularly proteins. In vitro studies have shown that α,β-unsaturated 
aldehydes have a high affinity for proteins (79, 82). In view of this, accurate and precise 
quantification of all such aldehydes in the cells can be difficult. However, previous 
studies have shown a direct correlation between free unsaturated aldehyde concentrations 
and AD progression, particularly in regions of the brain with memory function (49, 50). 
As such, a reliable quantification method for free aldehyde analysis (both aliphatic and 
unsaturated) would be a useful measure of oxidative stress, and therefore AD. 
 
Vulnerable Regions of the AD Brain 
 
Cortical degeneration, excluding the sensorimotor cortex, occipital poles and 
cerebellum, is considered as the primary basis for cognitive decline in AD (83, 84). Areas 
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of the brain typically affected in AD include portions of the frontal lobe associated with 
intelligence, judgment and social behavior, as well as areas of the temporal and parietal  
lobes that have memory and language function. Studies have shown a direct correlation 
between the prevalence of NFTs and SPs with levels of lipid peroxidation byproducts, 
including biogenic aldehydes, in different brain regions (11, 45, 48-50, 63, 81, 85). 
Cognitive deficits, particularly in memory, are associated with atrophy of the medial 
temporal lobe (MTL) (86). Structures comprising the MTL include the hippocampus, 
parahippocampal gyrus, entorhinal cortex and amygdala. Compared to age-matched 
controls, increased AD pathology, to varying levels, has been detected in the 
hippocampus, parahippocampal gyrus, superior temporal gyrus and middle temporal 
gyrus (Figure 1.1.6). Atrophy of the hippocampal formation is seen in AD patients with 
even very mild dementia. In situations of advanced dementia, atrophy extends to the 
parahippocampal gyrus and other structures in the temporal neocortex (87, 88). 
Phylogenetically one of the oldest regions of the brain, the hippocampus is 
located inside the temporal lobe and is part of the limbic system, a group of structures 
involved in transferring information into memory. The hippocampus is intimately 
associated with the formation and long-term storage of associative and episodic 
memories, as well as an individual’s ability to navigate. It is one of the first regions to 
succumb to AD pathology (89). Because of this, initial symptoms of AD 
characteristically include memory problems and disorientation. As with the hippocampus, 
the parahippocampal gyrus is also part of the limbic system. It is located in the most 
medial basal part of the temporal lobe and is also very susceptible to damage in AD. 
Medial temporal lobe atrophy, particularly the hippocampus and parahippocampal gyrus 
of the brain, can substantially impair the storage of new information and is believed to be 
site of initial change preceding the expression of AD symptoms. 
Regions that show AD pathology in the temporal neocortex include the superior 
and middle temporal gyrus. Among other functions, the superior temporal gyrus is 
closely associated with an individual’s ability to be insightful. The middle temporal gyrus 
is linked to the processing of language and semantic memory, as well as visual perception 
and multimodal sensory integration. Patients with damaged temporal lobes have 
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Figure 1.1.6. Regions of the human brain investigated (90, 91): hippocampus, superior 
temporal gyrus (STG), middle temporal gyrus (MTG), and cerebellum. 
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difficulty with remembering names and faces (92). Because of the association of the 
superior and middle temporal gyri with memory, it is not surprising that they do succumb 
to damage in AD. However, the pathology observed here is not as widespread and intense 
as that in the hippocampus and parahippocampal gyrus.  
The cerebellum is an example of a part of the brain that exhibits little or no 
pathology in AD. It aids in the coordination of voluntary motor movement, muscle tone, 
balance and equilibrium. While the cerebellum has limited function in memory for reflex 
motor acts, it is not particularly associated with memory formation, processing or storage 
(93). Since the prevalence of LPO byproducts appears to be directly associated with the 
level of AD pathology, it is to be expected that the greatest concentrations of these 
species would be located in the hippocampus and parahippocampal gyrus when 
comparing AD brains to age-matched controls. Intermediate concentrations would be 
detected in such areas as the superior and middle temporal gyrus that display intermediate 
AD pathology while the cerebellum and other structures not predominantly involved with 
memory should show little, statistically significant elevations in the levels of these 
compounds. A thorough quantitative study of the distribution of biogenic aldehydes or 
other LPO products in the brain calls for careful methods development and analysis. 
 
Biogenic Aldehyde Analysis 
 
Several techniques have been explored for the analysis of biogenic aldehydes. 
Many of these techniques involve high performance liquid chromatographic (HPLC) 
separation and spectrophotometric measurements of chromophoric derivatives, such as 
UV absorption of dinitrophenyl hydrazones (DNP) (94-97) and fluorescence detection of 
cyclohexanedione (dimedone or CHD) derivatives (62, 98-101). In the absence of 
chromatographic separation, spectrophotometric methods fail to distinguish between 
specific analytes and other species capable of forming derivatives that also absorb at the 
selected wavelength. Coupling spectrophotometric detection with separation techniques 
such as HPLC adds greater selectivity, but co-eluting compounds may still interfere with 
quantification of aldehydes at low levels. Aldehyde quantification is further complicated 
by their reactivity and metabolism in tissues and biological fluids.  
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Methods utilizing gas chromatography/mass spectrometry (GC/MS) offer high 
sensitivity and the further advantage of mass specificity. This results in a much lower 
limit of detection for aldehydes like HNE that are present in biological samples at very 
low concentrations (102). Selected ion monitoring (SIM) at masses specific for target 
analytes considerably improves instrumental sensitivity. In addition, derivatization (such 
as oxime derivatives) can often be employed to direct fragmentation, further improving 
limits of detection (103). As such, reduced sample volumes are often needed per analysis 
when using GC/MS. Several types of aldehyde derivatives have been explored in 
conjunction with GC/MS, most popularly o-pentafluorobenzyl-oxime-trimethylsilyl 
(PFB-oxime-TMS) (102-106) and DNP (107) derivatives. PFB-oxime-TMS derivatives 
react quantitatively with aldehydes at room temperature within 30 minutes. Other 
advantages include small sample size and mild derivatization conditions (105, 106). Due 
to low volatility, DNP derivatives are only practical for GC separation of low molecular 
weight aldehydes. Also, these derivatives tend to react incompletely if the aldehydes are 
in low abundance, which is often the case in biological matrices. Nevertheless, they offer 
the benefit of little or no side-reactions (106). 
GC/MS methods of aldehyde analysis are well established, however, the use of 
HPLC combined with tandem mass spectrometry offers several noteworthy advantages. 
For instance, a much greater proportion of the sample can be presented to the system, 
thus improving the overall sensitivity of the technique. In addition, while different classes 
of aldehydes can be simultaneously analyzed by HPLC/MS, multiple derivatizations are 
frequently necessary for the analysis of different classes by GC/MS methods (37). The 
temperatures applied in GC/MS for sample vaporization may not be suitable for certain 
analytes. Unlike GC/MS, little pre-MS sample cleanup is required in HPLC/MS methods. 
Furthermore, tandem mass spectrometry (MSn) coupled with HPLC is a well-
documented, specific and sensitive procedure using modern instrumentation. Scanning 
the precursor ions for a common product ion provides a straightforward method for 
aldehyde mixture analysis in biological samples, where the aldehyde composition may 
vary considerably. DNP (108, 109), ozonide (109) and dimedone (37, 110, 111) 
derivatives of aldehydes have been successfully analyzed using HPLC/MS. One report 
 24
described the detection and analysis of HNE by HPLC/MS without any form of 
derivatization (112). 
A noteworthy advantage of CHD derivatives is that they are formed with 
aldehydes only. Other carbonyl compounds simply do not react in this manner. As such, 
this method is completely selective for these compounds. The improved selectivity 
afforded by HPLC/MS/MS provides significant advantages over the fluorescence 
detection of such derivatives, especially in the case of co-eluting compounds. This, 
coupled to the fact that CHD-derivatized aldehydes provide over 90% recoveries makes 
this procedure ideal for trace aldehyde analysis (100). It has been observed that aldehydes 
derivatized with CHD reagents produce analytes that display excellent electrospray 
response, a further advantage of exploiting this derivatization technique in conjunction 
with HPLC/MS (37). 
 
Liquid Chromatography 
 
Liquid chromatography was brought into existence by the Russian botanist M. S. 
Tswett (1872-1919) as a means for the separation of colored plant pigments (113). Since 
then, high performance liquid chromatography, a highly developed version of its 
predecessor, has become a well established analytical technique. This technique is used 
for the separation and determination of organic and inorganic solutes in a variety of 
settings, including biological, pharmaceutical, environmental and industrial applications. 
HPLC instruments consist of a reservoir of mobile phase, a pump, an injector, a 
separation column and a detector (113). The mobile phase reservoirs, along with 
associated feed lines should be inert to prevent leaching of chemicals. Solvent feed lines 
are typically made of non-permeable Teflon. It is important for the pumps to be able to 
deliver mobile phase through the system as reproducibly as possible. Typical flow rates 
for microbore chromatography range from 0-150 μl/min. A six-port Valco or Rheodyne 
injector is suitable for LC systems (113). Samples are injected by micro-syringe into a 
sample loop, the size of which can be chosen to meet experimental needs. The stationary 
phase in LC systems usually consists of small diameter (3-10 μm) uniform particles, 
packed into a narrow bore (0.01 inches or less) cylindrical column to minimize band 
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broadening. Columns are made of resilient material, such as stainless steel or plastic. 
They are generally 5-30 cm long with an internal diameter in the range of 0.3-9 mm. In 
view of the small size of HPLC column packings, pumps that are able to deliver mobile 
phase at high backpressures (~6000 psi) at precise flow rates (<1% variation) are a 
necessity (113). 
In an LC separation experiment, the sample is first dissolved in the mobile phase 
and then passed, under pressure, through an immobile and insoluble stationary phase. The 
sample flows through the column by continuous addition of mobile phase, which 
completely permeates the stationary phase and elutes the solutes into the detector. The 
phases are chosen such that components of the sample have differing partitioning 
behavior between them. For instance, an analyte having high solubility in the stationary 
phase will take longer to traverse the column, compared to one that is not particularly 
soluble in the stationary phase but highly soluble in the mobile phase. The process of 
separation becomes possible because of these differences in mobilities between the 
analytes. Each analyte migrates through the column at a rate that is dependent on the time 
it spends in the mobile phase. At the detector, they each generate a signal which is 
recorded. Substantial benefits in the separation process can be achieved by careful 
consideration of chromatographic parameters. 
 
Separation Theory 
Analyte distribution between phases follows a dynamic equilibrium (113): 
stationarymobile AA ⇔ . (1.1.2) 
The equilibrium constant, K, for this process is the distribution coefficient. K is defined 
as the ratio of the molar concentration of analyte in the stationary phase and the molar 
concentration of the analyte in the mobile phase: 
m
s
C
CK = . (1.1.3) 
The time lapse between sample injection and a component analyte peak reaching a 
detector at the end of the column is the retention time (tR). Each analyte component is 
characterized by a different retention time. The time for the mobile phase to pass through 
the column is tM (Figure 1.1.7).  
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Figure 1.1.7. The separation process. The time interval between sample injection and the 
analyte peak reaching the detector is the retention time (tR). The time for the mobile 
phase to pass through the column is tM. The peak width at half height is w1/2.
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The capacity factor, k’, can be employed to define retention of an analyte on a 
column. For analyte1, the capacity factor is: 
k’1 = (mass of analyte1)s / (mass of analyte1)m 
= 
M
MR
t
tt − . (1.1.4) 
 Optimization of the chromatographic process is critical to any HPLC experiment. 
To this end, band separation and band broadening are of importance. Both are kinetic 
processes and a useful separation is only achieved when the rate of band separation is 
greater than the rate of band broadening. To obtain the best separations, efficiency and 
selectivity issues must be considered. Sharp, symmetrical chromatographic peaks can be 
obtained only when column efficiency is optimized.  
 
Plate Theory 
It is possible to describe column efficiency by the plate model, which assumes 
that the chromatographic column contains a large number of (hypothetical) separate 
layers, also known as theoretical plates. Furthermore, analyte equilibration between the 
two phases is said to occur at each plate. The analyte moves down the column as a result 
of transport of equilibrated mobile phase from one plate to the next. The number of 
theoretical plates that a real column possesses can be obtained by examining a 
chromatographic peak after elution (114): 
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where,  w1/2 = the peak width at half height. 
Column efficiency increases as the number of equilibrations or theoretical plates, 
increases. If the length of the column is L, then the height equivalent to a theoretical plate 
(H) is: 
N
LH = . (1.1.6) 
The number of theoretical plates is dependent on the length of the chromatographic 
column. H is a better indicator of column efficiency as it makes inter-column 
comparisons more feasible (113).  
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Rate Theory 
Chromatographic phenomena inside a column can be better understood when 
taking into account the time for the solute to equilibrate between the stationary and 
mobile phases (114). This approach is in contrast with the plate model, which postulates 
that equilibration is instantaneous. Rate theory highlights the kinetic factors that 
contribute to zone or band broadening, as represented by H (115). The resulting 
chromatographic peak shape is therefore influenced by the rate of passage of analytes 
through the column and by the various routes that solute molecules can take in their 
journey through the stationary phase. The different mechanisms that increase band 
broadening are described by the van Deemter equation (116): 
( )uCC
u
BAH ms +++=  (1.1.7) 
where,  u = Average velocity of mobile phase 
   A = Eddy diffusion 
   B = Longitudinal diffusion 
C = Resistance to mass transfer in the stationary (Cs) and 
mobile (Cm) phases. 
A plot of plate height versus average linear velocity gives an indication of the ideal flow 
rate (Figure 1.1.8). At mobile phase velocities below the optimum, the overall efficiency 
of the system is strongly influenced by longitudinal diffusion, or the B term. At velocities 
higher than the optimum, the efficiency decreases because resistance to mass transfer (C 
terms) becomes more important. Despite the reduced efficiency, it is generally acceptable 
to employ mobile phase velocities above the ideal value for the purposes of lowering 
analysis time (113). 
 For packed columns in situations of low velocity where the mobile phase random 
walk of solute particles is directed by longitudinal diffusion, the Eddy diffusion or A 
term, is eliminated. Eqn (1.1.7) then becomes (116): 
uCuC
u
BH ms ++= . (1.1.8) 
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Figure 1.1.8. The van Deemter plot. H is the plate height, A is the Eddy diffusion term, B 
is the longitudinal diffusion term, C is the resistance to mass transfer term and u is the 
mobile phase velocity. 
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Sometimes, other measures of column efficiencies can prove to be more useful. 
Solute separation is intimately tied to selective retention by the stationary phase. This 
selectivity by the stationary phase can be expressed as a form of adjusted retention: 
'
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===α . (1.1.9) 
Eqn (1.1.9) clearly shows the thermodynamic basis of this type of separation, as 
described by the relationship of the selectivity factor to the distribution coefficient (113). 
While the selectivity factor portrays the separation of solute zones, it does not 
take peak widths into consideration. As can be seen in Eqn (1.1.10), the resolution, Rs, is 
a more informative measure of separation. It considers the difference in retention, as well 
as column efficiency (113): 
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  where,  wB = peak width at the base. 
A more useful expression for resolution can describe the both the thermodynamic and 
kinetic aspects of the separation (117): 
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  where,  kavg = average k for two peaks of similar retentions. 
An increase in column selectivity (α) is a powerful way of improving resolution. As 
such, a careful selection of both stationary and mobile phases is critical to the HPLC 
process. 
 
Stationary Phase 
 A variety of particles are used in LC column separations, differing in type, size, 
shape and nature. Microparticulate (3-10 μm), porous materials (~300 Å pore diameter) 
offer large active surface areas for increased sample loadings, good column efficiencies 
and high speed of analysis (118). Silica packings are commonly used for LC columns 
because they can tolerate the high pressures created when 10-30 cm columns are packed 
with microparticulate materials. Silica is easily functionalized and the chemistry of its 
bonding reactions is quite well understood (113). Bonded-silica columns can be used  
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Figure 1.1.9. C18 stationary phase (monomeric bonding) for HPLC. 
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through a wide pH range (pH 1-10), although reproducibility is assured only in the range 
of pH 2-7.5. This is largely because of the fact that long-term exposure to pH extremes 
causes hydrolysis of the bonded phase (acid extremes) or degradation of the base silica 
(basic extremes) (119). Silica-based columns tend to offer vastly improved efficiencies, 
compared to non-silica materials. For the purposes of separating small, hydrophobic 
compounds, a carbon-chain bonded phase over microparticulate, porous silica would be 
useful. Longer chain bonded phases have more hydrophobic character and greater carbon 
loading (119). In the separation of dimedone derivatives of aldehydes, for instance, a 
hydrophobic C18 bonded phase would be suitable (Figure 1.1.9). Retention is largely 
based on van der Waals interactions. 
 
Column Packing 
In the wet-fill (slurry packing) method of column preparation, an appropriate 
solvent is used to suspend the stationary phase particles at a reasonable concentration. 
This suspension is then pumped under high pressure into an empty column. It is required 
that the solvent be able to maintain uniform particle distribution without agglomeration. 
The solvent must also thoroughly wet the packing material. LC packings that have low 
surface energy, such as C18 functionalized silica, can be packed in solvents of low 
polarity, such as a binary acetonitrile:water = 9:1 solvent mixture. To pack a column, the 
packing suspension is sonicated, stirred and placed in a specially designed reservoir, also 
known as a column bomb, which fits to the inlet end of the empty column. A porous 
screen (1-2 μm) or frit is placed at the outlet of the column and the packing material 
slurry is introduced into the column under gas pressure, producing a compact stationary 
phase bed (113). 
 
Mobile Phase 
 Solute retention and selectivity also depend on the strength of the interaction 
between the solute and the mobile phase. Solvents used as the mobile phase can enhance 
or diminish solute ionization and can also screen active adsorption centers on the 
adsorbent surface. In typical LC approaches, a logical and intelligent selection of the 
stationary phase is made first and then the selectivity is fine-tuned by manipulating the 
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mobile phase. Useful solvents will have reduced viscosity, flammability and toxicity. 
They will also be compatible with the detection system for the LC instrument and have 
little or no impurities (113). Detection of solutes in HPLC occurs online, so it is 
imperative that the solvent be compatible with the detection system.  
Solvents of low viscosity offer favorable solute diffusivity, which in turn 
improves column performance. It is important for solvents to be chemically inert towards 
the target analytes and be able to completely dissolve the analytes. In reversed-phase 
liquid chromatography (RP-HPLC), there is an inverse relationship between solvent 
strength and chromatographic elution power. For instance, pure water is a rather strong 
solvent but has little elution power in RP-HPLC. However, mixing water with a small 
quantity of an organic modifier with lesser polarity, such as acetonitrile, results in a 
solvent system that can elute a solute with a low capacity factor value (a solute with 
reduced stationary phase retention). Binary and ternary solvent mixtures provide a simple 
means for controlling solvent strength by varying the relative concentration of each 
component in the mobile phase mixture that enters the column (113). 
 
Gradient Methods 
 In LC experiments, it is possible to gradually change the composition of the 
mobile phase during the course of a chromatographic run through a process called 
gradient elution. This technique is quite similar in principle to temperature programming 
in GC, except that changes in solvent strength rather than temperature are used to elute 
target analytes (113). Each experiment is begun with a weak eluting solvent, such as 
water, followed by steady additions of increasing amounts of a strong eluting solvent, 
such as acetonitrile, over the length of the chromatographic run. In high-pressure gradient 
formation, the high pressure mixing of the two solvents is brought about by two pumps 
and a microprocessor controlling device (113). A gradient is generated by careful control 
of the output solvent flow from each pump (Figure 1.1.10). Manipulation of solvent 
strength in this manner allows improved resolution of poorly retained solutes at the 
beginning of the separation, while the more strongly retained solutes are eluted within a 
shorter time. Gradient elution offers significant improvements in peak shape, resolution, 
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Figure 1.1.10. High-pressure gradient formation in HPLC. 
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detection sensitivity and analysis time. Solvent gradients are widely used with RP-HPLC 
since a wide range of compounds can be separated using this approach. 
 
Reversed-Phase HPLC 
 RP-HPLC utilizes a non-polar stationary phase with a polar mobile phase and is 
very useful in separating hydrophobic analytes. Polar sample molecules interact the least 
with the stationary phase and are therefore eluted first. As a result, increasing the polarity 
of the mobile phase results in increased retention of solute. The hydrocarbon-like 
stationary phases have the ability to equilibrate rapidly with changes in mobile phase 
composition and are therefore very well suited for use with gradient elution (113). The 
mechanism of retention in RP-HPLC is complex and it is believed that various non-
specific hydrophobic interactions between the solute and stationary phase are involved. 
However, these interactions alone are much too weak to account for the degree of solute 
retention that is characteristic of RP-HPLC. The retention mechanism can be best 
described as involving a combination of partition and adsorption processes. Due to the 
heterogeneous nature of silica-based materials, it is possible for different mechanisms to 
operate over different regions of the stationary phase surface. To further complicate 
matters, the mechanism is not always constant over the entire range of mobile phase 
compositions. This is largely because mobile phase composition has a significant 
influence on the solvation of binding sites on the stationary phase (113). 
 To date, the solvophobic theory provides the most likely interpretation of RP-
HPLC retention. Predictions from this theory work best when using aqueous mobile 
phases with little organic modifier content. A basic assumption is that the stationary 
phase is a uniform layer of non-polar ligand. According to the solvophobic theory, the 
solute interacts with the stationary phase, thereby reducing the proportion of its surface 
area exposed to the mobile phase. This solvent effect drives the sorption of solute 
molecules. In other words, the solute is adsorbed because it is solvophobic. The theory 
assumes that aqueous mobile phases tend to be very structured because polar water 
molecules will self-associate by hydrogen bonding. Non-polar solutes, lacking hydrogen-
bonding capabilities, cause a perturbation in this structuring (113). As a result of the very 
high cohesive energy of the solvent, the less polar, more hydrophobic solutes are literally 
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squeezed out of the mobile phase and are non-covalently bound to the hydrocarbon 
portion of the stationary phase.  
The solvophobic theory stresses that retention occurs largely due to the strong 
interactions between the mobile phase and solute molecules. This implies that the mobile 
phase composition has a greater effect on separation selectivity than the stationary phase 
in RP-HPLC (113). For polar solutes, the dipolar or hydrogen bonding interaction 
between the solute and the mobile phase will resist the transfer of solute. It is the 
disparities in interactive energies between the non-polar and polar solutes with the mobile 
phase, along with disparities in the hydrophobic solute molecular surface areas that are 
the important factors associated with functional group selectivity observed in RP-HPLC 
techniques (113). 
 
Electrospray Ionization – Ion Trap Mass Spectrometry 
 
A particularly well-suited detector for LC is a mass spectrometer because it can 
be used in the analysis of a wide variety of compounds with diverse functional groups. 
Furthermore, MS offers high selectivity and sensitivity, together with considerable 
structural information, for the purposes of solving complex analytical problems (120). 
Performing LC-MS experiments online extends the well-established GC/MS methods to 
thermally labile compounds that are amenable to analysis through HPLC only (121). 
Since MS operates under a vacuum, one of the challenges of interfacing any separation 
system with this detector is the requirements of a suitable sample introduction method. 
Also, it can be difficult to completely eliminate the solvent from LC, maintain adequate 
vacuum levels in the mass spectrometer and generate gas phase ions. There are many 
reasons why electrospray (ES) is an ideal means of transferring eluent from the LC 
instrument into the mass spectrometer, a major one being that electrospray allows ion 
formation directly from solution. Also, in electrospray, ionization occurs at atmospheric 
pressure. These features have established ESI-MS as a convenient mass detector for 
liquid chromatography, as the mobile phase offers a suitable medium for analyte 
ionization. 
 
 37
Electrospray 
 Electrospray is an ion transport technique that enables the sensitive analysis of 
small, large and labile molecules, including such varied analytes as peptides, proteins, 
organometallics, oligosaccharides and polymers. Over 20 years ago, Fenn and co-workers 
demonstrated the applicability of this technique in directly coupling LC to mass 
spectrometry (122-124). In LC/MS, the HPLC line is attached to the electrospray probe, a 
metallic capillary surrounded with nitrogen gas flow, and the mobile phase is forced 
through the capillary. Solutes analyzed by electrospray undergo ‘soft ionization’ and are 
largely left intact in the ionization source. A major source of analyte charging is through 
protonation or deprotonation reactions (125). The capillary has a voltage applied to it 
while the sampling cone is held at low voltage. The potential difference between them 
can be anywhere between +500 and +4500 V. As a result of the voltage on the capillary, 
an aerosol of charged droplets is formed, assisted by a concentric flow of nitrogen. The 
droplets have both solvent and analyte molecules, and, depending upon the polarity of the 
applied voltage, the molecules develop a net positive or negative charge (126). Ionized 
molecules eventually discard the surrounding solvent and enter into the atmospheric 
pressure region of the mass analyzer through a low-pressure transport region (~1 torr). 
This part of the instrument contains a heated capillary, a skimmer and lens arrangements. 
The electrospray interface uses an octopole lens (Figure 1.1.11) for ion focusing into the 
mass analyzer of the spectrometer (121). 
The aerosol droplets generated in electrospray upon nebulization decrease in size 
due to solvent evaporation, resulting in an increased charge density on their surface. The 
mutual repulsion of like charges in the droplets eventually becomes greater than the 
surface tension, causing ions to be ejected from the droplets. Vaporization of these 
charged droplets results in the production of singly- or multiply-charged gaseous analyte 
ions. The electrospray instrument delivers a continuous current, causing redox reactions 
to take place at the source. Oxidation reactions at the metal capillary remove electrons 
from negative ions. Likewise, reduction reactions involving the sprayed positive ions 
occur at the negative counter electrode (127). It is expected that the reaction having 
lowest electrochemical potential will generally occur at the capillary tip. In an attempt to 
establish the mechanism for gas-phase ion formation from charged droplets in  
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Figure 1.1.11. The electrospray source. 
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electrospray, the ion evaporation model (IEM) and the charged residue model (CRM) 
have been suggested (127). Since both models have almost equivalent support in the mass 
spectrometry community, both are considered when discussing electrospray mechanisms. 
Ion Evaporation Model: The increased charge density on the droplet surface 
arising from solvent evaporation results in Coulombic repulsion becoming greater than 
the liquid’s surface tension. This enables the release of ions from the droplet before it 
breaks apart, as shown in Figure 1.1.12(A). 
Charged Residue Model: Evaporation of the droplets occurs continuously. The 
diameter of the droplet decreases while the total charge remains the same. The increased 
charge density, due to solvent evaporation, induces instability on the surface. This causes 
large droplets to divide into smaller droplets through a series of sequential fissions, 
eventually generating single ions, as shown in Figure 1.1.12(B). 
Electrospray offers the best sensitivity with lower flow rates. The effluent flow 
from the LC system that enters the electrospray source can be reduced by using a splitter. 
Since electrospray is not an ionization method, it is imperative that the mobile phase have 
a pH such that the analytes will be ionized. Acidified mobile phase is well-suited for the 
analysis of basic compounds using the positive electrospray mode, while a basic pH is 
desirable for acidic analytes. It is best to employ volatile buffers for routine use, although 
non-volatile buffers, such as phosphate, can be employed as well. It should be noted that 
when using non-volatile buffers the salt deposit in the source will have to be periodically 
removed. It is important that the concentration of the buffer acid or base used to 
manipulate the pH be low. This is to avoid competition between the analyte and 
electrolyte ions for conversion into the gas-phase, as it can potentially decrease analyte 
response (125). 
 
Quadrupole Ion Trap Mass Spectrometry 
Ions generated through electrospray can be detected with a quadrupole ion trap 
(QIT), a mass analyzer invented by Wolfgang Paul and co-workers in the 1950’s. Ions are 
guided from the source into the trap by focusing through a skimmer and two RF-only 
octopoles. Differential pumping with a series of mechanical and turbo pumps maintains a 
vacuum in the trap while the electrospray source is at atmospheric pressure. The ion trap 
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Figure 1.1.12. Electrospray mechanisms: (A) Ion evaporation model (IEM) and (B) 
Charge residue model (CRM).
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is comprised of three electrodes of hyperboloidal geometry: a ring electrode located 
between an entrance end-cap and an exit end-cap electrode (Figure 1.1.13). These 
electrodes form a cavity within which ions can be trapped and studied. The trapping 
volume in a QIT has dimensions r0 and z0, where r0 is the closest distance between the 
center of the trap and the ring electrode and z0 is the closest distance between the center 
of the trap and either end-cap (128). Both end-cap electrodes have small holes in their 
centers through which the ions can travel. Ion entry is controlled using a gating lens that 
switches from positive to negative voltages to repel or attract ions toward the entrance 
end-cap opening. For positive ion analysis, a negative potential is applied for ion entry 
and for negative ion analysis, a positive potential is applied. The ionization period or time 
during which ions are allowed entry into the trap is adjusted to maximize signal and 
minimize space charge, which can arise from an excess of ions in the trap producing 
changes in the electrical fields and decline in trap performance. On the other hand, too 
few ions can result in a loss of sensitivity (129, 130). 
In a quadrupole ion trap, a rf oscillating electrical potential on the ring electrode 
directs and focuses ions to the trap center. Helium gas in the instrument, at a pressure of 
about 1 mtorr, collides with the trapped ions and aids in the reduction of their kinetic 
energy and causes the contraction of trajectories toward the center of the trap. Ions within 
the trapping volume experience a potential described by (128, 131): 
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  where,  U = dc amplitude on end-cap electrodes 
    V = rf amplitude on ring electrode (fundamental rf) 
    Ω = oscillating frequency of rf (V), typically 1.1 MHz 
    r = 22 yx + = radial displacement. 
Each ion in this quadrupolar field experiences a force that is dictated by Newton’s law 
(128): 
zrzrzrzr ameEF ,,,,
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Figure 1.1.13. The quadrupole ion trap (QIT). 
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  where,  m = mass of ion 
    e = charge of ion 
    a = acceleration of ion 
    Er,z = electric field strength. 
The mass (m) and charge (e) of an ion, the size of the ion trap (r0), oscillating 
frequency of the applied voltage to the ring electrode (Ω) along with the amplitude of the 
voltages on the end-cap (U) and ring (V) electrodes all come together in a second order 
differential equation or Mathieu Equation to determine whether or not that ion will have 
stable motion in the trap (129, 132).  
( ) 02cos22
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=−+ uqa
d
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uu ξξ  (1.1.15) 
  where,  u = coordinate axes x, y and z 
    ξ = dimensionless parameter Ωt/2 (t is time) 
    au and qu = dimensionless trapping parameters. 
Solutions for the Mathieu equation that provide stable ion trajectories are described by 
the parameters qz and az in the axial direction, 
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as well as ar and qr in the radial direction: 
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In reference to ions, m/z (z is the ion charge) is synonymous with m/e. 
 
Mathieu Stability Diagram 
A plot of az vs qz or Mathieu Stability Diagram describes the regions of stability 
in the trap for ions of different m/z values (Figure 1.1.14). Depending upon the amplitude
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Figure 1.1.14. Mathieu stability diagram for a 3D quadrupole ion trap. The az parameter 
is proportional to dc and the qz parameter is proportional to rf. 
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of U and V, an ion of a given m/z will have a qz value that is located within the 
boundaries of the diagram. This means that the ion will have stable motion and be 
trapped. An ion can be maneuvered within the boundaries of the stability diagram by 
manipulation of U and V. In addition, the trajectory of an ion can be made unstable 
through careful selection of U and V, causing it to be selectively expelled from the trap. 
Whether or not stability exists for a particular ion within the trap depends solely on the 
parameters a and q and not on the initial parameters of ion motion, such as velocity. The 
Mathieu equation has two types of solutions (129): 
1. periodic and stable: These solutions dictate stable ion trajectories in the trap. Ions 
can be stored in a trap provided that their motion is stable in both the r- and z-
directions. 
2. periodic but unstable: These solutions apply to the boundaries of unstable regions 
in the aq map, which represent points at which ion trajectories become unstable.  
It should be noted that commercial ion traps generally do not offer the ability to 
manipulate dc voltages. With no dc potential applied, all ions are assured radial stability. 
Hence, in order to eject ions, they must be made unstable in the axial direction. 
On the q-axis (a=0, no dc voltage) there is a stability region extending from 0 < q 
< qmax = 0.908, which dictates the low-mass cutoff of the mass analyzer. As such, the 
lower m/z ions have q values closer to the exclusion limit, while higher m/z ions have q 
values closer to the origin. All masses between ∞ > m > mmin have stable orbits. Scanning 
V to higher voltages will make trapped ions move to higher q values and eventually, the 
lowest m/z ion reaches, and then crosses the stability boundary. In other words, the ion 
gains kinetic energy and its axial motion becomes increasingly larger until it is ejected 
from the trap through holes in the end cap aperture. A full scan mass spectrum is 
generated by sequentially ejecting ions from low m/z to high m/z and detecting them 
using a collision dynode and electron multiplier system. This is known as the mass 
selective instability scan (129). 
Although the angular frequency of the applied voltage V on the ring electrode is 
Ω, ions in the trap do not oscillate at this frequency because of their own inertia. Instead, 
the ions oscillate with a frequency known as the secular frequency fz that is lower than Ω 
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and decreases with increasing mass. This frequency is proportional to Ω by a constant of 
proportionality βz that is dependent on both az and qz (131): 
2
Ω
= zzf β . (1.1.21) 
When qz < 0.4, this constant of proportionality can be approximated in the following 
manner: 
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In situations where no dc voltages are applied to the ion trap and az = 0, the expression 
can be simplified to: 
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Since the maximum value of βz for a stable ion trajectory is βz = 1, the highest possible 
secular frequency fz that an ion can have is half the value of Ω (130). 
There is an alternate method to the mass selective instability scan that can be 
applied towards ion ejection. This method, termed resonance ejection, involves making 
the trajectory of a particular ion unstable through the application of a high-amplitude ac 
voltage or supplementary rf potential on the end-cap electrodes. The qz value of the ion is 
changed until the secular frequency of the ion matches the frequency of the applied rf 
voltage. In a special case of resonance ejection, the supplementary rf frequency is held 
constant (corresponding to a qz value less than 0.908) while the rf drive amplitude is 
ramped, a process known as axial modulation. In this manner, several or all ions can be 
ejected mass selectively. The ions absorb excess energy from the applied field, 
sequentially go into resonance, causing the amplitude of oscillations to linearly increase 
in the z direction. If the applied voltage is high enough, the oscillations will become so 
large that the ions are destabilized and finally ejected from the trap through the end-cap 
electrode. Axial modulation creates ‘holes’ in the qz axis so that ions can be expelled at 
values of V lower than those needed to attain qz = 0.908 in the standard instability scan. 
Furthermore, very large ions that may not be able to achieve this qz value no matter how 
high the value of V can be easily ejected with this approach. A full scan mass spectrum 
may be obtained by combining resonant ejection with an rf  (V) scan, thereby enabling 
 47
successively larger ions to move to the position in the stability diagram where they fall 
into resonance with the supplementary rf and are ejected. When the supplementary rf 
frequency is decreased, corresponding to a much lower value for qz, axial modulation can 
enable extension the mass range of the ion trap (128). 
 
Ion Isolation Methods 
It is often desirable to study a particular ion in detail, perhaps for the purposes of 
doing ion-molecule reactions or tandem mass spectrometry (MSn) experiments. 
Resonance ejection can be employed to isolate an ion of particular m/z, while ejecting all 
others. In this case, a supplemental rf waveform may be applied to the end-cap electrodes. 
This waveform creates unstable trajectories for all ions except the species that is to be 
trapped. Another approach to ion isolation is by a technique called reverse-then-forward 
scanning. An ejection hole is formed at low qz by applying a supplemental rf to the end-
cap electrodes. Scanning the rf amplitude on the ring electrode (V) in the reverse 
direction results in the ejection of all m/z values larger than that of the desired species 
through the ejection hole. Likewise, m/z values lower than that of the ion to be isolated 
are expelled from the trap by changing the supplemental rf to form an ejection hole at 
high qz. The rf amplitude on the ring electrode (V) is then scanned forward, thus ejecting 
all ions of lower m/z (131). If manipulation of dc is an option, then a further method of 
ion isolation is possible. By applying an appropriate combination of dc and rf  (V) 
potentials on the ring electrode, the ion of interest can be isolated at the apex of the 
stability diagram, while ejecting all other species (130). 
 
Tandem Mass Spectrometry 
Tandem mass spectrometry, abbreviated MS/MS or MS2, is any general mass 
spectrometric method of at least two mass analysis stages, either in association with a 
fragmentation mechanism or a chemical reaction that modifies the mass or charge of an 
ion (130). In the ion trap, it is possible to perform time-dependent multistage MSn 
experiments. Analysis of fragment ions generated from tandem experiments offers 
considerable structural information of precursor ions. While a high-amplitude 
supplemental rf applied to the end-cap electrodes can initiate resonance ejection of ions, 
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it is possible to induce ion fragmentation by applying a low-amplitude supplemental rf (a 
few hundred millivolts) to the same electrodes. This process is called resonant excitation.  
Prior to resonant excitation of a particular ion, all other unwanted ions are excited 
and expelled from the trap by applying an appropriate supplemental rf waveform to the 
end-cap electrodes. The remaining ions are then focused collisionally to the vicinity of 
the center of the trap under the influence of collisions with helium atoms. The process has 
been described as ‘ion cooling’ as ion kinetic energies are reduced to ~0.1 eV. At this 
point, ion migrations from the center of the trap are less than 1 mm. A low-amplitude 
supplemental rf is then applied to the end-caps, causing excitation of ions. As a result, the 
ions start to move away from the trap center, resulting in their experiencing a greater 
trapping field. Since the supplemental rf has low amplitude, ions undergo low-energy 
collisions with helium as opposed to being ejected. Resonance excitation increases ion 
kinetic energy and promotes collision induced dissociation (CID) with helium, resulting 
in the formation of fragment ions. A mass spectrum (MS2) is generated by successively 
ejecting the fragments from low m/z to high m/z by choosing supplemental rf amplitudes 
and V potentials that induce instability in the ion trajectories (128). 
 
Mass Spectrometric Experiment Design 
 With the advent of numerous decision-making algorithms, it has become possible 
to perform a wide array of mass spectrometric experiments focused on the needs of the 
sample under analysis. Data-dependent algorithms have been used to obtain both MS and 
MS/MS data during the course of a single LC/MS run. The ion trap mass spectrometer is 
ideal for these analyses because of its high sensitivity in the full scan mode and the ease 
of switching from the MS to MS/MS mode. Furthermore, the ion trap employs helium for 
both ion collection and fragmentation, which considerably simplifies the experiment. In 
data-dependent experiments, the instrument automatically performs MS/MS experiments 
on precursor ions in previously acquired full scan mass spectra. The switch from MS 
mode to MS/MS mode occurs once a signal threshold is reached. As can often be the 
case, some samples have multiple co-eluting species. Data-dependent scanning can easily 
be employed to obtain MS/MS information on these species. The mass analyzer performs 
an MS/MS analysis on the most intense ion and then puts this ion on an exclusion list. 
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The ion is not analyzed further for a pre-selected time window. Then the instrument 
proceeds with the analysis of other ions present in the full scan.  
The time for completion of one analytical full scan followed by one analytical 
MS/MS scan is determined by the duty cycle of the instrument. For the purposes of 
enhancing ion statistics, several micro-scans are averaged to produce one analytical scan. 
However, in doing so, the duty cycle of the mass analyzer tends to suffer, resulting in 
fewer full scans and MS/MS scans being acquired. This can be a substantial issue in 
instances of overlapping peaks produced as a result of mediocre chromatographic 
resolution. In such cases, fewer analytical scans per unit time are likely to preclude 
certain analytes from tandem mass spectrometry experiments. There is some user control 
on the rate of analytical scan acquisition through such parameters as the number of 
averaged full scans and MS/MS scans as well as the ion trap injection time. Wenner et al. 
investigated the factors that influence data-dependent scanning in ion trap MS (133). 
Data-dependent scanning enables the rapid analysis of all key components present 
in a particular sample. However, sometimes it may be required to perform mass 
spectrometric investigations on certain target analytes within the sample and more 
focused experiments are necessary. In such situations, it is desirable to perform 
segmented MS/MS analyses in which the data acquisition time window is divided into 
discrete sections. Each time segment is devoted exclusively for the MS/MS analysis of a 
target analyte. Any sections of the time window not involved in the analysis of particular 
solutes may be used to do data-dependent scanning to obtain a full picture of the MS 
fingerprint of the sample. Segmented analyses have the advantage of greatly improving 
the signal-to-noise ratio (SNR). Furthermore, the isolation of a particular analyte in this 
manner for exclusive MS/MS analysis can be described as a form of ion purification. 
Segmented MS/MS analysis can simultaneously provide structural and quantitative 
information on target analytes. 
 
Goals 
 
 This chapter has provided a background on the nature and importance of 
Alzheimer’s disease. The clinical criteria for AD diagnosis, histopathological hallmarks, 
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as well as elements of the etiology that have been established to date were discussed. 
Numerous studies have shown the relevance of Aβ and τ in oxidative stress and AD 
pathogenesis. These findings have been stressed, along with the connection of Aβ and τ 
to the widespread lipid peroxidation and oxidative stress observed in the AD brain. The 
importance of LPO byproducts as viable biomarkers for AD, such as the neurotoxic 
aldehydic species acrolein and HNE, was explained. Exploiting these compounds as 
biochemical indicators of AD requires the development of sensitive, selective and reliable 
methodologies for their detection and quantification. The benefits of derivatizing these 
biogenic aldehydes with cyclohexanedione reagents for analysis by LC/MS have been 
detailed. Furthermore, principles of LC/MS operation as applicable to biogenic aldehyde 
quantification were discussed. 
 Chapter 1.2 describes the development of LC-ESI-MS/MS methods for the 
detection and accurate quantification of aliphatic and unsaturated aldehydes of biological 
importance, particularly in AD pathogenesis. Several LC and MS parameters were 
explored and a description of how their values were optimized in order to arrive at the 
most effective methodology is provided. Appropriate calibration curves for quantitative 
analysis were constructed using standard aldehyde samples and their reliability and 
usefulness was investigated in the analysis of real tissues. 
 Chapter 1.3 focuses on the application of the developed LC-ESI-MS/MS method 
in the analysis of aldehydic products in vivo. Post-mortem samples from several brain 
regions of individuals that had been suffering from different stages of AD were analyzed 
for biogenic aldehydes. These results were then compared to the analysis of brain tissues 
from suitable age-matched controls. Detailed statistical examination of the data is given. 
 Chapter 1.4 provides some concluding remarks and highlights the significance 
and future direction of this work. 
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Chapter 1.2 
Development of LC-MS Methodologies for the Quantitative Analysis of Biogenic 
Aldehydes in Alzheimer’s Disease 
 
Introduction 
 
Liquid chromatography (LC) separations, coupled to a variety of detection 
methods, have been employed in the analysis of derivatized biogenic aldehydes. These 
include derivatization by 2,4-dinitrophenyl hydrazines followed by UV detection as well 
as fluorescence detection of several derivatives (40, 94-96, 98-101, 107). In cases where 
analysis was carried out by gas chromatography (GC), the detection method of choice has 
been mass spectrometry (MS) (103, 105-107). For instance, Zhang and co-workers (104) 
have recently developed a simple, rapid, sensitive, solvent-free GC/MS method with 
solid-phase microextraction (SPME) and on-fiber derivatization for the analysis of 
aldehyde levels in the blood of lung cancer patients. Aldehydes in blood headspace were 
extracted by a SPME fiber and reacted with O-2,3,4,5,6-
(pentafluorobenzyl)hydroxylamine hydrochloride (PFBHA) on-fiber. The resulting 
oxime derivatives were desorbed and quantitatively studied by GC/MS. The blood 
samples were shown to contain substantially elevated levels of hexanal and heptanal 
compared to controls, suggesting the potential use of these aldehydes as biomarkers for 
this disease. 
There are some noteworthy reports that describe the use of LC in association with 
mass spectrometry in aldehyde analysis of tissue samples (37, 97, 108, 109, 112). Several 
derivatization techniques have been explored, including the Hantzsch reaction (110). 
Compared to the more frequently used hydrazine reagents, this mode of derivatization 
displays some very interesting characteristics. In this reaction, an aldehyde, two β-
dicarbonyl compounds and ammonia combine to form a heterocyclic system. The 
resulting compound, known as a dimedone derivative, has fluorescent properties (110). 
Several β-dicarbonyl compounds have been studied. Acetylacetone was the first β-
diketone derivatized in this manner, producing a dihydropyridine derivative (134). 
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Sawicki et al. described the use of 5,5-dimethyl-1,3-cyclohexanedione as the β-diketone 
(135). The products of this reaction are decahydroacridines. Several researchers have also 
applied the use of other β-dicarbonyl compounds, such cyclohexanedione (134, 135), in 
this type of aldehyde derivatization. The derivatization mechanisms are described 
elsewhere (136). 
Mallet et al. (37) developed a LC-MS procedure for analyzing hexanal and larger 
aldehydes in blood plasma. Aldehyde derivatization using the Hantzsch reaction preceded 
analysis by a LC-Quattro instrument with electrospray (ES). Quantification was achieved 
by multiple reaction monitoring (MRM), with benzaldehyde as an internal standard. This 
is a non-physiological aldehyde of little structural similarity with the target compounds. 
The approach has the potential drawback that benzaldehyde reactivity in the 
derivatization may not be identical to that of the target aldehydes. However, experimental 
data did not suffer and indicated the applicability of LC-MS in plasma aldehyde 
quantification. Smaller (C1-C5) straight chain and unsaturated aldehydes were not studied. 
Karst and co-workers (110) described LC-MS methods for the determination of 
aliphatic aldehydes following derivatization with acetylacetone through the Hantzsch 
reaction. The authors employed atmospheric pressure chemical ionization (APCI) and 
electrospray in the positive ion mode to ionize the dihydropyridine and 
decahydroacridine derivatives, protonated at their basic secondary amine groups. The 
oxidation products of the formaldehyde derivatives were identified as side products. The 
authors concluded that the combination of LC and mass spectrometry offered 
considerably high selectivity in comparison to the conventional detection approaches. 
We extended and applied the protocols of Karst et al. and Mallet et al. in 
developing methodology for analyzing small aliphatic and unsaturated aldehydes of 
biological importance, especially in AD etiology. In contrast to other biogenic aldehyde 
studies, dimethyl CHD was our derivative of choice due to improved chromatographic 
quality. A range of aliphatic aldehydes were studied (C1-C6), along with acrolein and 
HNE. Furthermore, two internal standards were employed (heptanal and octanal) to 
accurately quantify low and high abundance aldehydes. Influence of several instrument 
parameters on the quality of mass spectral data was explored and a description of how 
their values were optimized is provided. We detail the development of sensitive, selective 
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and dependable methods for the detection and quantification of biogenic aldehydes in 
tissues by LC-ESI-MS/MS. 
 
Experimental 
 
Materials 
All aliphatic aldehydes except methanal (Sigma, St. Louis, MO) and ethanal (EM 
Industries, Inc., Hawthorne NY) were obtained from Wako Pure Chemical Industries, 
Ltd. (Osaka, Japan). HNE was obtained from Cayman Chemical Co. (Ann Arbor, MI). 
Acrolein, 1,3-cyclohexanedione (CHD), 5-methyl-1,3-cyclohexanedione (methyl CHD) 
and 5,5-dimethyl-1,3-cyclohexanedione (dimethyl CHD) came from Aldrich (St. Louis, 
MO). HPLC grade water, acetonitrile (ACN), methanol, glacial acetic acid, PrepSep C18 
solid phase extraction (SPE) cartridges and a PrepSep 12-port vacuum manifold were 
obtained from Fisher Scientific (Pittsburgh, PA). Ammonium acetate came from Sigma 
(St. Louis, MO). Standard solutions to generate calibration curve data for aldehyde 
quantification were prepared with Wiretrol disposable micro pipets from VWR Scientific 
Products (St. Paul, MN). 
 
Brain Tissue 
Specimens of the superior and middle temporal gyrus (SMTG) from one AD 
patient and one age-matched control subject were obtained from short post mortem 
interval (PMI) autopsies, immediately frozen in liquid nitrogen and subsequently stored 
at -80oC until used for analysis (blind experiment, performed in triplicate). 
 
Derivatization of Aldehydes 
 Aldehyde derivatization was carried out using the procedure of Lovell et al. (62) 
Figure 1.2.1. Several dimedone derivatives were explored. Similar schemes were used to 
derivatize standard aldehyde solutions and human brain samples. Derivatized standard 
aldehyde mixtures were employed in generating calibration curves for quantitative 
analysis. 
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Figure 1.2.1. Aldehyde derivatization. The reaction proceeded by cyclization of 2 β-
dicarbonyl compounds and an aldehyde in the presence of ammonia to form a 
heterocyclic system (110). 
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Derivatizing Agent 
Aldehydes were derivatized by heating them with appropriate amounts of a stock 
dimethyl CHD derivatizing agent solution, as described below. This solution was 
prepared by combining 10 g ammonium acetate, 10 mL glacial acetic acid, 0.25 g 
dimethyl CHD and diluting to 100 mL with water. (62) CHD and methyl CHD 
derivatizing solutions were prepared in a similar fashion. 
 
Standard Aldehyde Derivatives for Quantitative Analysis 
For the aliphatic aldehydes (C1-C6), a standardized aldehyde solution mixture was 
prepared by adding precalculated, weighed amounts of stock aliphatic aldehydes (C1-C6) 
to a class A volumetric flask and diluting with methanol. A separate solution of heptanal 
internal standard was prepared in a similar manner. A set of standardized solutions with 
increasing concentration of aldehydes (~1x10-9 g/mL to ~3x10-7 g/mL) was prepared in 
volumetric glassware by adding suitable amounts of the aliphatic aldehyde mixture, an 
excess of derivatizing agent, a fixed amount of internal standard and diluting to the mark 
with methanol. The aldehyde solutions, upon derivatization, were calculated to provide 1 
pg/µL to 300 pg/µL. The standardized solutions were incubated in a 60oC water bath for 
1 h and subsequently desalted with C18 SPE cartridges. The derivatized aldehydes were 
then eluted with 2 mL methanol (Figure 1.2.2). 
For the unsaturated aldehydes (acrolein and HNE), standardized solutions of 
acrolein and HNE were prepared in a similar manner as described above for the aliphatic 
species. The internal standard employed here was octanal (Figure 1.2.2). 
 
Brain Tissue 
For aldehyde analysis, 100 mg of tissue sample was homogenized using 5 mL 
HEPES buffer (pH 7.4) with 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM 
MgSO4, pepstatin (0.7 μg/mL), leupeptin (0.5 μg/mL), aprotinin (0.5 μg/mL) and 
phenylmethylsulfonyl fluoride (40 μg/mL). Next, 500 μL aliquots of homogenate were 
added to glass test tubes, followed by appropriate volumes of standardized internal 
standard solution (in methanol). Heptanal was chosen as the internal standard for the 
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Figure 1.2.2. Biogenic aldehyde derivatives investigated. Aldehydes derivatized included 
(1) methanal, (2) ethanal, (3) propanal, (4) butanal, (5) pentanal, (6) hexanal, (7) heptanal 
(internal standard for aliphatic aldehydes), (8) octanal (internal standard for unsaturated 
aldehydes), (9) acrolein and (10) HNE.
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aliphatic and octanal for the unsaturated aldehydes. Octanal internal standard was added 
at a 10-fold lower concentration compared to heptanal so that solvent concentration of the 
final derivatized brain sample by 10 enabled accurate quantification of low abundance 
unsaturated aldehydes. A review of the literature on aldehyde quantification in the brain 
indicates that this is adequate for acrolein and HNE analysis (49, 50, 62). Samples were 
vortexed for 30 sec for aldehyde extraction and centrifuged (850 x g for 10 min). A 500 
μL aliquot of supernatant was then mixed with 1 mL of dimethyl CHD derivatizing 
reagent and heated in a 60oC water bath for one hour. After cooling to room temperature, 
the reaction mixture was added to preconditioned C18 SPE columns, which were then 
washed with water to remove excess ammonium acetate. Derivatized aldehydes were 
eluted with methanol (62). 
 
Construction of a C18 HPLC Column 
 Fused silica tubing (Polymicro Technologies) with an internal diameter of 320 μm 
and an outer diameter of 440 μm was used to create the HPLC column. All other column 
constructing supplies came from Upchurch Scientific. Column length (containing packing 
material) was 15 cm. The base of the column was prepared from an assembly of a zero 
dead volume (ZDV) union, 2 μm stainless steel frit, poly ether ether ketone (PEEK) 
sleeve, ferrule and nut. The column was packed with Macrosphere C18 material with a 
300 Å pore size and 5 μm particle diameter (Alltech Associates, Inc.). A 10 mg/ml 
solution of this packing material was prepared in a solvent solution of 90% ACN and 
10% water. Prior to column packing, the solution slurry was sonicated and thoroughly 
stirred to assure homogeneity. The column was packed in-house under helium gas 
pressure (1000 psi) using a specially designed stainless steel reservoir, also known as a 
column bomb (Figure 1.2.3). 
 
Instrumentation 
A Hewlett Packard LC system (1100 series) with a home-made C18 reversed 
phase capillary LC column was employed in the separation of aldehyde derivatives for 
quantitative analysis. A mobile phase mixture of water and ACN, each containing 0.1% 
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Figure 1.2.3. LC column packing scheme. A 15 cm length reversed-phase column was 
packed with 5 μm (300 Å) macrosphere C18 particles. 
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formic acid, was used in all experiments. The acid assisted in enhancing chromatographic 
peak shape and provided a source of protons in reversed-phase LC/MS. The binary pump 
of the HPLC offered gradient generation by high-pressure mixing. Programmed gradient 
elution was utilized in these experiments to enhance the separation of analytes. Each 
experiment, lasting one hour, was begun with a large excess of the weak eluting solvent 
water in the mobile phase, followed by steady additions of increasing proportions of the 
strong eluting solvent acetonitrile (ACN) during the course of the separation. For the first 
2 minutes of a given run, the mobile phase composition was kept at 5% ACN. In the next 
8 minutes, the proportion of ACN was linearly increased to 20%. Another linear increase 
in percent ACN occurred for 20 more minutes to reach a concentration of 70%. In the 
following 20 minutes, the percent ACN was linearly changed to 90%. During the last 5 
minutes of the run, ACN content rose, once again linearly, to a maximum concentration 
of 95%. The column was restored to starting mobile phase conditions prior to beginning 
the next run (Figure 1.2.4). 
LC solvent flow rate was maintained at 4 μL/min throughout the course of each 
chromatographic experiment using a laboratory constructed 50 to 1 splitter between the 
pump and injector. Manual injections were performed with a six-port Rheodyne injection 
valve (model # 7725i) equipped with a 5 μL sample loop.  
A Finnigan LCQ Classic quadrupole ion trap mass spectrometer was interfaced to 
the LC system for reversed phase LC-MS/MS analyses (Figure 1.2.5). Samples with 
derivatized aldehydes were introduced into the LCQ following LC separation or by direct 
infusion in which case no chromatographic separation was achieved. The electrospray 
source was operated in positive ion mode. Desolvated ions migrated from the source into 
the ion trap, guided by several electrostatic focusing elements, including octopole lenses. 
Ions in the ion trap were subjected to mass analysis, sequentially ejected and detected by 
an electron multiplier. 
 
Tuning LCQ Parameters 
Dimethyl CHD heptanal was infused into the LCQ mass spectrometer and 
instrument parameters, such as lens offsets, capillary voltages, etc., were tuned for this 
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Figure 1.2.4. HPLC method. 
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Figure 1.2.5. Functional block diagram of the Finnigan LCQ system. Broad, single 
headed arrows represent flow of sample molecules through the instrument. Narrow, 
double headed arrows represent electrical connections. 
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compound to improve the quality of LC-MS/MS data obtained for aldehyde derivatives. 
Electrospray source parameters were tuned to the following values: 4 kV applied voltage, 
20 arbitrary units of sheath gas flow, 45 V inlet capillary voltage and 175oC inlet 
capillary temperature. Other mass spectrometric parameters were as follows: 37 V tube 
lens offset, -5 V multipole 1 offset, -9 V multipole 2 offset, 430 Vp-p multipole rf 
amplitude, -15 V lens voltage and -10 V trap dc offset. Similar values were assumed for 
the other derivatives. 
 
Results and Discussion 
 
 Initial experiments were performed to determine retention times for the aldehyde 
derivatives. In data-dependent scanning, the instrument acquires a full scan mass 
spectrum, evaluates the relative intensities of ions in a given mass range, then isolates the 
ion with the highest intensity for fragmentation and analysis (MS/MS mode). Masses 
utilized as precursors for MS/MS experiments are placed on an exclusion list and are not 
sampled again for a pre-selected time window. CHD, methyl CHD and dimethyl CHD 
derivatives of standard aldehyde solutions and several brain tissue samples with 
derivatized aldehydes (SMTG), were analyzed in this manner. Apart from its simplicity 
and compatibility with LC-MS/MS analyses, the Hantzsch reaction offers a high 
efficiency (above 90%), which was well suited for these studies (100). 
After determining the retention times for each derivatized aldehyde peak, method 
files for segmented analysis were constructed to perform MS/MS analysis on the 
aldehyde derivatives. In segmented analysis, acquisition time is divided into segments for 
exclusive MS/MS analysis of particular analytes. This offers a dramatically improved 
signal-to-noise ratio and the isolation of the desired species in this manner for exclusive 
MS/MS analysis is a means of ion purification. When a species is isolated for segmented 
analysis, several parameters must be considered and enhanced for spectral data 
improvement. It is also desired to obtain as much of the product ions as possible without 
completely obliterating the parent species. Therefore, upon establishing the time-
windows for segmented analysis of the aldehyde derivatives through data-dependent 
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studies, other parameters such as percent normalized collision energy (percent NCE or 
percent CID) and CID time were explored to improve the data from such experiments. 
This, in conjunction with tuning the ion trap as described in the Experimental section, 
enabled improved LC/MS analysis of aldehyde derivatives. 
As was discussed in Chapter 1.1, the resonance excitation process is used to 
induce fragmentation in an ion trap. Upon increasing the amplitude of the applied 
supplemental rf voltage, the precursor ion dissociates to fragments over a narrow energy 
range. The collision energy needed to achieve optimum fragmentation has a mass 
dependency, which is compensated by the LCQ as normalized collision energy. In other 
words, CID is the amplitude of the resonance excitation rf voltage scaled to the precursor 
mass as follows: rf amplitude = (%CID/30%)(precursor ion mass × tick amp slope + tick 
amp intercept). The tick amp slope and tick amp intercept are instrument-specific values. 
CID time is the time during which the resonant rf signal is applied to the end-cap 
electrodes for ion excitation. The rf voltage causes increased ion motion between the end-
caps, leading to fragmentation by increased collisions with helium gas. Infusion studies 
measuring ion intensity as a function of percent CID and CID time were performed to 
determine suitable conditions for segmented analysis of aldehyde derivatives.  
Aldehyde derivative solutions (nanograms per microliter) were infused into the 
LCQ at a rate of 3 μl/min. Percent CID and CID time were separately ramped in 
increments of 5% from 0 to 100% while acquiring data on precursor and product ion 
intensities. Each data point represents an average of approximately thirty mass spectral 
scans. A plot of precursor and product ion intensities as a function of percent CID and 
CID time revealed the values of these parameters at which most of the precursor was 
converted into products. For the ion intensity versus percent CID plot of dimethyl CHD 
heptanal (Figure 1.2.6), conversion of precursor to products at higher collision energies 
was about 80%. A similar situation was observed when varying ion intensity with CID 
time for this species (Figure 1.2.7). At 38% CID and 30 ms CID time, most (>95%) of 
the precursor ion current was converted into products, with a little precursor species 
remaining intact. Indeed, all the aliphatic aldehydes provided similar responses.  
In the case of ion intensity versus percent CID for dimethyl CHD acrolein, 
approximately 50% of precursor ion current was converted to products (Figure 1.2.8) 
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Figure 1.2.6. Ion intensity versus percent CID curve for dimethyl CHD heptanal. Data 
represents a single infusion experiment. Each data point is an average of thirty mass 
spectral scans. 
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Figure 1.2.7. Ion intensity versus CID time (ms) for dimethyl CHD heptanal. Data 
represents a single infusion experiment. Each data point is an average of approximately 
thirty mass spectral scans. 
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Figure 1.2.8. Ion intensity versus percent CID curve for dimethyl CHD acrolein. Data 
represents a single infusion experiment. Each data point is an average of approximately 
thirty mass spectral scans. 
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while in the case of the HNE derivative, only a third of the precursor ion current resulted 
in product formation (Figure 1.2.9). It is possible that some major products are below the 
low-mass cutoff of the ion trap and are therefore not detected. 
All aldehyde derivatives required similar percent CID (~38%) and CID times 
(~30 msec) for LC/MS analysis. Using the optimized parameters for aldehyde derivatives 
in the mass spectrometric methods resulted in >95% reduction in precursor ion counts 
and subsequent conversion to products. 
 
Data from Segmented Analysis 
 Segmented MS/MS analysis of aldehyde derivatives worked very well with LC 
gradient elution. The binary mobile phase system of water and acetonitrile generated 
well-resolved chromatograms for all the analytes. Gradient elution is particularly useful 
when the mixture of solutes to be analyzed has a wide range of capacity factors (ratio of 
analyte masses in the stationary phase and mobile phase). This was the case in the 
analytes described here, as the larger aldehyde derivatives were more hydrophobic and 
had greater retention times compared to their smaller counterparts. Starting mobile phase 
composition for every LC run was 5% ACN. It is important to start the gradient with 
some organic content in the mobile phase, especially for C18 columns, where the very 
long, very hydrophobic alkyl chains can mat down on the silica particle in an effort to get 
away from the high aqueous environment. When the alkyl chains mat down in this 
manner, they are unable to efficiently capture the target analyte, reducing the overall 
efficiency of the separation.  
 CHD, methyl CHD and dimethyl CHD aldehydes were studied using segmented 
analysis. The dimethyl CHD derivatized aldehydes offered the best data in terms of 
chromatographic peak quality. A possible explanation for this observation is that the 
greater hydrophobic nature of the dimethyl CHD derivatives promoted increased 
chromatographic focusing at the head of the column, thereby reducing peak width and 
improving the overall separation process. As such, this derivative was used exclusively 
for all further experiments.
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Figure 1.2.9. Ion intensity versus percent CID curve for dimethyl CHD HNE. Data 
represents a single infusion experiment. Each data point is an average of approximately 
thirty mass spectral scans. 
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Chromatographic Data 
The aliphatic aldehyde derivatives displayed increasing retention times with 
increasing mass of aldehyde derivative (Figure 1.2.10) in good agreement with the rise in 
hydrophobicity associated with greater mass. Reconstructed ion chromatograms for 
dimethyl CHD methanal to dimethyl CHD heptanal formed a stair-step of peaks. For the 
unsaturated aldehydes, dimethyl CHD acrolein had a shorter retention time than dimethyl 
CHD HNE, as was expected due to the increased mass of the latter (Figure 1.2.11). 
Indeed, the acrolein and propanal derivatives showed similar retention times, in 
agreement with their similar masses. Keeping with this hydrophobicity trend, the internal 
standard for unsaturated aldehydes, dimethyl CHD octanal, had the longest retention time 
of all. The R group (Figure 1.2.2) of dimethyl CHD HNE has a hydrophilic –OH group at 
the γ position from the dimedone ring which reduces its hydrophobicity compared to 
aliphatic derivatives of similar size. So, this species has a shorter retention time than 
dimethyl CHD heptanal, which has a 6-carbon chain and no hydroxyl moiety. 
 
Mass Spectrometric Data 
The aliphatic aldehyde derivatives fragmented in a characteristic pattern to 
produce a base peak of either m/z 273 or 274, depending on the size of the R group 
derived from the precursor aldehyde. The MS/MS spectra of aliphatic aldehyde 
derivatives is shown in Figure 1.2.12. For smaller aldehyde derivatives (C1-C4), the 
appearance of m/z 273 was consistent with a simple C-C bond dissociation between the 
dimedone group and the R group, followed by neutral loss of a saturated R radical. For 
larger aldehyde derivatives (C5-C8), a hydrogen rearrangement followed by cleavage of 
the (R-H) group became more feasible. For these derivatives, the C-H bond dissociation 
energies of 2o carbon atoms in the R group were sufficiently low enough for a base peak 
of m/z 274 to be generated as a result of the loss of an unsaturated (R-H) species (137). 
For all the derivatives, the major bond cleavage was between the R group derived from 
the original aldehyde and the heterocyclic ring from the derivatizing agent, with the latter 
retaining the charge at the nitrogen atom. Dimethyl CHD acrolein fragmented to produce 
a base peak at m/z 272, which appeared to be the loss of ethylene from the precursor 
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Figure 1.2.10. Segmented chromatograms of dimethyl CHD aliphatic aldehydes. 
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Figure 1.2.11. Segmented chromatograms of dimethyl CHD unsaturated aldehydes.
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Figure 1.2.12. MS/MS spectra of dimethyl CHD aliphatic aldehydes. 
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species. In the case of dimethyl CHD HNE, the base peak was at m/z 339 but a 
significant peak was also observed at m/z 382 (Figure 1.2.13). It is probable that m/z 382 
was produced from the loss of water with a subsequent loss of 43 amu (equivalent in 
mass to a propyl radical) resulting in the formation of the m/z 339 species. Mass 
spectrometric data for all aldehyde derivatives is summarized in Table 1.2.1. Mechanistic 
studies would be required to confirm fragmentation pathways. 
 
Construction of Calibration Plots 
Prior to proceeding with quantitative analysis, standard dimethyl CHD heptanal 
solutions of increasing concentrations were analyzed by segmented LC-MS/MS to 
determine the linearity of a plot of area counts versus concentration. Each solution was 
analyzed in triplicate to obtain standard deviation data. Figure 1.2.14 demonstrates that 
the plot was linear and so the heptanal derivative was a good choice for an internal 
standard in these experiments. Additionally, neither heptanal nor octanal are present in 
brain tissues to any significant concentrations, minimizing concerns regarding 
contributions of these aldehydes to internal standard peak areas (62). Due to similarity in 
structure, the octanal derivative produced a similar response.  
For each of the standardized solutions of increasing concentration prepared for 
aliphatic and unsaturated aldehyde derivatives, segmented analysis was performed in 
triplicate. The area counts of aldehyde derivative ‘X’ was divided by the area counts of 
internal standard to obtain the relative response factor (RRF) of aldehyde derivative ‘X’ 
with respect to its internal standard. Calibration plots were constructed by plotting the 
RRF of each aldehyde derivative versus the number of picograms on column delivered in 
each LC-MS/MS experiment. A review of the literature indicated that the lowest 
concentration of biogenic aldehydes in human brain is on the order of 0.02 nmol/mg 
protein (49, 75). Such levels were well-represented in the calibration plots presented here. 
For acrolein, 0.02 nmol/mg protein delivered ~15 pg on column. The calibration plot for 
this aldehyde derivative had one data point below this value.
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Figure 1.2.13. MS/MS spectra of dimethyl CHD unsaturated aldehydes. 
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Table 1.2.1. Mass spectrometric data of dimethyl CHD aldehyde derivatives.  
 
Aldehyde MW 
Parent 
Molecular Ion 
of Derivative 
Product Ion 
from Frag. Neutral Loss from Fragmentation 
Methanal 30 [M+H]+ = 274 m/z = 273 -- -- 
Ethanal 44 [M+H]+ = 288 m/z = 273 CH3 MW = 15 
Propanal 58 [M+H]+ = 302 m/z = 273 C2H5 MW = 29 
Butanal 72 [M+H]+ = 316 m/z = 273 C3H7 MW = 43 
Pentanal 86 [M+H]+ = 330 m/z = 274 C4H8 MW = 56 
Hexanal 100 [M+H]+ = 344 m/z = 274 C5H10 MW = 70 
Heptanal 114 [M+H]+ = 358 m/z = 274 C6H12 MW = 84 
Octanal 128 [M+H]+ = 372 m/z = 274 C7H14 MW = 98 
Acrolein 56 [M+H]+ = 300 m/z = 272 C2H4 MW = 28 
HNE 156 [M+H]+ = 400 m/z = 382, 339 H2O, C3H7 MW = 18, 43 
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Figure 1.2.14. Average area counts versus concentration plot for dimethyl CHD heptanal. 
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The aliphatic aldehyde derivatives produced linear calibration plots with r2 values 
≥ 0.99 and relative standard deviations (RSD) of approximately ≤ 5% (Figures 1.2.15 to 
1.2.20). The RRF values for these derivatives were comparable, with a slight trend 
towards lower RRFs with increasing aldehyde derivative mass, in agreement with their 
similarities in structure. The ethanal derivative showed a somewhat higher response 
factor compared to the others. The greatest RRFs would probably have been expected of 
the methanal derivative, which has the smallest mass. It should be noted, however, that 
methanal, which is a 37% stock solution, can exist in the form of other species, such as 
paraformaldehyde, which may not derivatize efficiently through the Hantzsch reaction or 
perhaps form different derivatives. This was evidenced by the observation of several 
‘extraneous’ peaks at earlier retention times in the reconstructed ion chromatogram for 
dimethyl CHD methanal. As such, it may be that a somewhat lower proportion of the 
methanal (compared to the calculated value) is actually partaking in the derivatization 
process to form the desired heterocyclic derivative. In other words, if the stock methanal 
solution was indeed 37% ‘pure methanal’, then this derivative would probably have 
produced the highest RRF values compared to the other aliphatic aldehyde derivatives. 
Calibration plots for unsaturated aldehyde derivatives were linear and with r2 and 
RSD values comparable to their aliphatic counterparts (Figures 1.2.21 and 1.2.22). The 
HNE derivative had a much lower RRF than the acrolein derivative, in agreement with 
data from infusion studies (Figures 1.2.8 and 1.2.9). It should be noted that the area 
counts versus percent CID infusion experiment for dimethyl CHD HNE generated 
product ion curves at much lower intensity values (about a third of the initial ion intensity 
of the precursor species at low percent CID) compared to the acrolein derivative. Data 
from calibration plots for all the aldehyde derivatives are given in Table 1.2.2. 
These calibration plots can be employed in the analysis of real tissue that has been 
subjected to oxidative stress for aldehyde content determination. As an example of how 
this methodology may be applied towards this purpose, brain samples (SMTG) from an 
AD subject and a suitable age-matched control (blind experiment) were analyzed in 
triplicate as described above. Data from these findings are summarized in Table 1.2.3. 
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Figure 1.2.15. Calibration plot for dimethyl CHD methanal. 
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Figure 1.2.16. Calibration plot for dimethyl CHD ethanal. 
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Figure 1.2.17. Calibration plot for dimethyl CHD propanal. 
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Figure 1.2.18. Calibration plot for dimethyl CHD butanal. 
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Figure 1.2.19. Calibration plot for dimethyl CHD pentanal. 
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Figure 1.2.20. Calibration plot for dimethyl CHD hexanal. 
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Figure 1.2.21. Calibration plot for dimethyl CHD acrolein. 
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Figure 1.2.22. Calibration plot for dimethyl CHD HNE. 
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Table 1.2.2. Calibration plot data for dimethyl CHD aldehydes. 
 
Aldehyde r2 pg on col. ald. deriv. RRF
* RSD** Aldehyde r2 pg on col. ald. deriv. RRF* RSD** 
11.3 0.65 3.72 % 6.5 0.19 5.29 % 
113 1.40 3.10 % 52 0.29 5.92 % 
226 1.85 3.06 % 130 0.61 4.87 % 
564 2.94 2.67 % 259 1.06 4.80 % 
1128 5.03 2.68 % 389 1.46 3.74 % 
1804 7.41 1.67 % 648 2.22 4.84 % 
methanal 0.997 
   
acrolein 0.999 
907 3.10 2.33 % 
8.5 0.31 5.27 % 6.4 0.01 5.79 % 
67 0.76 4.74 % 51 0.03 5.39 % 
167 1.24 3.70 % 128 0.05 4.56 % 
334 2.03 1.85 % 256 0.08 3.56 % 
501 2.87 2.51 % 384 0.09 3.42 % 
835 4.48 2.85 % 639 0.16 3.90 % 
ethanal 0.999 
1169 6.23 2.87 % 
HNE 0.996 
895 0.22 3.46 % 
7.1 0.28 5.31 %    
57 0.47 5.93 %    
143 0.92 4.35 %    
286 1.36 2.87 %    
429 1.74 2.70 %    
716 2.63 2.95 %    
propanal 0.995 
1002 3.50 2.90 % 
  
   
5.9 0.05 4.71 %    
59 0.12 3.36 %    
118 0.25 1.00 %    
294 0.91 3.41 %    
588 1.80 2.88 %    
940 2.89 2.13 %    
butanal 0.996 
1175 3.95 2.01 % 
  
   
6.1 0.06 5.82 %    
61 0.13 5.35 %    
122 0.21 3.68 %    
306 0.94 3.11 %    
612 1.73 2.66 %    
979 3.13 1.72 %    
pentanal 0.996 
1224 3.72 2.94 % 
  
   
6.5 0.02 4.77 %    
65 0.12 4.83 %    
129 0.18 4.56 %    
323 0.76 3.33 %    
646 1.67 0.94 %    
1033 2.98 2.94 %    
hexanal 0.996 
1292 3.82 1.97 % 
  
   
*Relative Response Factor    **Relative Standard Deviation 
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Table 1.2.3. Comparison of aldehyde concentrations in the brains (superior and middle 
temporal gyrus or SMTG) of AD versus control subjects. 
 
Aldehyde 
Subject with AD 
(nmol/mg protein) 
Mean ± SEM 
Age-Matched Control 
(nmol/mg protein) 
Mean ± SEM 
methanal 133 ± 20 290 ± 39 
ethanal 173 ± 21 175 ± 27 
propanal 84.9 ± 14.5 91.0 ± 14.7 
butanal 6.29 ± 1.09 8.42 ± 0.93 
pentanal 9.99 ± 1.56 11.4 ± 2.0 
hexanal 56.9 ± 5.7 13.8 ± 1.7 
acrolein 1.45 ± 0.21 0.475 ± 0.077 
HNE 0.550 ± 0.106 0.209 ± 0.039 
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Aldehyde content per milligram of protein from the brain tissue was reported as the mean 
value ± SEM (standard error of the mean). The AD sample showed similar levels of most 
aliphatic aldehydes and higher levels of unsaturated aldehydes, compared to the control. 
It is worth pointing out that AD development has been related to increased production of 
unsaturated aldehydes, in agreement with these findings (49, 50, 62, 68). The results 
indicated that the protocol outlined here can be effectively applied in aldehyde 
quantification in real tissues. Investigations on a larger set of tissues from various regions 
of the brain and from individuals presenting different levels of AD histopathology will 
provide an understanding on patterns of aldehyde generation in AD versus control 
subjects. 
 
Conclusions 
 
These studies aimed to develop sensitive, selective and reliable methods to 
analyze aldehydes in tissues using LC-MS/MS. It was shown that aldehydes typically 
found in brain tissues plagued by oxidative stress can be derivatized through the 
Hantzsch reaction to form cyclohexanedione (dimedone) derivatives, which can easily be 
quantified by MS. CHD, methyl CHD and dimethyl CHD derivatives were explored and 
it was determined that the dimethyl CHD derivatives provided the best LC/MS data. 
These compounds offered better peak quality due to their increased hydrophobicity, 
which resulted in greater chromatographic focusing of the sample at the head of the 
column. Analyte derivatization coupled with LC-MS/MS provided increased selectivity 
over established fluorescence methods (62, 98-101) for the analysis of low abundance 
biogenic aldehydes. Unsaturated aldehydes occur in the brain at much lower 
concentrations than their aliphatic counterparts and LC-MS/MS proved to be an ideal 
method for analyzing these two classes of compounds using two internal standards 
differing in concentration by an order of magnitude. 
The developed method was applied to the analysis of samples of human brain 
(SMTG) from an AD patient and an age-matched control subject. In comparison to the 
control sample, the tissue obtained from the AD subject displayed similar concentrations 
of most aliphatic aldehydes, however, substantially elevated levels of acrolein and HNE 
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were detected. These results confirm that the protocol described here can be reliably 
applied in the quantification of aldehydes in brain tissue. Concentration variations of 
aliphatic and unsaturated aldehydes have been investigated using the methodology 
outlined here by exploring a larger data set of AD and control subjects, as well as by 
investigating several different regions of the brain, based on the level of AD pathology. 
The findings from this study are detailed in Chapter 1.3. 
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Chapter 1.3 
Application of LC-MS Techniques to the Quantification of Biogenic Aldehydes in 
vivo in Alzheimer’s Disease Brain 
 
Introduction 
 
Several different types of neurodegenerative conditions, such as AD, Parkinson’s 
disease and Huntington’s disease, are associated in etiology by the significant prevalence 
of lipid peroxidation (LPO) products in the brain (50). The importance of biogenic 
aldehydes in LPO and therefore neurodegenerative disease etiology has been well 
established by mounting evidence of neuronal damage that they initiate. These 
compounds could potentially serve as important biomarkers for AD and as such, a 
detailed study of their occurrence and quantification would be worthwhile. Of the 
different aldehyde derivatization techniques available for quantitative analysis, the 
Hantzsch reaction is well-suited by virtue of its simplicity and efficiency. Quantification 
is achieved with a suitable internal standard, using a variety of detection methods, as 
detailed in Chapters 1.1 and 1.2. Several reports have described the quantitative analysis 
of saturated and unsaturated biogenic aldehydes using this derivatization technique. 
Lovell et al. (62) analyzed aldehydic markers of lipid peroxidation in biological 
specimens by high-pressure liquid chromatography. Biogenic straight-chain aldehydes 
and HNE were first derivatized through the Hantzsch reaction so as to make them 
amenable to fluorescence detection. The authors showed aldehydic products to be well-
separated and minimum detection limits achieved for HNE were approximately 0.1 pmol. 
Shot to shot reproducibility of standard HNE solutions was about 3-5%, with a signal to 
noise ratio of the order of 50. The authors postulated that their results reflected levels of 
both free and protein-bound aldehydes. A potential problem associated with this type of 
analysis is the co-elution of other compounds with the aldehydes under investigation. 
However, the authors maintained that since the derivatization is dependent on the 
reaction between the aldehydic group and the β-dicarbonyl compounds, it was unlikely 
that other compounds without aldehydic groups would be derivatized. 
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Markesbery et al. (50) employed HPLC separation coupled to fluorescence 
detection to quantify HNE levels in multiple regions of the AD brain and suitable age-
matched controls. Biogenic aldehydes in brain samples were chemically modified into 
stable, fluorescent, dimedone derivatives through the Hantzsch reaction for facile 
detection and quantification. The authors detected statistically significantly elevated 
levels of this aldehyde in the amygdala in AD (0.486 ± 0.096 nmol/mg) compared to 
controls (0.193 ± 0.062 nmol/mg) (p = 0.008) and in the hippocampus and 
parahippocampal gyrus in AD (0.543 ± 0.123 nmol/mg) compared to controls (0.265 ± 
0.056 nmol/mg) (p = 0.02). Such areas of the brain typically show the most dramatic 
histopathological alterations in AD. The highest mean levels of the aldehyde (AD: 1.490 
± 0.376 nmol/mg; control: 1.404 ± 0.363 nmol/mg) were detected in the middle frontal 
gyrus. The authors also quantified several aliphatic aldehydes but found no statistical 
difference between AD and control subjects. The study demonstrated that HNE may be 
an important substance in the pathogenesis of neuron degeneration in AD. 
 In another report by Markesbery and co-workers (51), elevated HNE levels were 
detected and analyzed in the ventricular fluid of AD patients. Using HPLC separation 
coupled with fluorescence detection of dimedone derivatives of this aldehyde, free and 
protein-bound HNE levels were quantified in AD and control subjects. Free HNE levels 
were found to be significantly elevated in the ventricular fluid of individuals with AD 
(33.10 ± 8.9 nmol/mg protein), compared to control subjects 13.5 ± 3.8 nmol/mg protein) 
(p = 0.0096). The authors also employed dot-blot immunoassay to determine protein-
bound HNE and reported that there were no significant differences between AD and age-
matched controls. The levels of HNE in ventricular fluid observed in this study can 
potentially affect a host of molecular systems essential for neuron viability. The authors 
concluded that their results indicated increased lipid peroxidation in the AD brain and 
suggested a role for HNE in neurodegenerative mechanisms. 
 Mark et al. (75) explored the influence of HNE in oxidative stress, the disruption 
of ion homeostasis and neuronal death brought about by the amyloid β-peptide (Aβ25-35). 
To determine whether Aβ induced production of HNE in hippocampal neurons, they 
exposed primary hippocampal cell cultures (18-day rat embryos) to 50 μM Aβ for 2 h 
and quantified the levels of free HNE in the cells by HPLC analysis with fluorescence 
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detection of dimedone derivatives. A 5- to10- fold increase in HNE concentration was 
observed as a result of the Aβ exposure, compared to control samples. The concentration 
of HNE in these cells was measured at ~4 μM. Western blot analysis of Aβ-exposed 
cultured neurons treated with physiologically dangerous HNE concentrations revealed 
increased HNE immunoreactivity in proteins, compared to controls. Since HNE had 
previously been established to be neurotoxic at physiologically relevant concentrations of 
1-100 μM, the authors concluded that this aldehyde mediated Aβ-induced oxidative 
damage and eventual neuronal apoptosis. 
 Compared to HNE, there have been considerably fewer reports on the 
quantification and analysis of acrolein in association with neurodegenerative diseases. In 
a noteworthy study by Lovell et al. (49), this aldehyde was quantified in AD brain tissue 
and its effect on primary hippocampal cultures was investigated. As with other studies 
described earlier, aldehyde quantification was achieved by HPLC with fluorescence 
detection of dimedone derivatives. Increased mean concentrations of extracted acrolein 
were detected in all three brain regions studied, in comparison to age-matched controls. 
Statistical analysis of the data clearly demonstrated that acrolein was considerably 
elevated (p < 0.05) in the AD amygdala (2.5 ± 0.9 nmol/mg protein) compared to controls 
(0.3 ± 0.05 nmol/mg protein), and in the AD hippocampus and parahippocampal gyrus 
(5.0 ± 1.6 nmol/mg protein), compared to controls (0.7 ± 0.1 nmol/mg protein). Both 
these brain regions are characterized by marked pathological alterations in AD. Acrolein 
was also seen to be elevated in the AD inferior parietal lobule, although the disparity was 
not considered statistically significant. By exposing primary rat hippocampal neurons to 
increasing concentrations of acrolein, the authors demonstrated that this aldehyde is toxic 
to the cells in a time-and concentration-dependent manner. Indeed, neuronal death was 
shown to be brought about much more aggressively by acrolein exposure, compared to 
HNE exposure. 
A thorough, quantitative study of biogenic aldehydes in different regions of the 
brain at different stages of AD would provide insight into patterns of aldehyde generation 
in the course of AD etiology. While there have been studies of HNE and acrolein in late-
stage AD, there have been few studies of oxidative stress in the brain in subjects with 
mild cognitive impairment (MCI) or early AD (EAD). Mild cognitive impairment is 
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generally characterized by mild memory disturbances and is considered to be a transition 
between normal aging and AD (138-140). To determine if increased lipid peroxidation 
and generation of HNE and acrolein are associated with MCI and EAD, we measured 
levels of these neurotoxic aldehydic by-products in the hippocampus/parahippocampal 
gyrus (HPG), superior and middle temporal gyrus (SMTG) and cerebellum of MCI, EAD 
and age-matched control subjects. The methodology used in these investigations, 
described in Chapter 1.2, exploited the Hantzsch reaction to synthesize derivatized 
aldehyde mixtures for constructing appropriate calibration curves to quantify each 
aldehyde of interest (111). Since both aliphatic and unsaturated aldehydes are generated 
during lipid peroxidation, we described the analysis of both types of compounds with this 
approach. Interpretation of quantitative data from the different brain regions is provided 
and an explanation of their statistical significance is given. This is the first study to report 
an in-depth comparison of aldehyde levels between these three types of individuals. For 
the development of diagnostic tests and medication for AD, a thorough appreciation of 
the pathological and biochemical differences between MCI, EAD and normal subjects is 
becoming critical. In agreement with previous findings, we detected no statistical 
significance in the distribution of aliphatic aldehydes in the different brain regions and 
stages of AD under investigation. However, in agreement with earlier studies, the results 
presented here clearly show that HNE and acrolein are statistically significantly elevated 
in both MCI and EAD brain and suggest that oxidative damage occurs early in the 
pathogenesis of AD. 
 
Experimental 
 
Tissue Specimens  
 Specimens of HPG, SMTG and CER were obtained from short post mortem 
interval (PMI) autopsies of 7 subjects with MCI (3M, 4F), 6 subjects with EAD (3M, 3F), 
and 7 age-matched control subjects (5M, 2F). Specimens were immediately frozen in 
liquid nitrogen and stored at -80ºC until used for analysis. Control subjects were followed 
longitudinally in the control clinic of the University of Kentucky Alzheimer’s Disease 
Center (UK-ADC) and had neuropsychologic testing annually and physical examinations 
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biannually. All control subjects had neuropsychologic scores in the normal range and 
showed no evidence of memory decline. Subjects with MCI and EAD were derived from 
the control cohort and were followed longitudinally in the memory disorders clinic of the 
UK-ADC. 
The clinical criteria for diagnosis of amnestic MCI were those of Peterson et al. 
(139) and included: (a) memory complaints, (b) expected memory impairment for age 
and education, (c) normal general cognitive function, (d) intact activities of daily living 
(ADLs), and (e) the subject did not meet criteria for dementia. The clinical criteria for 
EAD were: (a) a decline in cognitive function from a previous higher level, (b) declines 
in one or more areas of cognition in addition to memory, (c) a clinical dementia rating 
score of 0.5 to 1 and (d) a clinical examination that excluded other causes of dementia. 
Objective memory test impairment was based on a score of ≤ 1.5 standard deviations 
from the mean of controls on the Consortium to Establish a Registry for Alzheimer’s 
Disease (CERAD) Word List Learning Task (141). In several cases, the data were 
corroborated with the Free and Cued Selective Reminding Test (FCSRT). CERAD was 
established in 1986 by a grant from the National Institute of Aging (NIA) to standardize 
procedures for the evaluation and diagnosis of patients with AD. The CERAD test battery 
includes measures in the areas where impairments associated with AD first occur (verbal 
memory, naming) and is highly reliable for assessing memory dysfunction (142). The 
FCSRT is also a list-learning test which includes immediate category-cued recall and 
provides retrieval practice before the test phase. 
 
Tissue Staining 
Histopathologic examination of sections of neocortex, hippocampus, entorhinal 
cortex, amydgala, basal ganglia, nucleus basalis of Meynert, midbrain, pons, medulla and 
cerebellum were performed by staining with hematoxylin and eosin, the modified 
Bielschowsky stain, 10D-5 (for beta amyloid) and α-synuclein.  
 Hematoxylin and Eosin: This staining method employs two dyes – hematoxylin 
and eosin. A hematoxylin-metal complex, dark purple in color, acts as a basic dye and 
stains nucleic acids in the nucleus and the cytoplasm dark blue, brown or black. Eosin is 
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an acidic aniline dye which imparts a pink color to the more basic proteins within the 
cytoplasm and extracellular spaces. (143). 
 Bielschowsky Stain: This is a silver stain to determine the presence of NFTs, 
nerve fibers and SPs in the AD brain. A silver solution is employed to sensitize nerve 
fibers. The sections undergo treatment with ammoniacal silver and are then reduced to a 
visible metallic silver. Degenerating axons, NFTs and SPs develop a black stain and the 
background becomes yellow to brown (144). 
 10D-5:  The 10D5 monoclonal antibody-DAB immunoperoxidase technique 
enables the detection of SPs in the AD brain. 10D-5 is an antibody to the Aβ peptide, 
which is the key component of SPs (145). 
 Alpha-Synuclein: This is a normal, unstructured and soluble protein commonly 
found in the brain. The function is unknown but it predominantly occurs as presynaptic 
neuronal protein and is sometimes detected in glial cells. Alpha-synuclein is a marker for 
Lewy bodies, pathologic feature in substantia nigra seen in Parkinson's disease and in 
neocortical regions of subjects with mixed Alzheimer's disease and Lewy body 
pathology. (146). 
All of these staining experiments revealed only age-associated changes in the 
brain tissues in control subjects. 
 
Staging of AD Pathology in Subjects 
Braak Staging Scheme: The Braak method was employed for staging the severity 
of AD pathology in the brain tissues. This method, developed by Braak and Braak (147, 
148), makes the assumption that the prevalence and nature of NFTs in the AD brain 
develops in a progressive and specific manner in the medial temporal lobe (MTL), 
subcortical nuclei and neocortical areas of the brain. A higher Braak score indicates 
greater spread of Alzheimer’s pathology in the brain and vice versa. Six stages have been 
detailed, with a seventh stage or Stage 0, representing the absence of NFTs in the brain. 
The six stages can be collapsed into three stages. Stages I and II are the transentorhinal 
stages in which NFT pathology is in effect restricted to the transentorhinal and entorhinal 
cortex. Slight pathology may be observed in the CA1/CA2 regions of the hippocampus. 
In the limbic stages or Stages III and IV there is acute participation of the entorhinal 
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areas, modest pathology in the hippocampus and some expansion into the amygdala, 
thalamus, hypothalamus and basal forebrain. Symptoms of AD pathology usually appear 
in the neocortical stages or Stages V and VI. At this point, extensive NFT pathology is 
seen in the neocortex.  
National Institute on Aging (NIA)-Reagan Institute Scheme: The NIA-Reagan 
Institute Consensus Conference proposed an AD progression scheme which can be used 
to corroborate the Braak scores. This scheme stresses topographic staging of both NFTs 
and SPs. It designates cases to categories of high, intermediate or low likelihood that the 
dementia is a result of AD (149). 
Control subjects in this study showed Braak staging scores of I and II and met the 
NIA-Reagan low likelihood criteria for the histopathologic diagnosis of AD. The major 
difference between normal controls and MCI patients was a significant increase in 
neuritic plaques in neocortical regions and an increase in neurofibrillary tangles in the 
amygdala, hippocampus and entorhinal cortex (150). MCI subjects demonstrated Braak 
staging scores of III-V and met intermediate likelihood criteria for the histopathologic 
diagnosis of AD. EAD subjects showed Braak staging scores of V and met high 
likelihood criteria for the histopathologic diagnosis of AD.  
 
Aldehyde Derivatization 
Aldehydes were extracted and derivatized with a stock 5,5-dimethyl-1,3-
cyclohexanedione derivatizing agent solution (0.25 g dimethyl CHD + 10 g ammonium 
acetate + 10 mL glacial acetic acid/100 ml water), as previously described (50, 98, 111). 
Briefly, 100 mg tissue was homogenized in 5 mL HEPES buffer (pH 7.4) containing 137 
mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4, and the protease inhibitors 
pepstatin (0.7 μg/mL), leupeptin (0.5 μg/mL), aprotinin (0.5 μg/mL) and 
phenylmethylsulfonyl fluoride (40 μg/mL) using a chilled Dounce homogenizer. 
Heptanal was chosen as the internal standard for the aliphatic and octanal for the 
unsaturated aldehydes. Octanal internal standard was added at a 10-fold lower 
concentration compared to heptanal so that solvent concentration of the final derivatized 
brain sample by 10 enabled accurate quantification of low abundance unsaturated 
aldehydes. Aliquots of homogenate (500 µL) were added to glass test tubes and mixed 
 97
with 500 µL of methanol containing 2 μM heptanal and 0.2 µM octanal (Wako Pure 
Chemical Industries, Ltd., Osaka, Japan) as internal standards. Samples were vortexed for 
30 sec for aldehyde extraction and centrifuged for 10 min at 850 x g. A 500 μL aliquot of 
supernatant was mixed with 1 mL of dimethyl CHD derivatizing reagent and heated in a 
60oC water bath for one hour. After cooling to room temperature, the reaction mixture 
was added to a C18 solid phase extraction (SPE) column (Fisher Scientific, Pittsburgh, 
PA) preconditioned with 10 mL methanol and 10 ml water. The column was washed with 
2 mL water to remove excess ammonium acetate and derivatized aldehydes were eluted 
with 2 mL methanol.  
In the interest of quality control, blank, spiked and duplicate analyses were 
performed for every brain region under investigation. Dimethyl CHD butanal was used as 
the aliphatic and dimethyl CHD acrolein as the unsaturated aldehyde for spiked analysis. 
As with the octanal internal standard for unsaturated aldehydes, acrolein was spiked at a 
10-fold lower concentration compared to butanal. 
 
 Instrumentation  
A Hewlett Packard 1100 series HPLC system was interfaced to a Finnigan LCQ 
Classic quadrupole ion trap mass spectrometer for reversed phase LC-ESI-MS/MS 
analyses. A mobile phase mixture of water and acetonitrile, each containing 0.1% formic 
acid, was used in all experiments. Details of HPLC gradient elution, LCQ instrument 
parameters and segmented LC-MS/MS analysis were as described previously (111). 
 
Statistical Treatment of Data 
 
Several statistical approaches were used to determine the significance of data 
obtained, including ANOVA with Dunnett’s post hoc test (ABSTAT software), 2-tailed-
t-test and the Mann-Whitney U-test. 
 
ANOVA with Dunnett’s post hoc Test 
ANOVA (analysis of variance) is a procedure to compare and contrast the means 
of three or more populations, by comparing their variances, for the purposes of 
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establishing whether or not they came from identical populations. In situations where 
there are more than two populations under investigation, the Student’s t test cannot be 
applied, making ANOVA very useful. There are three basic assumptions to ANOVA: 
• The populations are normally distributed 
• The populations have identical standard deviations (σ) 
• The samples are selected independently 
When these conditions are met, the F distribution is used as a test statistic. The null 
hypothesis (H0) is that the population means are the same. H0 would be rejected if the 
computed value of F is greater than the critical value. The strategy in ANOVA is to 
estimate the population variance by two separate methods and determine the ratio of 
these two estimates. If the ratio is close to 1, then the two estimates are the same and the 
population means are interpreted as being identical. If the ratio is different from 1, then it 
can be deduced that the population means are different. The F distribution determines 
when the ratio is too much different than 1 to have occurred by chance.  
 First, the sum of squares total (SStotal) is calculated. This is the sum of the squared 
differences between each observation and the overall mean: 
( )
n
X
XSStotal
2
2 ∑∑ −=  (1.3.1) 
  where,  ΣX2 = X values squared and then summed 
    (ΣX)2 = X values summed and then squared 
    n = total number of observations. 
Next, the sum of squares due to treatments (SStreatments), or the different populations under 
investigation, is determined: 
( )
n
X
n
TSS
T
T
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22 ∑∑ −⎟⎟⎠
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⎛
=  (1.3.2) 
  where,  TT = sum total for each treatment/population 
    nT = number of observations for each treatment/population. 
The sum of squares error (SSerror) is computed as follows: 
treatmentstotalerror SSSSSS −= . (1.3.3) 
Finally, the mean square for treatments (MStreatments) and error (MSerror) is determined: 
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1df
SSMS treatmentstreatments =  (1.3.4) 
2df
SSMS errorerror =  (1.3.5) 
  where,  df1 = number of treatments – 1 
    df2 = n – number of treatments. 
The F statistic is the ratio of the mean square for treatments and error: 
error
treatments
MS
MSF = . (1.3.6) 
The computed value of F is compared to the critical value to accept or reject the null 
hypothesis (151). 
 In situations when ANOVA shows a significant disparity between populations 
and one of the populations is a control, the Dunnett’s Test is used as a post hoc test. The 
technique allows for comparisons to be made between the experimental populations and 
the control population. However, it does not permit experimental populations to be 
compared to one another other. In an experiment consisting of a-1 treatments plus a 
control group, the Dunnett’s test can test each treatment against the control mean: 
 H0:  μ1 = μc 
 H0:  μ2 = μc 
 H0:  μ3 = μc 
 H0:  μa-1 = μc 
  where,  H0 = null hypothesis 
    μi = mean of experimental population i 
    μc = mean of control population. 
The q’ statistics are calculated as follows: 
Dunnett
ic
obs SE
q μμ −='  (1.3.7) 
( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛
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ci
errorDunnett nn
MSSE 11  (1.3.8) 
  where,  ni = total numbers in population i 
    nc = total numbers in control population. 
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The critical value of the q’ statistic (qcrit’) is compared to the calculated value (qobs’). At a 
given confidence level, if qcrit’ < qobs’, then the null hypothesis is accepted (152). 
 
2-Tailed-t-Test 
The Student’s t test is a parametric test to determine the significance between 
means of two sample sets or between a mean and a theoretical value. The test presumes 
that all data points are distributed normally and the ratio of variances in the two samples 
is ≤ 3. In a 2-tailed-t-test, the area α under the distribution curve is split in half, placing 
half in each tail. The null hypothesis (H0) in this case is a particular value and there are 
two alternative hypotheses (H1), one positive and one negative:  
 H0: μ = a 
 H1: μ ≠ a 
The critical value of t (tcrit), is written with both a plus and minus sign (±). For instance, 
the critical value of t when there are 10 degrees of freedom (df = 10) and α is set to 0.05, 
is tcrit = ± 2.228. The sampling distribution model used in a 2-tailed-t-test is given in 
Figure 1.3.1. When comparing the mean from a sample set to a theoretical or ‘true’ value, 
the critical value for rejecting the null hypothesis is as follows: 
N
tsa ±=−μ  (1.3.9) 
  where,  N = total number of measurements 
    t = statistical parameter 
    s = standard deviation 
    μ = mean of measurements 
    a = true value. 
 
The situation is slightly different when comparing the mean of one sample set to 
another, as in the case of Nx replicate analyses of X to yield a mean of μx and Ny analyses 
of Y to yield a mean of μy, the data being gathered in a similar manner. It can be 
considered that the standard deviations of the two measurement groups are identical. The 
2-tailed-t-test can be used to determine if differences in measurements of X and Y are the 
result of random errors or because they happen to be two different samples. The null 
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Figure 1.3.1. Regions of nonrejection and rejection for a 2-tailed-t-test. Significance 
level: 0.05. 
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hypothesis (H0) is that X and Y are the same and any disparity (μx - μy) is due to random 
errors (153). The standard error of the means μx and μy are expressed as the ratio of the 
standard deviation to the square root of the number of data points: 
x
x
mx N
ss =  (1.3.10) 
y
y
my N
s
s =  (1.3.11) 
  where,  smx = standard error of μx 
    smy = standard error of μy 
sx = standard deviation of x 
    sy = standard deviation of y. 
Therefore, the variance sd2 of the difference (d = x - y) between the two means is 
described as follows: 
222
mymxd sss += . (1.3.12) 
Inserting values of sd, smx and smy into this equation: 
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It can be supposed that the pooled standard deviation spooled is a reasonable approximation 
of both sx and sy: 
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Substituting into Eqn (1.3.9) generates the following: 
yx
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pooledyx NN
NN
ts
+
±=− μμ . (1.3.15) 
As such, the test value of t is given by: 
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 (1.3.16) 
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for, 2−+= yx NNdf . (1.3.17) 
This test value of t is compared with tcrit obtained from appropriate statistical tables for 
the desired confidence level. If │t│< tcrit, the null hypothesis holds true. If, on the other 
hand, │t│> tcrit, it can be reasoned that there existas a significant difference between μx 
and μy (153). 
 
Mann-Whitney U Test 
 Nonparametric tests are often used in place of their parametric counterparts when 
certain assumptions about the underlying population are questionable. For example, when 
comparing two independent samples, the Mann-Whitney U test does not assume that the 
difference between the samples is normally distributed whereas its parametric 
counterpart, the two sample-t-test, does. Nonparametric tests may be, and often are, more 
powerful in detecting population differences when certain assumptions are not satisfied. 
The Mann-Whitney U test is used to test the null hypothesis that two samples come from 
the same population (i.e. have the same median) or, alternatively, whether observations in 
one sample tend to be larger than observations in the other. The test assumes that the two 
distributions are similar in shape. 
Consider a sample of nx observations {x1, x2, …, xn} in one group (from one 
population) and a sample of ny observations {y1, y2, …, yn} in another group (from 
another population). The Mann-Whitney U test is based on a comparison of every 
observation xi, in the first sample set with every observation yj in the other sample set. 
The total number of pairwise comparisons that can be made is nxny. If the samples have 
the same median, then each xi has an equal chance (i.e. probability ½) of being greater or 
smaller than each yi. The null hypothesis is as follows: 
H0: P (xi > yi) = ½ 
while the alternate hypothesis is: 
H1: P (xi > yi) ≠ ½. 
The number of times (Ux) an xi from sample X is greater than a yi from sample Y is 
determined and vice versa. Under the null hypothesis, it would be expected that Ux and 
Uy are approximately equal. 
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 First, all observations are arranged in order of magnitude. Each observation is 
denoted as being either from population X or Y. The number of ys that are smaller than 
every given x are counted (this indicates xi > yj) and vice versa (this indicates yj > xi). The 
total number of times (Ux) that xi > yj is determined and vice versa (Uy). It should be 
noted that Ux + Uy must equal nxny. Finally, U = min (Ux, Uy) is determined. Statistical 
tables for the Mann-Whitney U test are used to find the probability of observing a value 
of U or lower. If the test is one-sided, this would be the p-value. If the test is two-sided, 
the probability is doubled to obtain the p-value. 
 If the number of observations is such that nxny is large enough (>20), a normal 
approximation can be used with 
2
yx
U
nn
=μ  (1.3.18) 
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12
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Nnn yx
Uσ  (1.3.19) 
  where,  N = nx + ny. 
 Sometimes, it may be that two or more observations are the same. If this is the 
case, U can still be calculated by allocating half of the tie to the X value and half of the tie 
to the Y value. However, in such a situation the normal approximation must then be used 
with an adjustment to the standard deviation. This becomes (154): 
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  where,  N = nx + ny 
    g = the number of groups of ties 
    tj = the number of tied ranks in group j. 
 
Results and Discussion 
 
 Aldehyde levels were compared statistically using ANOVA with Dunnett’s post 
hoc test for individual differences and the commercially available ABSTAT software 
(AndersonBell, Arvada, CO). Age and PMI were compared using a 2-tailed t-test. Braak 
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staging scores were compared using non-parametric testing and the Mann-Whitney U 
test. Statistical significance was set at P < 0.05 (Table 1.3.1). 
 Levels of aliphatic aldehydes (C1-C6), HNE and acrolein were measured in the 
HPG, SMTG and CER of 7 subjects with MCI (3M, 4F), 6 subjects with EAD (3M, 3F) 
and 7 age-matched control subjects (5M, 2F) using an improved mass spectrometric 
method (LC/ESI/MS/MS) that provides unequivocal identification of the compounds of 
interest (111). Subject demographic data are shown in Table 1.3.1. There were no 
significant differences in PMI for any of the three subjects groups. There was a 
significant (p < 0.05) difference in age of EAD subjects (89.0 ± 1.8 y) compared to 
control subjects (81.4 ± 2.6 y). There was no significant difference in age between 
control and MCI subjects (88.4 ± 1.4 y). Median Braak staging scores were significantly 
higher in MCI (III) and EAD (V) subjects compared to controls (II). Delayed memory 
recall scores from the MMSE were significantly lower in MCI (4.1 ± 0.8) and EAD (4.2 
± 0.7) compared to control subjects (7.9 ± 0.7). 
 No statistically significant differences in the levels of aliphatic aldehydes were 
observed for the various brain regions and levels of AD pathology under investigation. 
Figure 1.3.2 shows that HNE levels were statistically significantly elevated in a disease 
progression-related manner in all three brain regions under investigation. Post hoc testing 
showed that HNE was significantly increased (P < 0.05) in EAD HPG (1.45 ± 0.5 
nmol/mg protein) and MCI HPG (1.5 ± 0.3 nmol/mg protein) compared to control 
subjects (0.4 ± 0.1 nmol/mg protein). Levels of HNE were also significantly elevated in 
MCI SMTG (2.4 ± 0.3 nmol/mg protein) and EAD SMTG (2.9 ± 0.3 nmol/mg protein) 
compared to control SMTG (0.8 ± 0.1 nmol/mg protein). In contrast to a previous study 
of late-stage AD subjects (50), levels of HNE in CER were significantly elevated in MCI 
(1.5 ± 0.2 nmol/mg protein) compared to control CER (0.8 ± 0.1 nmol/mg protein). There 
were no significant differences in HNE between EAD and MCI for any of the brain 
regions analyzed. Comparison of regional differences showed a statistically significant 
elevation of HNE in SMTG compared to both HPG and CER in EAD and MCI. 
Figure 1.3.3 shows that levels of acrolein increased in a disease progression 
related manner with statistically significant increases in EAD HPG (2.7 ± 0.2 nmol/mg 
protein) compared to control HPG (1.2 ± 0.3 nmol/mg protein). There were no significant
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Table 1.3.1. Subject demographic data. 
* p < 0.05
 Mean ± SEM Age (years) Sex 
Mean ± SEM 
PMI (h) 
Median 
Braak Score 
MCI 88.4 ± 1.4 3M, 4F 4.0 ± 1.0 III* 
EAD 89.0 ± 1.8* 3M, 3F 5.4 ± 2.4 V* 
Control 81.4 ± 1.4 5M, 2F 2.7 ± 0.3 II 
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Figure 1.3.2. Mean ± SEM 4-hydroxynonenal (HNE) levels (nmol/mg protein) in MCI, 
EAD and control hippocampus/parahippocampal gyrus (HPG), superior and middle 
temporal gyrus (SMTG) and cerebellum (CER).  There was a statistically significant (p < 
0.05) elevation of HNE in MCI and EAD HPG and SMTG and in MCI CER.  
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Figure 1.3.3. Mean ± SEM acrolein levels (nmol/mg protein) in MCI, EAD and control 
HPG, SMTG and CER.  There was a statistically significant (p < 0.05) increase in 
acrolein in EAD HPG, SMTG and CER and in MCI SMTG.  
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differences in HPG acrolein between MCI and control subjects or between MCI and EAD 
subjects. In SMTG, there was a statistically significant increase in acrolein in MCI (1.1 ± 
0.1 nmol/mg protein) and EAD (1.3 ± 0.2 nmol/mg protein) compared to control subjects 
(0.4 ± 0.1 nmol/mg protein). There were no significant differences in acrolein between 
MCI and EAD subjects. In contrast to a previous studies of late stage AD brain (49), 
EAD CER showed a significant increase in acrolein (1.3 ± 0.1 nmol/mg protein) 
compared to control subjects (0.7 ± 0.1 nmol/mg protein). Correlation analysis of Braak 
staging scores and HNE or acrolein levels showed no significant trends. Correlation 
analysis of HNE and acrolein levels with delayed memory recall scores showed negative 
trends although the results were not statistically significant. 
 This is the first study to quantify levels of specific, neurotoxic by-products of 
lipid peroxidation in brain specimens from subjects with MCI and EAD. The results 
clearly showed that HNE and acrolein increase in a disease progression-dependent 
manner with statistically significant elevations of HNE in MCI and EAD HPG and 
SMTG and in MCI CER. Acrolein levels were significantly elevated in EAD HPG and in 
MCI and EAD SMTG. In contrast to a previous study of late stage AD brain (50), the 
data presented here suggest that there is a generalized increase in oxidative damage in the 
brain in MCI, including the CER. In light of the potential role of lipid peroxidation and 
HNE generation in the pathogenesis of neuron degeneration, the observation of elevations 
of HNE in MCI CER where there is limited neuropathology may appear contradictory. 
However, a previous study of glutathione transferase (GST), the enzyme responsible for 
detoxification of reactive aldehydes including HNE and acrolein, showed that GST 
activity is significantly decreased in HPG and amygdala but remains unaltered in CER in 
late stage AD (155), suggesting that the AD brain retains the ability to detoxify HNE in 
areas unaffected by pathology, whereas brain regions showing increased neuropathology 
(HPG) do not. 
Levels of HNE and acrolein measured in this current study using improved 
analytical methodology were comparable to those measured in previous studies of late-
stage AD and control subjects (49, 50). Using HPLC with fluorescence detection, it has 
been shown HNE was significantly elevated in AD HPG (0.54 ± 0.12 nmol/mg protein) 
compared to age-matched control subjects (0.3 ± 0.1 nmol/mg protein). Similar to the 
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results of this study, previous analyses of late-stage AD brain showed the highest HNE 
levels in SMTG (1.5 ± 0.4 nmol/mg protein (AD); 1.4 ± 0.4 nmol/mg protein (control)). 
Levels of acrolein observed in EAD and MCI HPG in this study were also comparable to 
those observed in late stage AD (5.0 ± 1.6 nmol/mg protein) and age-matched controls 
(0.7 ± 0.1 nmol/mg protein). Slight differences in absolute levels of HNE and acrolein 
may be due to differences in analytical methods and slight subject to subject variability. 
The increased levels of neurotoxic markers of lipid peroxidation in MCI and EAD 
reported here are consistent with previous studies of oxidative stress in extra cerebral 
fluids in MCI. Pratico et al. (156) showed substantially increased levels of isoprostane 
8,12-iso-iPF2α-VI, a specific marker of lipid peroxidation, in plasma, urine and 
cerebrospinal fluid (CSF) of MCI subjects compared with age-matched controls. In a 
study of peripheral leukocytes in MCI and late-stage AD, Migliore et al. (157) showed 
substantially increased oxidative DNA damage in MCI and AD subjects compared to 
age-matched controls using comet assay analysis. 
Keller et al. (85) showed substantially increased protein oxidation (protein 
carbonyls) in SMTG in MCI but not EAD, compared to age-matched control subjects. 
Additionally, significant elevations of thiobarbituric acid reactive substances (TBARs) 
and malondialdehyde, an aldehydic marker of lipid peroxidation with limited toxicity, 
were observed in MCI and EAD SMTG compared to control subjects. Although TBARs 
have been widely used as a marker for lipid peroxidation, the assay is subject to several 
interferences. This study, using LC-ESI-MS/MS, allows unequivocal identification of the 
target molecules based on their mass spectra and is free of possible confounding 
interferences. More recently, statistically significant elevations of 8-hydroxyguanine, a 
widely studied marker of DNA oxidation, were observed in nuclear DNA from frontal 
and temporal lobe specimens and in mitochondrial DNA from temporal lobe in MCI 
compared to age-matched control subjects (158). Statistically significant elevations of the 
markers of adenine oxidation (8-hydroxyadenine and 4,6-diamino-5-
formamidopyrimidine) were also detected in nuclear and mitochondrial DNA in frontal, 
parietal and temporal lobes from MCI subjects compared to age-matched control 
subjects. No differences in DNA oxidation were observed in CER in MCI. 
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Conclusions 
 
This study was conducted in the interest of obtaining a thorough understanding of 
the distribution of aldehydic products from LPO in different brain regions at different 
stages of AD. Here, we described the application of a previously developed, sensitive and 
selective LC-ESI-MS/MS methodology (111) in the quantification of aldehyde 
concentrations in the HPG, SMTG and CER of subjects with MCI and EAD compared to 
age-matched controls subjects (159). Individuals with amnestic MCI show memory 
impairment compared to normal controls, but lack the broader cognitive deficits of AD 
patients and likely represent the earliest stage of AD. Understanding the differences 
between MCI, EAD and normal subjects is becoming increasingly important in the 
interest of developing early diagnostic methods and viable treatments for this debilitating 
disease (159).  
In agreement with previous studies, it was observed that aliphatic aldehydes do 
not display statistically significant differences when comparing HPG, SMTG and CER 
brain regions and different levels of AD pathology (50). The data given here coupled 
with other studies suggest that oxidative damage occurs early in the course of AD and 
reaches a plateau during EAD, consistent with the hypotheses of Nunomura et al. (160) 
and Perry et al. (161). These researchers suggested that oxidative damage is most 
pronounced early in AD development. However, a recent clinical study by Petersen et al. 
(162) showed that treatment of MCI subjects with Vitamin E did not alter the overall rate 
of progression from MCI to AD compared to subjects who received placebos, suggesting 
that limiting oxidative damage does not affect the progression of AD. Although the data 
presented here appear to contrast with the findings of the clinical study, it has been 
suggested that acrolein can inhibit the enzyme responsible for the reduction of Vitamin E 
radicals (13, 80) and thus may limit the therapeutic effects of Vitamin E. The observation 
of elevations of acrolein in MCI and EAD in this study may help to explain why Vitamin 
E showed no protective effects in MCI in the clinical trial. In addition, it has been shown 
that Vitamin E taken in conjunction with Vitamin C decreases markers of lipid 
peroxidation in CSF of AD patients (163). Vitamin C was not used in the clinical trial by 
Petersen et al. (162) 
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The observations from this study suggest that oxidative stress occurs as an early 
event in the progression of AD and that preventive measures for those at risk for AD 
should be initiated in the presymptomatic phase of the disease (at or prior to MCI) to be 
effective. 
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Chapter 1.4 
Conclusions 
 
Alzheimer's disease is a progressive, irrevocable ailment of the brain, the etiology 
and cure of which have eluded scientists and clinicians to this day. The disease attacks 
and gradually steals the minds of its victims. Symptoms of AD include judgment 
deterioration, mental confusion, loss of memory, changes in personality, disorientation, 
and impairment of language skills. Alzheimer's disease is the most common form of 
irreversible dementia amongst the elderly community. Due to the devastating nature of 
AD, considerable research is focused on developing early diagnostic methods, medication 
for symptom alleviation, as well as cures for the disease. The AD brain is marked by 
considerable oxidative stress and lipid peroxidation, particularly in areas responsible for 
cognition and memory. In recent years, various by-products of lipid peroxidation, 
including biogenic aldehydes, isoprostanes and neuroprostanes, have piqued the interest 
of the AD research community as potential biomarkers for lipid peroxidation and 
therefore, AD. 
Since acrolein and HNE, amongst other biogenic aldehydes, are produced as a 
consequence of LPO, their prevalence above normal concentrations can be indicative of 
AD. As such, their quantification can serve as a measure of the progression of the 
disease. To this end, a sensitive, selective LC-ESI-MS/MS methodology for the detection 
and accurate quantification of acrolein, HNE and the aliphatic aldehydes C1-C6 was 
designed (111). This is the first report to describe the use of MS/MS analysis in brain 
aldehyde quantification. Researchers have explored spectrophotometric methods coupled 
to HPLC in biogenic aldehyde analysis but co-eluting species are difficult to analyze 
accurately using these techniques. Methods involving GC/MS come with high sensitivity, 
greater mass specificity and lower LODs, although different derivatization techniques are 
often required to analyze different classes of aldehydes. LC-ESI-MS/MS techniques are 
the some of the best analytical tools for biogenic aldehyde investigations as they offer 
greatly improved sensitivity, little sample cleanup and simultaneous analysis of multiple 
classes of aldehydes with a single derivatization method. Furthermore, in contrast to GC 
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experiments, analytes are not exposed to high temperatures in the analysis, which may 
not be suitable for some compounds. 
The Hantzsch reaction proved to be a very beneficial means of easily derivatizing 
aldehydic species with high efficiencies for trace LC/MS analyses. This derivatization 
method offers high selectivity, as other carbonyl compounds do not react in a manner to 
generate dimedone derivatives. Furthermore, CHD derivatives of aldehydes have very 
good electrospray responses. The dimethyl CHD derivative demonstrated the best 
chromatographic response of all derivatives explored. The use of two internal standards 
for separate quantification of aliphatic and unsaturated aldehydes enabled accurate 
quantification of very low concentrations of acrolein and HNE typically observed in the 
brain. Standard aliphatic and unsaturated aldehydes gave linear responses over a wide 
concentration range.  
The LC-ESI-MS/MS methodology was successfully applied in the detection and 
quantification of biogenic aldehydes in vivo (159). For the purposes of determining 
whether or not LPO-generation of aliphatic and unsaturated aldehydes occurred early in 
the pathogenesis of AD, levels of these aldehydes were studied in HPG, SMTG and CER 
of subjects with MCI, EAD and age-matched controls. This is the first study to report an 
in-depth comparison of aldehyde levels between MCI and EAD. At a 95% confidence 
level, no significant differences were observed in patterns of aliphatic aldehyde 
generation in different regions of the brain for MCI and EAD subjects, compared to the 
control group. This was in agreement with studies from other laboratories, as discussed in 
Chapter 1.3. However, also in agreement with previous findings, the results presented 
here clearly indicated statistically significant concentration differences for the 
unsaturated aldehydes HNE and acrolein. Noteworthy increases in HNE levels in HPG, 
SMTG and CER for MCI subjects were observed, compared to the control group. 
Individuals with MCI also demonstrated significantly elevated levels of acrolein in 
SMTG, compared to controls. In the case of subjects with EAD, a statistically significant 
increase in the production of HNE was detected in HPG and SMTG, compared to the 
control group. Furthermore, in contrast to the age-matched controls, significantly high 
concentrations of acrolein were observed in HPG, SMTG and CER in subjects with EAD. 
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A comparison of MCI and EAD subjects revealed no statistically significant differences 
in aldehyde levels.  
The methodology developed here was very well-suited for detecting and 
quantifying biologically relevant aldehydes in AD progression. It was evident from the 
study of HNE and acrolein levels in different brain regions of individuals at different 
stages of AD that lipid peroxidation occurred early in the pathogenesis of AD, at the MCI 
stage of development, when little, if any, clinical symptoms are observed. Hence, our 
results indicated that effective diagnostic methods for AD must be designed to target the 
MCI stage. Furthermore, drug development for symptom alleviation and the ultimate cure 
of AD should also focus on subjects with MCI. As with any illness, the best mode of 
action is preventive medicine. While considerable research is devoted to determining the 
cause of AD, the answers still remain at large. In situations when preventive care is not 
possible or simply did not happen, early detection, diagnosis and treatment are the key 
ingredients to a better quality of life. 
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Chapter 2.1 
Introduction 
 
Ethanol Tolerance in Thermophilic Bacteria 
 
Fossil fuels, including coal, oil and natural gas, are the major source of 
inexpensive energy that powers modern industrial civilization. These energy sources have 
been produced over millennia from the remains of prehistoric plants and animals. As 
humanity becomes increasingly advanced in technology, more energy is consumed to 
sustain the pace of changing requirements. Aside from heightened concerns about 
pollution, global warming and national security issues, existing reserves of this energy 
resource are depleting at a rapid rate. Use of fossil fuels has nearly doubled every 20 
years since 1900. Petroleum geologists have known for the past 50 years that global oil 
production would hit the zenith and begin its inexorable decline soon after the year 2000. 
Furthermore, no renewable energy systems to date have the potential to generate more 
than a fraction of the power currently being delivered by fossil fuels. As a result, research 
in alternative sources of fuel has received considerable focus in recent years. Harnessing 
microbes to convert abundant fibrous biomass from the agricultural sector into ethanol 
for exploitation as fuel can offer an efficient and environmentally clean answer to the 
energy question. The thermophile Clostridium thermocellum, a gram-positive, 
chemotrophic, cellulolytic and obligately anaerobic bacterium, has generated 
considerable interest in the area of bio-ethanol production due to its ability to ferment 
complex carbohydrates, such as cellulose, in a single step reaction, thus eliminating the 
need for biomass pretreatment (1). When this organism grows on cellulose as the sole 
carbon source, ethanol, acetic acid, lactic acid and CO2 are generated. The ability of C. 
thermocellum to ferment cellulose is a remarkable advantage over fungal species such as 
yeast, which can only ferment simple sugars via multi-step mechanisms.  
 Despite the benefits, C. thermocellum is strongly inhibited at low ethanol 
concentrations (< 2% v/v) and provides reduced ethanol yields compared to established 
industrial fermenters, including yeast (> 6% v/v). The restrained growth of the ethanol-
challenged species displays a short time span of little or no inhibition followed by a 
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period of growth impediment, and finally a time of stunted but sustained exponential 
growth (2). This is in contrast to ethanol inhibition observed in yeast, where an 
immediate cessation of growth occurs. Studies have shown that inhibition of fermentation 
is due to a staling effect, which refers to accumulation of toxic metabolic byproducts 
from the organism (3). Recovery of alcohol at such low concentrations with conventional 
distillation techniques becomes unfavorably expensive. In order for C. thermocellum to 
be effectively exploited in ethanol production, it is necessary to increase the growth rate, 
improve cellulase activity and increase ethanol tolerance and production (4). Through 
sequential transfer techniques, several ethanol-tolerant strains have been developed, some 
able to tolerate as high as 8% ethanol (1, 4-7). The ability of these bacteria to sustain 
themselves on cellulose indicates the presence of a viable cellulase system that can 
generate ethanol. While none of the strains to date can match fungal ethanol tolerance, an 
understanding of the biochemistry behind this phenomenon can offer insight into the 
future development of more ethanol-tolerant derivatives of this organism. 
 The effects of ethanol on microbes have been investigated in some detail (2, 3, 8-
12). The capacity of this alcohol to shut down metabolism is related to its partitioning 
between the aqueous and hydrophobic milieu in the cell. It has been shown that most of 
the effects of ethanol do not involve specific interactions or receptors but are the 
aftermath of a more generalized mechanism associated with hydrophobic associations 
(11). Nonionized species in the cellular matrix, including ethanol, influence membrane 
physiology through partitioning in lipid bi-layers and interfering with lipid-lipid and 
lipid-protein interactions (2). It is believed that the effect of ethanol may be due to 
physical disturbances of the bi-layer or perhaps more direct interactions with membrane 
proteins, such as permeases. Roberts and co-workers (2) have shown that when ethanol is 
added to C. thermocellum cultures, changes in membrane composition occur after the 
period of growth arrest. They reported an increase in the proportion of normal and 
anteiso-branched fatty acids (lower melting points) at the expense of iso-branched fatty 
acids (higher melting points), leading to increases in fluidity and permeability of the 
membrane. Studies have shown that key targets for microbe growth inhibition are 
hydrophobic in nature and that cessation of growth is directly proportional to the 
concentration of perturbing molecules that have partitioned into the hydrophobic 
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environment (2). Such evidence clearly highlights the vulnerability of the cell membrane 
to ethanol-induced changes. 
 Since a significant contributor to bacterial death at elevated ethanol 
concentrations is the disruption of the cellular permeability barrier (3), it is most likely 
that a majority of the changes brought about by ethanol adaptation center around the 
membrane proteome (Figure 2.1.1). Herrero et al. proposed that effects of ethanol on 
membrane fluidity and inhibition of certain enzymes associated with sugar metabolism 
lead to low tolerance of the bacterium to ethanol (2). In ethanol-challenged systems, the 
leakage of appreciable quantities of proteins also indicates membrane disruption (11). 
Hydrophobic associations are elemental in the preservation of membrane integrity and 
structure, protein folding and quaternary structure of proteins. The hydrogen bonding 
network of water is largely responsible for the strength of hydrophobic associations. 
While ethanol does form hydrogen bonds, its presence in aqueous solutions can limit the 
freedom of the hydrogen bonding lattice structure. This decline in the strength of the 
hydrophobic interactions can weaken the membrane by weakening van der Waal’s 
interactions among acyl chains and hydrophobic protein surfaces, further increasing 
membrane permeability (3). It is also believed that ethanol can increase the polarity and 
dehydrate the cell membrane. By replacing water, ethanol induces altered protein folding 
and interactions within the bi-layer (11). While the exact mechanism of bacterial growth 
inhibition and adaptation to ethanol is unknown, analysis of differentially expressed 
membrane proteins in wild type and ethanol-adapted strains through proteomics studies 
can provide the insight necessary to tackle questions about the nature of ethanol 
tolerance. 
 
Proteomic Analysis of Cell Membranes 
 
Proteomics is the study of the structural and functional aspects of the protein 
complement of the genome. The term was created to draw parallels with genomics, 
although it is significantly more complicated. While the genome of an organism is rather 
static, the proteome can differ radically and is constantly changing through biochemical 
interactions with the genome and the environment. Protein expression can also vary with 
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changing stages of the cell cycle and environmental conditions. Needless to say, 
proteomics investigations have played a dominant role in the field of biological mass 
spectrometry in the aftermath of the human genome project. As such, a considerable 
amount of resources and manpower have been dedicated to the improvement of protein 
separation and analysis techniques. Despite its limitations, sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) is still the gold-standard of protein 
separation for subsequent analysis by mass spectrometry. Pre-fractionation techniques 
(i.e. to separate hydrophobic membrane proteins from cytosolic proteins) coupled to 
SDS-PAGE have been useful in studying the proteome at increasingly detailed levels. 
However, the cell membrane sub-proteome is frequently under-represented on 2D gel 
maps. This has largely been attributed to their low abundance, hydrophobicity and 
solubility issues encountered in the first dimension or isoelectric focusing step of 
standard 2D-PAGE (13). By virtue of the unique nature of the cell membrane as the site 
of first contact of the external environment with the cell, a detailed understanding of the 
membrane proteome is critical in many biological investigations. 
In recent years, shotgun analyses have become popular ‘gel-free’ alternatives. 
MudPIT (Multidimensional Protein Identification Technology) is a technique for the 
separation and identification of complex protein and peptide mixtures that has developed 
considerable interest (14-16). In place of 2D gel electrophoresis, MudPIT separates 
peptides in 2D liquid chromatography, which allows the direct interfacing with a mass 
spectrometer. In the MudPIT experiment, biphasic columns are constructed of strong 
cation exchange (SCX) stationary phase in series with reversed phase (RP) material 
inside fused silica capillaries. The chromatography proceeds in cycles, each comprising 
an increase in salt concentration to free peptides from the SCX resin, after which they 
bind to the RP resin. A typical RP gradient to increasing hydrophobicity is then applied to 
progressively elute peptides from the RP into the ion source for analysis by mass 
spectrometry. A disadvantage to this methodology is that data interpretation and analysis 
is often not as straightforward compared to 2D-PAGE (17).  
 Despite the problems encountered with gel-based approaches, they are effective in 
providing a useful analytical tool for the generation of membrane protein profiles, along 
with quantitative comparisons of numerous proteins concurrently. Significant research 
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and methods development has been focused in the gel electrophoresis of membrane 
proteins to exploit the many advantages of this technique in membrane proteome 
analyses. Organic solvents and chemical modifiers in IEF solubilization buffers followed 
by analysis on one-dimensional gels or carefully modified two-dimensional gels 
(excluding isoelectric focusing) provide effective alternatives for improving membrane 
protein representation in these techniques. However, it should be noted that no approach 
offers a universal solution for all membrane proteins, and, experimental conditions ought 
to be optimized for the particular membrane-enriched sample at hand.  
 
Polyacrylamide Gel Electrophoresis 
 
The polyacrylamide gel electrophoresis technique (PAGE) was introduced by 
Raymond and Weintraub in 1959 (18). Since then, the methodology has been improved 
and adapted to various applications in a variety of scientific fields. SDS-PAGE is the 
most widely used method for qualitatively analyzing protein mixtures. Separation is 
based primarily on molecular weight (19). SDS (CH3-(CH2)10-CH2OSO3-Na+) is an 
anionic detergent that can bind to hydrophobic portions of a protein (one SDS anion to 
two amino acids), disrupting its three dimensional structure and allowing it to exist stably 
in solution in an extended conformation. As a result, all the proteins contain primary 
structure only, have a large negative charge and the length of the SDS-protein complex is 
proportional to its molecular weight.  
During an SDS-PAGE experiment, current is applied to opposite ends of an 
acrylamide gel support matrix (stationary phase) in the presence of an appropriate 
running buffer. Sample proteins are loaded on the cathode end of the assembly. The 
current from the cathode repels the negatively charged SDS-protein complexes while the 
anode, on the opposite end of the gel, simultaneously attracts them. The macromolecules 
are thus forced to move through the pores when electrical current is applied. Their rate of 
migration through the electric field depends on the strength of the field, size and shape of 
the molecules, relative hydrophobicity of the samples and the ionic strength and 
temperature of the buffer in which the molecules are moving. After staining, the 
separated macromolecules can be observed on the gel. The relative ease of execution and 
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wide application of SDS-PAGE have made it an important analytical technique in many 
areas, particularly macromolecular separations. 
 
Electrophoresis Theory 
 Electrophoresis instruments are simple electrical circuits that operate in 
accordance with Ohm’s law: 
V = IR (2.1.1) 
  where,  V =  electrical field in volts 
     I = current in milliamperes 
    R = resistance in ohms. 
For a given an amount of voltage, a constant amount of current will flow through the 
circuit. With increasing resistance across any element, the total applied voltage increases. 
The resistance is inversely proportional to the ionic strength of the buffer, as well as the 
cross sectional area of a given element. As such, gel analysis can be fine-tuned by 
manipulating these parameters.  
 The electrophoresis technique is based on the property of charged molecules 
migrating in an electric field (20). A particular molecule with charge q in an electric field 
(E) experiences a force (F) as follows: 
 
qEF = . (2.1.2) 
 
The molecule quickly reaches a velocity (v) in which the electric field is balanced by the 
frictional force: 
 
fvqE =  (2.1.3) 
  where,  f = frictional coefficient. 
 
The electrophoretic mobility of the molecule (μ) is the velocity per unit field strength. It 
is expressed as a ratio of the net charge to the frictional coefficient. 
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f
q
E
v
==μ (cm2/V-sec). (2.1.4) 
 
The frictional coefficient can be defined as: 
 
rf πη6=  (2.1.5) 
  where,  η = viscosity of the medium 
    r = stokes radius of the molecule. 
 
In ‘free’ electrophoresis, mobility is dependent on charge-to-mass-ratio. However, there 
are some complications to this simplistic view. The charges and frictional coefficients of 
a molecule are not only determined by size, shape and composition but by solvent 
conditions as well, including pH, counter-ions and temperature. Furthermore, counter-
ions can shield the migrating analyte from the electric field, reducing the effective field 
strength it experiences. 
 
Acrylamide Polymerization 
 First introduced by Chrambach and Rodbard (21), polyacrylamide is a synthetic 
polymer prepared by polymerizing the acrylamide monomer into long chains, cross-
linked into three-dimensional structures. Cross-linked gels are prepared from the 
polymerization of acrylamide monomer in the presence of smaller amounts of N,N’-
methylene-bis-acrylamide (bis), as shown in Figure 2.1.2. This type of polymerization is 
an example of free-radical catalysis, brought about by the addition of ammonium 
persulfate (APS) and the base N,N,N’,N’-tetramethylenediamine (TEMED). TEMED 
catalyzes the decomposition of the persulfate ion to produce a free radical (22): 
 
S2O82- + e- → SO42- + SO4-• (2.1.6) 
 
The polymerization reaction can be represented as follows: 
 
 R• + M → RM• 
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Figure 2.1.2. Polymerization of acrylamide. 
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RM• + M → RMM• 
RMM• + M → RMMM• and so forth (2.1.7) 
  where,  R• = sulfate radical 
    M = acrylamide monomer. 
 
In this manner, long chains of acrylamide are synthesized, which are then cross-linked by 
the introduction of the occasional bis-acrylamide molecule. Oxygen has a tendency to 
quench free radical reactions and so the gel mixture is normally degassed prior to 
addition of catalyst. The polymerization efficiency can range from 95 – 98%. The 
polyacrylamide gel serves two purposes. It facilitates the diffusion of convective currents 
that would result in localized heating in the matrix, causing irregular migration patterns. 
The gel also provides a molecular sieve that enhances analyte separation based on 
molecular weight. 
 
The SDS-PAGE Experiment 
Gel solutions for SDS-PAGE are usually prepared with appropriate amounts of 
SDS (to maintain denaturing conditions) and Tris buffer (to maintain the desired pH and 
create a greater ionic strength within the gel). The stacking gel is usually prepared with a 
pH of 6.8 while the separating gel has a pH of 8.8. Catalysts are added immediately 
before pouring the gel sandwich between two glass plates. The main separating gel 
solution is poured first and allowed to polymerize. Next, a shorter stacking gel is poured 
on top of the separating gel, and it is in this gel that wells are formed and proteins loaded. 
Samples for SDS-PAGE analysis are boiled for 5 min in sample buffer (pH 6.8) to 
denature the proteins. The β-mercaptoethanol in this buffer is added to prevent oxidation 
of cysteine residues of protein disulfide bridges while SDS binds to the proteins. The end 
result is a collection of completely denatured, rod-shaped protein-SDS complexes with 
net negative charge. These charges overwhelm the inherent charge of the proteins and 
give every protein the same charge-to-mass ratio. Bromphenol blue or some other 
ionizable dye in the sample buffer allows the progress of the electrophoresis experiment 
to be tracked. The cathodic and anodic ends of the electrophoresis setup are filled with 
Tris-based running buffer. Sucrose or glycerol, present in the sample buffer, increases the 
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density of the sample solution thus enabling the sample to settle through the 
electrophoresis buffer to the bottom when injected into the loading well.  
Electrophoresis is conducted under constant voltage or constant current 
conditions. Once all samples have passed through the stacking gel and entered the 
separating gel, the negatively charged protein-SDS complexes continue to move toward 
the anode. Since they have the same charge per unit length, these complexes migrate into 
the separating gel with the same mobility for a given electric field. During passage 
through the separating gel, the proteins separate as a result of the molecular sieving 
properties of the gel. Smaller proteins can travel more quickly compared to larger ones, 
which are successively retarded by frictional resistance. Being a small molecule, the 
bromphenol blue dye is almost totally unretarded and therefore indicates the 
electrophoresis front. As soon as the dye front reaches the bottom of the gel, the power is 
turned off and the gel is removed from between the glass plates for subsequent protein 
staining and analysis.   
Polyacrylamide gels can be cast in a single percentage of acrylamide or with 
varying gradients. The gradient gels provide continuous decrease in pore size from the 
top to the bottom of the gel, either exponentially or linearly, and can offer improved 
resolution of proteins. During electrophoresis in gradient gels, proteins continue to 
migrate until the decreasing pore size impedes further advancement. Once the pore limit 
is reached, the protein banding pattern remains more or less the same with time, although 
migration does not cease completely. The main advantage of using gradient gels is that a 
much greater range of protein MW range can be interrogated, compared to a fixed-
percentage gel. It is possible for larger proteins to enter the gel but they start to separate 
immediately because of the sieving effect of the gel (22). 
The use of a short stacking gel on top of the separating gel also allows for better 
resolution. The stacking gel aids in the concentration of the protein sample into a sharp 
band prior to entering the main separating gel. By preparing a stacking gel with large 
pore size, the proteins can migrate freely and concentrate under the electric field, as a 
result of isotachophoresis. This band sharpening effect relies on the fact that the trailing 
ions (i.e. glycine in standard Laemmli-SDS-PAGE) in electrophoresis buffers have a 
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lower electrophoretic mobility than the protein-SDS complexes, which in turn have lower 
mobility than the leading ions (i.e. Cl-) in regions of high field strength (22).  
 
Protein Visualization 
 A suitable staining protocol can be used to visualize separated proteins on a 
polyacrylamide gel. The Colloidal Coomassie (Coomassie Brilliant Blue G 250) staining 
protocol offers a sensitive, consistent, simple method and provides nanogram-level 
detection of proteins (23). The technique is based on the colloidal properties of 
Coomassie Blue dyes generated in methanol-water binary solvents containing inorganic 
acids and high salt concentrations (Figure 2.1.3). The anionic form of the dye is produced 
in acidic staining media and combines with the protonated amino groups of proteins 
through electrostatic interactions. The free dye in solution is greatly reduced due to the 
hydrophobic effect, resulting in low background staining and high affinity binding of the 
dye to the proteins fixed in the gel. 
 In the Colloidal Coomassie Blue staining protocol, gels are fixed for one hour 
with a solution containing 80% water, 20% methanol and 1% o-phosphoric acid. This 
ensures that the separated proteins do not diffuse and migrate. Overnight staining is 
performed in an aqueous solution of 0.001 g/mL Coomassie G-250 dye, 0.08 g/mL 
ammonium sulfate, 20% methanol and 1.6% o-phosphoric acid. The gel is then 
transferred into neutralization buffer (0.1M Tris, pH 6.5) for 1-3 min. This is followed by 
washing with 25% methanol for less than a minute. Then, the gel is immersed in an 
aqueous stabilizing solution of 0.2 g/mL ammonium sulfate. The gels can be safely stored 
in 1% aqueous glycerol solutions until further analysis. 
 
In-Gel Digestion 
 
As staining methods with increasing sensitivity were developed, protein 
identification became limited by the sensitivity of Edman sequencing, since this was the 
most well-established method for protein analysis. With the development of ESI-MS and 
MALDI-TOF-MS, mass spectrometry became recognized as a much more sensitive and 
worthwhile tool for such purposes. Following separation on a polyacrylamide gel,  
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Figure 2.1.3. Coomassie Brilliant Blue G 250. 
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proteins are excised, digested and the resulting peptides subjected to peptide mass 
fingerprinting (PMF) methods. For protein identification, PMF uses the peptide masses to 
search the protein databases for in silico or theoretical digest patterns that match the 
experimental data. Mass spectrometric analyses can now be performed on picomole and 
sub-picomole levels of PAGE-separated proteins following in-gel digestion procedures to 
fragment the proteins into peptides.  
In-gel digestion techniques can vary from laboratory to laboratory but they all 
share some basic components. It is essential that contamination from human keratins be 
reduced as far as possible, so that peptide signals are not suppressed during mass 
spectrometric experiments. Protein spots/bands are excised from the gel. SDS, 
unpolymerized acrylamide and other buffer constituents that could potentially generate a 
high background in MS analyses are removed from the excised gel plugs in several 
NH4HCO3/ACN washing steps. One particular method employs a 25 mM NH4HCO3 as 
the first wash (10 min), followed by a 1:1 mixture of 25 mM NH4HCO3 and ACN (10 
min), terminating with a pure ACN wash (10 min). The washing steps dry the gel pieces, 
which are subsequently rehydrated with a 25 mM NH4HCO3 buffer containing a 
proteolytic enzyme, such as trypsin. In most work, trypsin is the protease of choice of 
peptide mass fingerprinting because it is very reliable and substrate-specific. Tryptic 
digests produce peptides with C-terminal basic residues (Arg and Lys), rendering them 
easily ionizable, thus facilitating mass spectrometric analyses. Approximately 10% of all 
bonds in a protein are suitable cleavage sites for this enzyme. Trypsin is usually dissolved 
in ice cold buffer, just prior to use, so as to limit auto-proteolysis. The gel pieces are 
incubated in trypsin at 4oC for 40 min, following which the enzyme solution is removed 
and fresh 25 mM NH4HCO3 buffer (~10 μL) is added. After incubation of the gel pieces 
at 50oC for 4 hours, 1 μL of formic acid is added to encourage protonation of tryptic 
peptides. The resulting peptides are then subjected to mass spectrometric analysis. 
 
MALDI-TOF-MS 
 
Matrix-assisted laser desorption/ionization or MALDI was first introduced by 
Karas and Hillenkamp in 1988 (24). They discovered that the incorporating the analyte 
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into the crystalline structure of small UV-absorbing organic molecules (matrix) provided 
a vehicle for ions to be created from polar or charged biomolecules. This assured that the 
once restrictive mass limitations of laser desorption/ionization could be circumvented. 
Since then, MALDI has evolved into a powerful ionization method for biological 
molecules and synthetic polymers. MALDI coupled to time-of-flight MS (TOF-MS), a 
mass analyzer designed in 1955 by Wiley and McLaren (25), has evolved into the 
workhorse and benchmark macromolecule analyses. Since MALDI ions are produced by 
a pulsed laser, these ion sources can be conveniently coupled to TOF mass spectrometers, 
which require a well-defined start time. With the establishment of proteomics as a key 
area of research in mass spectrometry, interest in the analysis of biomolecules has risen 
dramatically and with it, interest in MALDI-TOF-MS. 
 
The MALDI Process 
 In the MALDI technique, the sample is mixed with an excess of an appropriate 
matrix and irradiated with a laser beam of short (10 – 20 ns) pulses. The laser power is 
normalized with respect to the irradiated area (~ 50 μm), with power densities in the 
range of ~106 W/cm2 irradiance power (26). Multiple laser pulses are usually averaged to 
enhance signal-to-noise ratio (SNR). The primary function of the matrix is to absorb 
radiation at the wavelength of the laser and subsequently transfer it to the analyte. 
Absorption of energy from the laser beam causes desorption of the matrix, along with 
analyte molecules. Ionization of the analyte follows through gas-phase proton-transfer 
reactions. MALDI is amenable to both positive and negative ion analyses. The MALDI 
mass spectra of proteins and peptides typically display singly protonated analyte 
molecules, along with their oligomeric ions (i.e. [M+H]+, [2M+H]+, etc.). In some 
instances, doubly and triply charged protonated ions of low abundance can also be 
generated. The higher the mass of the analytes, the greater their propensity to form 
multiply charged ions. 
 
Sample Preparation 
In a MALDI experiment, analyte and matrix is spotted onto a MALDI target 
(Figure 2.1.4) and subjected to laser irradiation. There are several methods available for 
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Figure 2.1.4. The MALDI process. 
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sample preparation and a good choice is made based on the needs of the sample at hand. 
For the analysis of tryptic peptides, the fast matrix evaporation method can be used (27). 
Matrix solution (in a volatile solvent, such as acetone) is applied to the surface of the 
MALDI target (Figure 2.1.5) to create a thin film of crystals. HCCA or α-cyano-4-
hydroxycinnamic acid (Figure 2.1.6) is a well-suited matrix for peptide samples. This 
matrix can be prepared as a 10 mg/mL solution in acetone : 0.1% aqueous TFA = 9:1. 
Once the matrix layer is dry, about 0.8 μL of a protein digest is added on top of the 
polycrystalline film. Upon drying, the sample spots are washed with 0.1% aqueous TFA 
to remove unwanted salts. The matrix/analyte spots are dried again and subjected to MS.  
Analysis by MALDI-TOF-MS is very sensitive to sample preparation and so care 
must be taken at each step to avoid contamination and eliminate any potential 
interference that could mask peptide peaks. By virtue of the homogeneous crystal 
structure generated, the fast matrix evaporation approach provides higher resolution, 
sensitivity and signal reproducibility compared to other sample preparation methods. 
 
Mechanism of Desorption and Ion Formation 
 The mechanism by which molecules are desorbed and photoionized is not very 
well understood (Figure 2.1.4). However, three different models are now recognized as 
viable candidates for explaining this phenomenon. The first one involves quasithermal 
evaporation as a result of increased molecular motion. The second model describes the 
expulsion of upper lattice layers in the MALDI process. Finally, the third possibility 
explains desorption/ionization from a standpoint of increases in the hydrodynamic 
pressure due to rapidly expanding molecules in the crystal lattice (26). Regardless, all 
three hypotheses agree that the MALDI matrix plays a pivotal role in sample ionization. 
A good MALDI matrix should have high molar absorptivity at the selected laser 
wavelength (337 nm for a nitrogen laser), be able to form microcrystals with the analyte, 
have low sublimation temperature and possess the ability to engage in photochemical 
reactions (27). Laser radiation strikes the matrix, causing absorption of energy and 
heating of matrix crystals when they emit the absorbed energy. Matrix molecules sublime 
due to the heat generation, sending both matrix and analyte molecules into a dense 
gaseous plume.
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Figure 2.1.5. The MALDI target. 
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Figure 2.1.6. MALDI matrix: α-cyano-4-hydroxycinnamic acid (HCCA). 
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Since the analyte is embedded within the matrix during sample preparation, this process 
can also remove buffer and salt contaminants (26). 
One popular hypothesis (26) states that following desorption as neutral species, 
the analyte molecules become ionized through acid-base reactions with the protonated 
matrix. This is said to occur within the plume of particles ablated by the laser pulse and 
just above the matrix layer. The protonated matrix molecules are produced by 
photochemical reactions. Another possibility is that the singly excited matrix molecules 
(and not the photoionized matrix molecules) are responsible for analyte ionization. 
According to this model, two excited matrix molecules are needed to produce ionized 
gaseous analyte ions. Karas et al. (28) suggested the formation of initial matrix clusters, 
protonated/deprotonated analyte molecules and counter-ions, as well as the desolvation of 
desorbed clusters to generate free ionic species through acid/base reactions and 
evaporation of neutrals. Electrons generated during matrix photoionization are captured 
by charged clusters to form singly charged ions. Electron capture is also believed to be 
responsible for fragmentation (26). 
 
TOF-MS 
A time-of-flight mass spectrometer is one of the simplest mass analyzing devices 
(Figure 2.1.7) available. It is commonly used for MALDI-MS because ion pulses 
produced in MALDI provide the sampling mode required by TOF analyzers. A TOF 
mass spectrometer is a velocity spectrometer, in which ion separation occurs as a result of 
velocity differences. Following laser desorption, a short pulse of ions leaves the MALDI 
source and is dispersed in time by allowing it to drift in a field-free region (FFR) of a 
long flight tube. It is in this FFR where separation based on m/z occurs. TOF mass 
analyzers offer a variety of advantages, including high analysis speed, simplicity of 
design, high transmission, (theoretically) unlimited mass range, concurrent detection of 
all ions (multiplex advantage), as well as compatibility with pulsed ionization sources, 
such as MALDI (26).  
Ions produced by a laser pulse through MALDI are extracted into the TOF 
analyzer by an electrical field V. The principle behind the mass analysis is that after 
acceleration to a constant kinetic energy, the ions travel at velocities, v, that are inversely 
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Figure 2.1.7. Time-of-flight (TOF) mass spectrometry. 
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proportional to the square root of their m/z values. The kinetic energy can be expressed as 
follows (27): 
zeVKE =  (2.1.8) 
 where,  z = charge of molecular ion 
   e = charge of an electron (Coulombs) 
   V = electric field strength (Volts). 
In ideal situations, all ions, small and large, enter the FFR with the same kinetic energy. 
According to Newton’s law: 
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Compared to the flight path and time of flight, the source region is very short and ions 
spend comparatively little time there. Thus, the velocity can be considered to be constant 
in these equations. As such, the instantaneous velocity can be expressed as a ratio of the 
total field free flight path (Δx) and flight time (Δt). The m/z for a given ion can be 
calculated as follows (27): 
2
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teVzm
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Δ
=  (2.1.11) 
  where,  m = mass (kg) 
    Δx = flight path length (m) 
    Δt = flight time (s). 
The short ion pulse is eventually dispersed into packets of iso-mass ions, as it travels 
through the flight tube. Ion arrival time can be used to perform mass analysis: 
2/1
2
⎟⎠
⎞⎜⎝
⎛Δ=Δ=Δ
zeV
mx
v
xt . (2.1.12) 
If all ions obtain the same kinetic energy, the ions of lesser m/z will have greater velocity 
than ions of greater m/z. Therefore, as ions traverse the analyzer, they separate in space. 
A detector is positioned at the end of the analyzer to measure the arrival time of ions. The 
ions of lesser m/z arrive first, followed by ions of greater m/z (26). 
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Since MALDI typically generates singly charged ions, a mass analyzer with high 
mass range is required. In theory, TOF has an unlimited mass range, which places strict 
requirements on the detector because they are velocity-sensitive detectors. Due to the fact 
that velocity decreases inversely with the square root of the mass, the sensitivity of TOF-
MS is lower for larger ions. 
 
Pulsed Ion Extraction 
 When ions are formed in MALDI, they have a kinetic energy, directional, spatial 
and temporal spread due to the ionization process, which can cause peak broadening. By 
generating ions in a weak electric field and applying a high voltage extracting field 
following a time delay, the effect of this spread can be minimized. Ions are first allowed 
to expand into a field-free region in the source and after a certain delay (hundreds of 
nanoseconds to several microseconds) a voltage pulse is applied to extract the ions 
outside the source (26). 
 
The Reflectron  
 Further improvements in resolution can be achieved by incorporating a reflectron 
(29) in the TOF instrument. Due to the large kinetic energy spread of the ions (which 
increases with mass) produced at the surface of the sample/matrix spot, linear TOF 
(Figure 2.1.8) analyzers are unable to offer high mass resolution in the absence of any 
compensation. The reflectron TOF (Figure 2.1.9) features two linear field-free regions 
and an ion mirror, which corrects for kinetic energy and spatial dispersions of ions of the 
same m/z. The ion mirror consists of an array of electrical lenses, each having 
progressively higher repelling potential. The initial spatial spread is translated to a 
velocity spread, which can be easily corrected by the mirror.  
Ions entering the reflectron, after traversing the first FFR, are slowed down and 
then their direction of motion is reversed. This is followed by acceleration into a second 
FFR. Ions of a given m/z with faster velocities spend less time in the drift regions, but 
penetrate to a greater depth into the reflecting field. As a result, they spend more time in 
the reflectron, which compensates for the shorter flight times of faster ions in the drift 
regions. The end result is that all ions of the same m/z arrive simultaneously at the 
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Figure 2.1.8. Linear mode TOF-MS operation. 
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Figure 2.1.9. Reflectron mode TOF-MS operation. 
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detector, situated at the end of the flight path. Considerable improvements in mass 
resolution can be achieved in this manner. An additional contributing factor in improving 
the mass resolution is the longer path length provided by reflectron. Dramatic 
improvements are realized over linear TOF-MS instruments for <10 kDa molecular mass 
compounds. The total flight time of an ion in the reflectron is given by: 
( )dLL
zeV
mt 4
2 21
2/1
++⎟⎠
⎞⎜⎝
⎛
=  (2.1.13) 
  where,  L1 = first field-free region 
    L2 = second field-free region 
    d = depth of ion penetration into the reflecting field. 
Reflectrons can be either single-stage or dual-stage. A single-stage reflectron is a simple 
ion mirror that provides a singe retarding-reflecting field. The device consists of an 
entrance grid electrode and a series of ring electrodes. With a single-stage reflectron, first 
order correction for the kinetic energy spread is achieved. Dual-stage reflectrons feature 
two linear retarding voltage regions separated by an additional grid and can provide 
improved resolution at the expense of sensitivity (26). 
 
Protein Identification by MALDI-TOF-MS 
MALDI-TOF-MS is a powerful technique for proteomics analyses. Mass 
spectrometric analysis generates a mass fingerprint or profile which is unique to a 
particular protein. Comparison of this peptide mass fingerprint (PMF) with databases of 
known protein digest fingerprints provides the means of protein identification. PMF 
works well with analytical proteomics because it combines a conceptually simple 
approach with robust, high-throughput instrumentation. The quality of protein 
identifications made depend on the quality of the MS data, the accuracy of the databases 
and power of the search algorithms and software used. 
 
Database Searching 
 
 An algorithm is a set of rules that specify how to solve a well-formulated problem 
in a finite number of steps. The problem is described in terms of inputs and outputs and 
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the algorithm facilitates the conversion of inputs to outputs. As the field of proteomics 
acquires momentum in the wake of the genomics era, several algorithms and computer 
programs have been described for protein identification. Many programs involve the 
interrogation of a sequence database with mass spectrometric data from the unknown 
protein. An in silico digestion of the entire sequence database according to suitable 
fragmentation rules (depending upon the proteolytic enzyme being used) produces a list 
of theoretical peptide mass values which can be compared to the experimental data. 
Equivalent peptide masses are tallied or scored such that the peptide or protein providing 
the closest match with experimental data can be identified (30).  
In situations where the target protein is not present in the database, entries with 
homology similar to the protein in question are identified. These entries are usually 
proteins of similar structure and/or function from related organisms. Of the protein 
identification algorithms available, the MASCOT algorithm offers the substantial 
advantage of probability-based scoring. In this approach to peptide mass scoring, a 
straightforward mathematical rule can be employed to evaluate the significance of the 
result, thereby avoiding false positives. Furthermore, it is possible to draw comparisons 
between these scores and those derived from other types of searches, including 
determination of sequence homology. Finally, the search parameters can be optimized 
through iteration (30). 
 With MASCOT, the database can be searched using a peptide mass fingerprint 
(PMF), sequence query and MS/MS information from target proteins. MASCOT was 
originally designed as an extension of the MOWSE (Molecular Weight Search) scoring 
algorithm (31). In a typical MOWSE search, the theoretical peptide masses for all the 
entries in the sequence database are compared with the experimental data. A match is 
said to occur when a calculated value falls within a pre-defined mass tolerance of an 
experimental mass. A molecular weight range for the intact protein from gel 
electrophoresis data can be applied as a pre-filter. MOWSE assigns a statistical weight to 
each peptide match by considering several empirically determined factors.  
In the MOWSE approach, a matrix F of all the weighting factors of in silico 
peptides is calculated during the database build stage. Each row in this matrix represents 
a 100 Da interval in peptide fragment mass while each column is an interval of 10 kDa in 
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intact protein mass. With the analysis of each sequence entry, the appropriate matrix 
elements fij are incremented to generate statistical information on the size distribution of 
peptide masses as a function of protein mass. Matrix normalization is achieved by 
dividing the elements of each 10 kDa column in F by the largest number in the column. 
This produces the MOWSE factor matrix M: 
maxjij
ij
ij f
f
m = . (2.1.14) 
Experimental mass values are searched against the theoretical peptide mass database and 
the score for each entry is determined: 
∏×=
n
ijprot mM
Score 50000  (2.1.15) 
  where,  Mprot = molecular weight of the entry. 
The product term in the denominator is determined from the MOWSE factor elements for 
each match between the experimental data set and peptide masses calculated from the 
entry (32). 
The MASCOT algorithm uses a probability-based approach of the MOWSE 
algorithm. As such, it incorporates the significant benefits of MOWSE, including the 
ability of this program to accurately model the behavior of a proteolytic enzyme. There 
are noteworthy differences between MOWSE and MASCOT aside from probability-
based scoring, such as the removal of pre-built indexes (30). A FASTA format of the 
sequence database is directly compatible with MASCOT. To maximize search speed, the 
FASTA format can be compressed and incorporated into the computer memory.  
The basic modus operandi in MASCOT is the determination of the likelihood that 
the observed match between the experimental data set and each sequence database entry 
occurs at random. The match securing the lowest probability is reported as the best 
match. This match may or may not be a significant one, depending upon the size of the 
database. A generally accepted significance threshold is that the probability of the 
observed result being a chance event is less than 5% (p < 0.05). MASCOT reports the 
scores as -10Log10P, where P is the probability. MASCOT accepts MS data as lists of 
centroided mass values (peak lists), and if preferred, with associated intensity values as 
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well. When using MS/MS data, it is also necessary to detect the peaks in the 
chromatogram. Several spectra from a single peptide may be added together while at the 
same time eliminating spectra from the chromatogram baseline that would otherwise 
contribute to noise (32).  
 One of the challenges in using PMF data with MASCOT is the elimination of 
false positive results. Some basic assumptions are associated with a MASCOT search. 
Experimental data are considered to be independent measurements taken from the larger 
population of all possible measurements. In situations when data are not independent, the 
absolute score becomes an unreliable indication of significance. Another problem is the 
frequent observation of identical masses. For pairs of duplicate masses, if one matches, 
then so will the other. The score determined on the presumption that these are 
autonomous matches, is higher than it should be. In PMF data, this can occur because the 
mass error window specified by the user is too large. Another possibility is that the peaks 
are split by noise or poor calibration. For MS/MS data, scans for a single 
chromatographic peak may not have been averaged. In some situations, particularly when 
non-quantitative modifications are applied, data lacking duplicate values can produce 
statistically significant scores in searches against the random database. It is possible that 
the data contain pairs of masses differing by the mass difference of the modification. For 
these pairs, if one of the values happens to match a theoretical sequence containing the 
modifiable residue, the likelihood of the other value matching the same sequence 
becomes significant. The experimental data are then not independent and the score is 
higher than it ought to be (30). While the use of probability-based scoring in MASCOT is 
a significant improvement over other approaches, there is certainly much room for further 
improvements in protein identification technology. 
 
Goals 
 
 The importance of research in alternative sources of fuel, particularly biofuels 
research, has been highlighted in this chapter. The applicability of bacterial fermenters in 
industrial bio-ethanol production was considered and an overview of the current 
knowledge in bacterial ethanol tolerance and adaptation has been provided. In light of 
 156
evidence suggesting that a majority of changes associated with ethanol adaptation occur 
in the bacterial membrane proteome, a closer look at membrane protein expression 
patterns is warranted. The advantages and pitfalls associated with membrane protein 
analysis using gel-based approaches were discussed, along with other gel-free 
alternatives. A review of the literature clearly indicates that gel electrophoresis methods 
are still the gold standard of protein separation. A description of gel-based proteomic 
analyses is provided, including a discussion of polyacrylamide gel electrophoresis, in-gel 
digestion of proteins, methods for protein visualization, MALDI-TOF mass spectrometry 
of protein digests, as well as protein identification using database searching.  
Through careful study of the gel electrophoresis experiment, a new and more 
improved SDS-PAGE methodology was developed which could be effectively applied to 
the analysis of membrane proteins, particularly those of the bio-ethanol producer 
Clostridium thermocellum. Information from these investigations should provide a better 
understanding of ethanol adaptation by this organism. Chapter 2.2 describes the design of 
doubled SDS-PAGE (dSDS-PAGE) methodologies for membrane protein analysis. The 
wild type C. thermocellum membrane proteome was chosen as the model system for 
these experiments. Standard glycine-based running buffers (Laemmli protocol) (19), 
along with tricine-based (33) and the newly developed bicine-based buffer systems (34) 
were examined in their suitability for separation of such proteins. The parameter space of 
gel preparation in Tricine- and Bicine-dSDS-PAGE was explored and a description of the 
optimization of these parameters is given. The compatibility of these dSDS-PAGE 
methods with mass spectrometric analysis of digested proteins extracted from the gel was 
investigated. The improved suitability of bicine-based running buffers in membrane 
proteome analyses was explained through capillary electrophoresis experiments.  
 Chapter 2.3 focuses on the application of the Bicine-dSDS-PAGE methodology in 
the analysis of membrane proteins derived from wild type and ethanol-adapted C. 
thermocellum strains. Definitive changes in membrane protein expression patterns were 
observed between these bacteria and a discussion of differentially expressed proteins in 
the backdrop of ethanol tolerance is provided. 
 Chapter 2.4 offers some concluding remarks and highlights the significance and 
future direction of this work.
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Chapter 2.2 
Methods Development in Two-Dimensional Polyacrylamide Gel Electrophoresis for 
Membrane Proteins 
 
Introduction 
 
 Since Laemmli’s introduction of the discontinuous SDS-PAGE system (19), 
several modifications and improvements have led to significant strides in gel-based 
protein separations. Inclusion of urea has shown benefits in terms of resolution and 
enabling the use of higher levels of cross-linker (%C - N’,N’-methylenebisacrylamide or 
Bis) for the separation of low molecular weight proteins (35-38). However, despite these 
benefits, urea can carbamylate proteins, thus complicating proteomic analysis, 
particularly for larger proteins. Other reports have explored high Tris concentrations in 
the buffer and gel (39), glycerol in the gel (40) and running buffer modifiers (35, 36, 41) 
in lieu of or in addition to urea. These investigations have led to benefits in dynamic 
range, resolution and protein representation. The advent of 2D-SDS-PAGE enabled 
orthogonal protein separation by both charge and size, further improving the technique 
and vastly increasing protein representation (42). However, with all these advances also 
came the realization that the cellular proteome is comprised of many sub-proteomes 
which often require different sample preparation conditions for optimum separation. 
 One particular sub-proteome that has been notoriously resistant to detailed 
analysis by 2D-SDS-PAGE includes the proteins associated with cell membranes. Many 
of these proteins are hydrophobic in nature, which makes them very difficult to solubilize 
in the first dimensional or isoelectric focusing (IEF) step (13). Typically used IEF sample 
buffers are detergent free and are not adequate to dissolve these proteins and furthermore, 
dissolved membrane proteins have a tendency to precipitate at their isoelectric points 
(15). As a consequence, they are quite consistently under-represented in traditional 2D-
SDS-PAGE. Improvements that have been suggested include the use of various ionic, 
zwitterionic and nonionic detergents, as well as different combinations of these, to 
promote solubilization (43-54). Other reports described the substitution of dithiothreitol 
(DTT) with the uncharged reducing agent tributyl phosphine (TBP; (44, 55-57)), which 
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assists in maintaining reducing conditions during IEF and lowers the likelihood of 
precipitation that could occur through aggregation initiated by disulfide bonding. 
Subproteomics and prefractionation techniques have recently been explored to improve 
representation of membrane proteins expressed in low copy numbers (58, 59). Selective 
enrichment of certain classes of proteins, such as periplasmic proteins, to enhance their 
abundance in 2D gels has also been described (60). While all these approaches have 
improved membrane protein analysis to some extent, solubility issues associated with IEF 
have not been fully eliminated. 
Since the main problems with membrane protein separation arise during IEF 
separation, alternatives to the standard 2D-PAGE approach that circumvent this step have 
been considered. Schägger and co-workers (17) described a doubled SDS-PAGE (dSDS-
PAGE) experiment in which SDS-PAGE separation of membrane proteins in the first 
dimension was followed by an additional SDS-PAGE separation in a second dimension 
to generate a diagonal arrangement of protein spots. The effectiveness of this dSDS-
PAGE approach is influenced by the type of buffer system (e.g. glycine- or tricine-
based), presence of urea and acrylamide content in the gels. Indeed, highly hydrophobic 
membrane proteins from bovine heart mitochondria were successfully separated with this 
approach (17). In a similar set of experiments, Sánchez et al. (61) separated outer 
membrane protein complexes and heat-modifiable proteins in Neisseria strains.  The 
authors explored different combinations of non-denaturing and denaturing conditions in 
1D and 2D for the purposes of optimizing separation.  Eliminating β-mercaptoethanol 
from the 1D sample buffer enhanced spot resolution.  They also postulated that 
incubating the 1D sample strip under denaturing conditions prior to running the second 
dimension offered better separation and spot resolution compared to incubation under 
non-denaturing conditions. Despite these  benefits of dSDS-PAGE, the technique is still 
not widely used and in fact, there are few other reports of its application (62, 63).  
Tricine-based running buffer systems (17) have been successfully applied in the 
separation of various types of proteins (17) and cell surface structures (e.g., bacterial 
lipopolysaccharides) (33, 64-73). Advantages of tricine over glycine-based buffers 
include improved protein migration, especially in the presence of potentially interfering 
substrates (72); and improved stacking and destacking of middle (64) and low (67) 
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molecular weight proteins, resulting in better resolution. This improved resolution was 
theoretically (74-76) and experimentally (77) explained by increases in ionic strength, as 
would be associated with a Tricine-SDS-PAGE buffer system. 
As with any separation method, modification of the mobile phase or running 
buffer can change the separation process. Since Tricine-dSDS-PAGE is a powerful tool 
in membrane protein separation, we explored other buffer systems in conjunction with 
the dSDS-PAGE approach and describe an orthogonal Bicine-dSDS-PAGE method for 
the analysis of membrane proteins from the anaerobic bacterium, Clostridium 
thermocellum. This organism produces ethanol from fibrous biomass but has low 
tolerance to ethanol build-up in the medium. Recently, strains able to tolerate up to 8% 
ethanol have been developed and studies have shown that changes in the membrane 
proteome are elicited by ethanol (78). Comparisons of Bicine-dSDS-PAGE to Tricine-
dSDS-PAGE and the standard Glycine-dSDS-PAGE (Laemmli method) revealed a 
considerably better separation method for membrane-associated proteins, as well as 
highly basic proteins, in addition to the advantage of circumventing solubility issues in 
the first dimension of standard 2D-SDS-PAGE experiments. These differences between 
bicine, tricine and glycine were explained through capillary electrophoresis investigations 
of electrophoretic migrations. Both Bicine- and Tricine-dSDS-PAGE were amenable to 
protein spot analysis and identification by mass spectrometry. 
 
Experimental 
 
Materials 
 All materials and chemicals for the growth of bacterial cultures were from Sigma 
(St. Louis, MO) except yeast extract, which was obtained from Difco Laboratories 
(Detroit, MI). Laemmli sample buffer, Coomassie stains, Tris base, SDS, acrylamide, 
N,N-methylene-bis-acrylamide (bis), ammonium persulfate (APS), N,N,N,N-tetramethyl-
ethylenediamine (TEMED), glycine and tricine were obtained from Bio-Rad (Hercules, 
CA). Bicine, ammonium bicarbonate and the MALDI matrix α-cyano-4-
hydroxycinnamic acid (HCCA) came from Sigma. Methanol, glycerol, o-phosphoric 
acid, hydrochloric acid, formic acid, trifluoroacetic acid (TFA), boric acid, acetonitrile 
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and trypsin were purchased from Fisher Scientific (Pittsburg, PA). Ammonium sulfate 
was obtained from EMD Chemicals (Gibbstown, NJ). 
 
Bacterial Strains and Growth Conditions 
Clostridium thermocellum ATCC 27405 was obtained from the American Type 
Culture Collection and cultured in a medium that contained 10.8 mM Na2HPO4, 11.05 
mM KH2PO4, 9.35 mM NH4Cl, 3.79 mM (NH4)2SO4, 0.44 mM MgCl2.6H2O, 0.27 mM 
CaCl2, 2.0 g/L yeast extract, 0.5 g of cysteine, 10 mL of a vitamin standard mixture (79), 
5 mL of a modified micromineral mixture (79) and 1 mg/L of the oxygen indicator 
resazurin. The stock micromineral mixture was modified to provide 10 mg of 
Na2WO4.2H2O and 1 mg of Na2SeO3 per liter of medium. The basal medium was 
adjusted to pH 6.7 with 10% NaOH and autoclaved for 10 min to remove dissolved 
gases. Carbon dioxide was then immediately bubbled through the solution until it was 
cooled to room temperature and an anaerobic solution containing 4 g of Na2CO3 was then 
added. The medium was anaerobically dispensed into culture tubes and bottles and 
sterilized by autoclaving for 20 min. This basal medium was supplemented with an 
anaerobic solution of cellobiose to provide a final concentration of 4 g/L.  
Cell cultures were grown at 55ºC and harvested once the optical density at 600 
nm had reached approximately 1.0. The cultures were then centrifuged at 15,000 x g for 
10 min at 4oC. The supernatant was discarded and the pellets re-suspended with 40 mL of 
50 mM Tris, pH 7.5. This was followed by another 10 min centrifugation and an 
additional wash step. Cell pellets were finally re-suspended in the Tris buffer to a final 
optical density of approximately 50. The concentrated cells were stored at -80oC. 
 
Preparation of Membrane Protein Fractions 
Concentrated C. thermocellum cells were thawed and 
phenylmethylsulfonylfluoride (PMSF) and DTT were added to achieve final 
concentrations of 5 mM for each. The cells were then lysed by passage through a French 
Press (SLM Aminco, Urbana, IL) three times at 137 MPa. The broken cells were 
centrifuged for 10 min at 5,700 x g and 4oC. The pellets were discarded and the 
supernatant centrifuged at 200,000 x g and 4oC for 45 min. The resulting membrane 
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pellet was re-suspended in 10 mL of 10 mM Tris, pH 7.5. Next, the pellet was 
centrifuged twice (200,000 x g, 4oC, 45 min), and finally re-suspended in 10 mM Tris, 
pH 7.5, to obtain a protein concentration of approximately 6.4 mg/mL. Protein content 
was determined using the Lowry assay (80). Aliquots of re-suspended proteins were 
stored at -80oC until further use. 
 
The dSDS-PAGE Experiment 
Small (7 cm x 8 cm) and large (20 cm x 20 cm) format gel experiments were 
performed at 4oC with Mini PROTEAN II and PROTEAN II xi electrophoresis cells 
(Bio-Rad), respectively. Linear acrylamide gradients in the second dimension of dSDS-
PAGE were generated using a Model 485 Gradient Former and all gels were run at 4oC. 
The first dimension of a dSDS-PAGE experiment consisted of a 4% acrylamide stacking 
gel and a 10% separating gel. Gel thickness was 0.75 mm and 1.0 mm for small and large 
formats, respectively. The Laemmli protocol (19) was used to separate the proteins in the 
first dimension for Glycine-, Tricine- and Bicine-dSDS-PAGE. Small format gels were 
run at a constant 200 V, with run times of approximately 50 min. The large format gels 
were run at 16 mA/gel for protein migration through the stacking gel, and this was then 
increased to 24 mA/gel when the dye front entered the separating gel. Run times for large 
format 1D gels were approximately 7 h.  
Membrane proteins were then further resolved in the second dimension by a 9-
12% linear acrylamide gradient gel. After staining with Coomassie R-250 overnight, gel 
strips (approximately 5 mm wide) were excised from the first dimension, swelled for 30 
min in buffer (100 mM Tris, 150 mM HCl, approximately pH 2) (17), and then placed in 
between the glass plates and on top of the separating gel of the second dimension (Figure 
2.2.1). Gaps between the excised gel lane and spacers of the second dimension were 
filled with gel mixtures that contained 10% acrylamide, the same composition as in the 
1D strip. Gel and running buffer preparation for the second dimension of Glycine-dSDS-
PAGE followed the Laemmli protocol (19). In the case of Tricine-dSDS-PAGE, the 
second dimension running buffer was prepared as described by Hunte et al. (81) and a 
similar system was designed for Bicine-dSDS-PAGE (Table 2.2.1). In the interest of 
methods development and optimization, a series of experiments were performed for the 
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Figure 2.2.1. Doubled SDS-PAGE (dSDS-PAGE) experiment with molecular weight-
based separations in two dimensions. A first dimensional separation was performed 
(Laemmli protocol) using a 4% stacking gel and 10% resolving gel. The 1D sample strip 
was then further separated in the second dimension by a 9-12% linear acrylamide 
gradient gel using glycine-, tricine- or bicine-based buffer systems. 
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Table 2.2.1. Running buffer composition of second dimension dSDS-PAGE gels. 
 Glycine-dSDS-PAGEa 
Bicine-dSDS-
PAGE 
Tricine-dSDS-
PAGEb 
 
Anode Buffer 
 
25 mM Tris 
192 mM glycine 
0.1% SDS 
pH 8.3 
 
200 mM Tris 
pH 8.9 
 
200 mM Tris 
pH 8.9 
 
Cathode Buffer 
 
25 mM Tris 
192 mM glycine 
0.1% SDS 
pH 8.3 
 
100 mM Tris 
100 mM bicine 
0.1% SDS 
pH 8.3 
 
100 mM Tris 
100 mM tricine 
0.1% SDS 
pH 8.3 
aAs previously described (19) 
bAs previously described (33) 
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second dimension of Tricine- and Bicine-dSDS-PAGE. In all second dimension 
experiments, the gel thickness for the small and large formats was 1 mm and 1.5 mm, 
respectively. For the second dimension of Bicine- and Tricine-dSDS-PAGE small format 
gels, electrophoresis was performed by applying a constant 100 V for 30 min to allow 
protein migration through the width of the 1D strip and overlay gel. When the dye front 
entered the separating gel, the voltage was increased to and maintained at 150 V. Run 
times were typically 2.5 h. For large format gels in the second dimension of Bicine- and 
Tricine-dSDS-PAGE, running conditions were 90 V for the first 30 min and 120 V 
thereafter, with run times of approximately 24 h. All second dimension gels were stained 
with G-250 Colloidal Coomassie (23). 
 
Image Analyses 
Gel images were captured using a Bio-rad Versadoc Imaging System and analysis 
of 1D and 2D images was performed by Bio-Rad Quantity One and PDQuest software, 
respectively. Images shown in figures are Gaussian representations generated by the 
software. 
 
Protein Identification 
Tryptic digests of membrane proteins were examined in positive ion mode using a 
Bruker Autoflex MALDI-TOF or a Finnigan LCQ Classic quadrupole ion trap mass 
spectrometer. HCCA was used as the matrix of choice for protein samples. MALDI 
spectra were internally calibrated using peptides generated from trypsin autolysis. Peptide 
mass fingerprinting data (PMF) with monoisotopic peak mass lists were analyzed using 
the MASCOT algorithm and the C. thermocellum database (82). Protein spots that could 
not be identified by MALDI were subjected to LC-ESI-MS/MS and C. thermocellum 
database searching with MASCOT. 
A Hewlett Packard LC system (1100 series) with a custom-made C18 capillary LC 
column was interfaced to the ion trap mass spectrometer for reversed phase LC-MS/MS 
analyses. A mobile phase mixture of water and acetonitrile (ACN), each containing 0.1% 
formic acid, was used in all experiments. Gradient elution was employed in these studies, 
 165
similar to the profile described in Chapter 1.2 of Part 1. LCQ data was also analyzed by 
the MASCOT algorithm and the C. thermocellum database. 
 
Capillary Electrophoresis 
 Capillary electrophoresis (CE) experiments were performed on a Groton 
Biosystem CE equipped with a UV detector (Boxborough, MA). The detection 
wavelength was set at 290 nm. An uncoated fused silica capillary (Polymicro 
Technologies, Phoenix, AZ) with dimensions of 95 cm (70 cm effective length) x 75 μm 
I.D was used for separation. A background electrolyte (BGE) containing 100 mM borate 
buffer at the desired pH and 10 mM 2-methyl-1,3-cyclohexanedione was used in all 
experiments. Prior to use, the capillary was rinsed with 1.0 M NaOH for 10 min, 
followed by 0.1 M NaOH for 10 min, water for 5 min and finally with BGE for 10 min. 
After each run, the capillary was rinsed with 0.1 M NaOH for 1 min, methanol for 1 min 
and with BGE for 5 min. Samples were injected hydrodynamically at a pressure of 50 
mbar for 6 seconds. BGE was replaced after every alternate run. Analytes were identified 
by indirect UV detection and 2-methy-1,3-cyclohexanedione was included in the BGE as 
a UV-absorbing probe. 
 
Results and Discussion 
 
Optimization of the dSDS-PAGE Experiment 
As with any separation experiment, manipulation of the mobile and stationary 
phases can often yield improved sensitivity and resolution. Therefore, the parameter 
space of gel preparation (stationary phase) and the running buffer system (mobile phase) 
were manipulated to arrive at the optimal separation conditions for C. thermocellum 
membrane proteins. Tricine-dSDS-PAGE and the newly developed Bicine-dSDS-PAGE 
were explored in this regard. Bicine or N,N-bis(2-hydroxyethyl)glycine is a tertiary 
amine and has buffering capacity for the pH range of 7.6 – 9.0 (pka1 = 1.84 and pka2 = 
8.35). Tricine or N-tris-(hydroxymethyl)-methylglycine is a secondary amine buffer for 
the pH range of 7.4 – 8.8 (pka1 = 2.3 and pka2 = 8.15). SDS-PAGE gels and running 
buffers are normally operated in the 6.6 – 8.8 pH range, which makes bicine- and tricine-
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based buffer systems somewhat more suitable as the range is within a reasonable 
proximity of their pka2 values. To ensure maximum buffering action of bicine and tricine, 
the pH of running buffers based on these ions were adjusted to be close to their pKa2 
values. Operating at higher pH to accommodate the pH range of 8.8 – 10.6 buffering 
region of the primary amine glycine (pka1 = 2.35 and pka2 = 9.78) used in the Laemmli 
approach of dSDS-PAGE is not advised due to the susceptibility of acrylamide to 
hydrolysis (83). 
Optimization of gel preparation parameters was performed using small format 
gels. We previously determined that a 10% acrylamide gel in the first dimension, 
followed by a 9-12% linear gradient gel in the second dimension of dSDS-PAGE 
provided reasonable protein spot resolution across the entire molecular weight range of 
the C. thermocellum membrane proteome (84). An overlay gel containing the same 
acrylamide percentage as the 1D sample strip and 150 mM Tris-HCl, pH 7.4, provided 
electrical conductivity similar to that of the 1D strip and maintained a neutral pH for 
efficient polymerization of acrylamide (17). Running buffer compositions for all 
experiments are given in Table 2.2.1. The method of Schägger et al. (81) was used to 
prepare running buffer for Tricine-dSDS-PAGE and a suitable protocol was designed for 
Bicine-dSDS-PAGE. Preliminary investigations involved applying the standard Laemmli 
gel preparation protocol with these two buffer systems. Bicine- and Tricine-dSDS-PAGE 
resulted in similar spot number, which was much poorer compared to Glycine-dSDS-
PAGE. Considerable vertical streaking was observed and overall, it was evident that the 
Laemmli method for gel preparation was not well-suited for use with these buffer 
systems, as shown in Figures 2.2.2(A) and (B). 
There have been reports of enhanced electrophoretic performance by 
incorporating glycerol in the gel, due to improved sieving (36) and mechanical stability 
(40). Enhanced resolution, particularly for peptides, is a result of either exclusion or 
ordering of water in the resolving gel (39). Furthermore, due to its viscous nature, 
glycerol is believed to aid in the separation and staining processes by reducing diffusion 
(40). In our experiments, addition of glycerol to the gel solution while keeping all other 
ingredients similar to the Laemmli protocol did not result in any significant increases in 
spot numbers for Tricine-dSDS-PAGE, although there were marginal increases in the 
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Figure 2.2.2. Standard Laemmli protocol in gel preparation for (A) Bicine-dSDS-PAGE 
and (B) Tricine-dSDS-PAGE. 
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case of Bicine-dSDS-PAGE. Vertical streaking remained a significant problem. 
However, there appeared to be improvements in spot resolution, particularly in Tricine-
dSDS-PAGE, as shown in Figures 2.2.3(A) and (B).  
The effect of increasing the Tris concentration in the gel solution was also 
investigated, as theoretical (74-76) and experimental (39, 77) evidence suggested that 
increased ionic strength can play a pivotal role in the successful stacking, migration and 
resolution of proteins. Just as with glycerol, high amounts of Tris in the resolving gel is 
also believed to improve resolution by excluding or ordering water in the gel (39). 
Keeping all other gel preparation parameters the same as the Laemmli protocol, higher 
concentrations of Tris were explored in the gel recipie for Bicine- and Tricine-dSDS-
PAGE. Compared to the gels with glycerol, no detectable increases in protein spot 
numbers were observed in either case. Problems with vertical streaking were improved, 
especially for Tricine-dSDS-PAGE. In addition, spot resolution was better (spots less 
diffuse) for both Bicine- and Tricine-dSDS-PAGE, as shown in Figures 2.2.4(A) and (B). 
Dramatic improvements were observed when both glycerol and increased Tris 
concentrations were incorporated into the gel solutions for Bicine- and Tricine-dSDS-
PAGE. Gels that had glycerol and a high Tris concentration displayed remarkable 
improvements in spot number for Bicine-dSDS-PAGE. Spot resolution was better in both 
systems and furthermore, vertical streaking was negligible. The improved gel sieving 
offered by glycerol in conjunction with a high ionic strength produced a stationary phase 
with better resolving power, as shown in Figures 2.2.5(A) and (B). A tighter separating 
gel mesh with narrower sieve was also investigated for the purposes of improving the 
separation. Previous studies have indicated that such a gel offers better resolution and 
reduced leakage of low molecular weight proteins from the gel during the protein staining 
process (38). Gels made with a higher percentage cross-linker (6%) showed improvement 
in spot number for Bicine- and Tricine-dSDS-PAGE, as shown in Figures 2.2.6(A) and 
(B). Spot resolution improved and virtually no vertical streaking was observed. Other 
parameters, such as presence of different types of spacer gels, were explored (data not 
shown) and determined to have little effect in enhancing the separation process. Based on 
these results, the optimized parameters for gel preparation in Bicine- and Tricine-dSDS-
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Figure 2.2.3. Effect of glycerol in gel preparation for (A) Bicine-dSDS-PAGE and (B) 
Tricine-dSDS-PAGE. 
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Figure 2.2.4. Effect of increased Tris buffer in gel preparation for (A) Bicine-dSDS-
PAGE and (B) Tricine-dSDS-PAGE. 
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Figure 2.2.5. Effect of glycerol and increased Tris buffer in gel preparation for (A) 
Bicine-dSDS-PAGE and (B) Tricine-dSDS-PAGE. 
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Figure 2.2.6. Effect of glycerol, increased Tris buffer and high percentage cross-linker in 
gel preparation for (A) Bicine-dSDS-PAGE and (B) Tricine-dSDS-PAGE. 
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PAGE were 10.7% glycerol, 1 M Tris, 0.1% SDS and 6% bis-acrylamide cross-linker, 
along with 0.05% APS and 0.05% TEMED for polymerization.  
 
Large Format Gel Experiments with Optimized Parameters 
To further improve protein representation and increase protein loading capacity of 
the gel, large format experiments for Laemmli-, Bicine- and Tricine-dSDS-PAGE were 
performed using optimized gel preparation protocols, as shown in Figures 2.2.7 to 2.2.9. 
Comparing these optimized large format gels for the three buffer systems, it was clear 
that Bicine dSDS-PAGE offered significant improvements in spot number over Tricine- 
and Glycine-dSDS-PAGE. Tricine-dSDS-PAGE showed a 112% increase in protein spot 
number and Bicine-dSDS-PAGE showed a 151% increase over Glycine-dSDS-PAGE. 
Spot resolution in Bicine-dSDS-PAGE was also dramatically better, particularly in the 
high molecular weight range. Although Tricine- and Glycine-dSDS-PAGE showed 
similar spot count, resolution of spots was superior in the former. Protein spot excision, 
in-gel digestion and MALDI-TOF analysis demonstrated that both Bicine- and Tricine-
dSDS-PAGE were compatible with mass spectrometry (Figures 2.2.7 to 2.2.9). The 
dSDS-PAGE experiment was well-suited for the analysis of hydrophobic proteins and 
highly basic proteins, unlike traditional 2D-PAGE approaches. Combining this power 
with the added advantages of improved spot resolution and protein representation 
observed in a bicine-based system produced a separation method that is amenable to 
detailed probing of the membrane proteome. 
Since all dSDS-PAGE techniques investigated involved identical first dimensions 
using the Laemmli protocol, the resolving power of each method can be effectively 
demonstrated when considering the conversion of total number of protein bands in the 
first dimension to total number of protein spots in the second dimension in large format 
gels. For Glycine-dSDS-PAGE, 42 bands in the first dimension were translated into 109 
second dimensional protein spots. In the case of Tricine-dSDS-PAGE, 42 1D bands were 
converted into 122 second dimension spots. Finally for Bicine-dSDS-PAGE, 42 protein 
bands were resolved into 165 protein spots in the second dimension. The identical first 
dimensional experiments in each protocol served as a normalizing factor in clearly 
demonstrating the relative resolving capabilities of each dSDS-PAGE technique. 
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Figure 2.2.7. Standard Laemmli-dSDS-PAGE separation of C. thermocellum membrane 
proteins. A 10% acrylamide 1D experiment was followed by a 9-12% 2D acrylamide 
gradient gel separation. Proteins identified by mass spectrometry included S-layer 
proteins (#35 and 36), extracellular solute-binding protein (19) and small GTP-binding 
protein domain (23). 
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Figure 2.2.8. Tricine-dSDS-PAGE of C. thermocellum membrane proteins. A 10% 
acrylamide 1D experiment was followed by a 9-12% 2D acrylamide gradient gel 
separation. Proteins identified by mass spectrometry included S-layer proteins (#35 and 
36) and molecular chaperone (31). 
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Figure 2.2.9. Bicine-dSDS-PAGE of C. thermocellum membrane proteins. A 10% 
acrylamide 1D experiment was followed by a 9-12% 2D acrylamide gradient gel 
separation. Proteins identified by mass spectrometry included S-layer proteins (#35 and 
36), glycoside hydrolase family 10 enzyme (33), ribosomal protein L16 (26), 
extracellular solute-binding protein (19) and ABC transporter (16). 
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A closer look at the electrophoresis process offers insight into the observed 
differences in resolving powers for the three dSDS-PAGE methods. Tricine-based buffer 
systems have been typically used for the separation of low-molecular weight proteins and 
peptides. The stacking of low molecular weight polypeptides (5 kDa) by Glycine-SDS-
PAGE is complicated by the fact that their complex with SDS has about the same size as 
that of the SDS micelle (18-32 kDa) (33). The small proteins stack together with the SDS 
from the sample buffer and they co-migrate in the resolving gel together with SDS, 
producing inferior resolution. Substituting the trailing ion glycine in the electrode buffer 
with the faster moving tricine prevents stacking of the SDS ions with the low molecular 
weight protein bands, thus improving their resolution. Ion mobility depends on charge 
density of a molecule and the voltage gradient. Under gel electrophoresis pH conditions, 
more tricine is in the migrating anionic form, compared to glycine. As a result, tricine 
migrates faster than glycine under such conditions, despite the fact that tricine has the 
higher molecular weight (Table 2.2.2). Evidence from previous studies suggests that 
highly hydrophobic peptides are unable to bind with SDS at high SDS:protein ratios, 
suggesting a greater role of the trailing ion in electrophoretic separations (85). A similar 
argument can be considered for hydrophobic membrane proteins, indicating that a faster 
ion than glycine would be more suitable to obtain better resolution. Unlike peptides, 
however, membrane proteins are considerably larger in size and less mobile. As such, a 
very fast ion, such as tricine, would not be able to provide sufficient time and opportunity 
for optimum separation and resolution.  
 
Capillary Electrophoresis Experiments 
The driving force for ion motion in gel electrophoresis is electrophoretic mobility, 
as electroosmotic flow is non-existent. An examination of the electrophoretic mobilities 
of trailing ions in the three buffer systems can provide insight into the selectivity and 
separation efficiency offered by Glycine-, Bicine- and Tricine-dSDS-PAGE. To this end, 
capillary electrophoresis with indirect UV detection was performed on glycine, bicine, 
and tricine. In CE, ion mobility is a vector addition of electroosmotic flow (μeo) and 
electrophoretic mobility (μe). Electroosmotic flow is the movement of a liquid in contact 
with the solid capillary surface when a tangential electric field is applied. The migration 
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Table 2.2.2. Charge states of various gel electrophoresis buffers. 
 
 
 
 
 
 
 
 
 
 
pH 6 7 8 9 10 11 12 13 14 
Glycine 
 
pka1 = 2.35 
pka2 = 9.78 
 
 
Bicine 
 
pka1 = 1.84 
pka2 = 8.35 
  
Tricine 
 
pka1 = 2.30 
pka2 = 8.15 
  
Tris 
 
pka = 8.30 
 
  H N
+
OH
OH
OH
H
H
H
N
OH
OH
OH
H
H
N
+
O
H O
H H
N
O
H O
OH
N
OH
O
O
OH
N
+
OH
O
O
H
OH
OH
N
+
O
O
OH
H
H OH
OH
N
O
O
OH
H
 179
of a charged species under the influence of this electric field is known as electrophoretic 
mobility. Analyte mobility is dependent not only on the charge density of the solute but 
on the dielectric constant and viscosity of the electrolyte as well. The apparent mobility 
of a species (μ) in CE is expressed as (86): 
eeo μμμ ±= . (2.2.1) 
A positive sign indicates that μe for the ion has same direction as μeo and vice-versa.  
For a given CE experiment, μeo is a constant and dominant factor in the apparent 
mobility of analytes. Therefore, separation of analytes will be exclusively dictated by 
differences in their μe, as given by the following (86): 
( )ttV
lL
eo
e
−
=μ . (2.2.2) 
where L is the capillary length, l is the capillary length to the detector, V is the applied 
voltage, teo is the μeo front migration time and t is the analyte migration time. 
In the standard CE operation mode, the sample is injected at the anodic end of the 
capillary and detection occurs at the cathodic end. The electroosmotic flow front under 
such conditions will travel from anode to cathode. On applying a suitable voltage, 
analytes migrate toward the electrode of opposite charge according to their μe. If μe were 
the dominant or sole driving force in ion mobility, anions, such as bicine and tricine at 
basic pH, would hardly migrate from the anode and never reach the detector. Since the 
magnitude of μeo is much greater than that of μe, the apparent mobilities of all species 
dictate a unidirectional flow from anode to cathode. The direction of μe for cations is the 
same as that of the electroosmotic flow front, enabling cations to migrate faster than μeo 
and reach the detector first. Neutral species travel along with μeo, reaching the detector 
after cations. The anions reach the detector last, as their μe vector is in the opposite 
direction of μeo. 
The electrophoretic mobilities of glycine, bicine and tricine at pH 8.3 and 8.9 
were evaluated by performing standard CE experiments on mixtures of these analytes. 
These pH values were chosen because they are identical to the pH of gel electrophoresis 
running buffers in dSDS-PAGE. For identification purposes and to determine migration 
times, individual analytes were also run separately at each pH. The electropherograms 
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generated from experiments conducted at BGE pH 8.3 and 8.9 are given in Figures 
2.2.10(A) and (B). At both pH values, glycine displayed the shortest migration time, 
followed by bicine, and tricine had the longest migration time. Since apparent mobility 
(μ) is inversely proportional to migration time (86), these experiments demonstrated that 
of the three analytes, glycine showed the highest μ, followed by bicine, with tricine 
having the lowest μ.  
Eqn (2.2.1) dictates that μ for anions will be less than the μeo. Thus, a higher value 
of μ implies a smaller μe since μeo is constant for a given system. So glycine displayed the 
smallest μe (0.12 x 10-4 cm2V-1s-1), followed by bicine (1.50 x 10-4 cm2V-1s-1), and tricine 
displayed the highest μe (2.27 x 10-4 cm2V-1s-1). These results are in direct agreement with 
the pH-dependent charge states of the various analytes (Table 2.2.2). The predominant 
equilibrium for all analytes at the experimental pH values occurs between the zwitterionic 
and anionic forms. At pH 8.3, approximately 50% of bicine is anionic, slightly greater 
than 50% of tricine exists as anions, and a large majority of glycine is zwitterionic. Since 
a larger fraction of tricine is anionic compared to the other analytes, tricine migrated the 
slowest. The constant re-equilibration between the zwitterionic and anionic glycine 
during the course of migration was enough to retard this species and give it a slightly 
greater migration time than μeo. A similar migration order with longer migration times 
was observed for pH 8.9, at which greater amounts of each analyte exists as anions. As in 
CE, bicine would also show intermediate μe in gel electrophoresis experiments. It is 
likely that the intermediate μe of bicine provides the key to better resolution in dSDS-
PAGE of hydrophobic membrane proteins compared to tricine and glycine. 
 
Conclusions 
 
With the typically low abundance of membrane proteins in biological systems, it 
is imperative that analytical protocols for studying such proteins afford the highest 
resolution and protein representation possible. Increased resolution and representation of 
membrane proteins was achieved by exploring electrophoretic buffer systems other than 
the traditional Laemmli approach. Tricine-dSDS-PAGE provided better spot count and
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Figure 2.2.10. Electropherograms of a mixture of glycine, bicine and tricine dissolved in 
background electrolyte (BGE). The BGE used was 100 mM borate + 10 mM 2-methyl-
1,3-cyclohexanedione at (A) pH 8.3 and (B) pH 8.9; capillary dimensions 75 μm x 100 
cm; distance to detector 75 cm.
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resolution compared to Glycine-dSDS-PAGE (112% increase in spot count over Glycine-
dSDS-PAGE) and Bicine-dSDS-PAGE (151% increase in spot count over Glycine-
dSDS-PAGE) provided the best separation conditions of all. Gels with low water content, 
high ionic strength and improved sieving capabilities were better suited for Tricine- and 
Bicine-dSDS-PAGE, compared with the standard Laemmli protocol for gel preparation.  
Due to the hydrophobic nature of membrane proteins, they typically have low 
SDS:protein binding ratios and as such, their migration in an electric field is more 
strongly dictated by the trailing ion in the running buffer. Tricine-dSDS-PAGE, with a 
faster trailing ion than the glycine-based system, provided better electrophoretic 
separation of membrane proteins, as demonstrated by increased spot number in the 
optimized gels. Tricine-based systems have been previously demonstrated to be well-
suited for analysis of peptides, due to their low molecular weight and high mobilities, in 
an electric field. However, with slower moving membrane proteins, a slightly slower 
trailing ion such as bicine can provide adequate time for improved stacking and 
separation. Capillary electrophoresis experiments with indirect UV detection suggested 
that CE data can provide a suitable guide for selection of the trailing ion in gel 
electrophoresis running buffers. In this way, the dSDS-PAGE experiment can be 
appropriately tailored to the particular sample under investigation so as to produce 
optimum separation conditions. The Bicine-dSDS-PAGE approach has been successfully 
applied towards the analysis of differentially expressed proteins in wild type and ethanol-
adapted C. thermocellum membranes to obtain a better understanding of the nature of 
ethanol tolerance (Chapter 2.3). 
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Chapter 2.3 
Analysis of Proteomic Profile Changes in Membranes of Ethanol-Adapted 
Clostridium thermocellum 
 
Introduction 
 
 The effects of ethanol on microbes have been investigated extensively (2, 3, 8-
12), but the mechanisms contributing to growth inhibition are many and complex. A 
major cause of the negative effects of elevated ethanol levels is disturbance and 
disruption of membrane permeability (3), and so it is likely that changes induced by 
ethanol adaptation involve membrane physiology and the membrane proteome. A 
thorough analysis of membrane protein expression in wild type and ethanol-adapted cells 
would shed light on the biochemistry of ethanol tolerance. Due to the disadvantages of 
membrane protein analysis using 2D-PAGE, Schägger and co-workers (17) described a 
doubled SDS-PAGE (dSDS-PAGE) experiment in which SDS-PAGE separation of 
membrane proteins in the first dimension is followed by SDS-PAGE separation in the 
second dimension. They applied tricine-based and standard glycine-based running buffers 
in the analyses. While these buffer systems were suitable for membrane protein analysis, 
the newly designed Bicine-dSDS-PAGE method (34), described in Chapter 2.2, offered 
the best  resolution and protein spot representation of the three approaches. A two-part 
Bicine-dSDS-PAGE analysis was performed on wild type and ethanol-adapted C. 
thermocellum membrane proteins to bring different regions of the membrane proteome 
into focus and obtain a clear picture of differential protein expression patterns. 
Although wild type strains of C. thermocellum are typically inhibited by ethanol 
concentrations less than 2%, strains able to tolerate as high as 8% have been generated (1, 
2, 8-10) through sequential transfer techniques. Previous investigations (78) indicated 
that cell surface proteins could be accumulating at the site of manufacture (cytosol) in 
ethanol-adapted cells. Based on the hypothesis that membrane protein expression in wild 
type and ethanol-tolerant strains is different, the proteomes of these cultures were 
evaluated and compared. Understanding membrane protein expression changes instigated 
by ethanol adaptation is essential in the interest of developing more robust microbes with 
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increased abilities to tolerate and produce biogenic ethanol. To our knowledge, this is the 
first investigation on differential membrane protein expression in C. thermocellum. 
 
Experimental 
 
Materials 
All chemicals and materials for the growth of bacterial cultures were purchased 
from Sigma (St. Louis, MO) except yeast extract, which was obtained from Difco 
Laboratories (Detroit, MI). Laemmli sample buffer, Coomassie G-250, Coomassie R-250, 
Tris base, SDS, acrylamide, N,N-methylene-bis-acrylamide (bis), ammonium persulfate 
(APS) and N,N,N,N-tetramethyl-ethylenediamine (TEMED) were obtained from Bio-Rad 
(Hercules, CA). Bicine, ammonium bicarbonate and the MALDI matrix α-cyano-4-
hydroxycinnamic acid (HCCA) came from Sigma. Methanol, glycerol, o-phosphoric 
acid, hydrochloric acid, formic acid, trifluoroacetic acid (TFA), acetonitrile and trypsin 
were purchased from Fisher Scientific (Pittsburg, PA). Ammonium sulfate was obtained 
from EMD Chemicals (Gibbstown, NJ). 
 
Bacterial Strains and Growth Conditions 
C. thermocellum ATCC 27405 was obtained from the American Type Culture 
Collection. Adaptation of wild type cells to 5% ethanol was brought about using a 
sequential transfer procedure as previously described (78). Briefly, the wild-type strains 
were initially grown in a basal medium containing 0.5% (w/v) ethanol. The rate and 
extent of growth were monitored and upon cessation of growth, cultures were 
immediately transferred to fresh medium containing ethanol at 0.5% (w/v). Several 
(typically 3 or 4) repeated transfers of this sort were performed to ensure that ethanol 
tolerance was not lost. The ethanol concentration was then raised to 1%. Additional 
rounds of repeated transfers were performed and involved incrementally increasing the 
ethanol concentration by 0.5% to arrive at bacteria that could tolerate 5% ethanol. 
The organisms were cultured in a medium that contained 10.8 mM Na2HPO4, 
11.05 mM KH2PO4, 9.35 mM NH4Cl, 3.79 mM (NH4)2SO4, 0.44 mM MgCl2.6H2O, 0.27 
mM CaCl2, 2.0 g/L yeast extract, 0.5 g of cysteine, 10 mL of a vitamin standard mixture 
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(79) and 5 mL of a modified micromineral mixture stock (79). This micromineral mixture 
also contained 10 mg of Na2WO4.2H2O and 1 mg of Na2SeO3 per liter of stock, as well as 
1 mg/L of the oxygen indicator resazurin. The basal medium was adjusted to pH 6.7 with 
10% NaOH and autoclaved for 10 min to remove dissolved gases. Carbon dioxide was 
then immediately bubbled through the solution until it was cooled to room temperature, 
following which an anaerobic solution of Na2CO3 was added to provide 4 g per liter 
(final concentration). The medium was then anaerobically dispensed into culture tubes 
and bottles and sterilized by autoclaving for 20 min. This basal medium was 
supplemented with an anaerobic solution of cellobiose (final concentration of 4 g/L). 
Ethanol-adapted cell cultures were grown in a similar medium that also contained 5% 
(w/v) ethanol. 
 
Preparation of Crude Membrane Protein Fractions 
Cell cultures were grown at 55ºC and harvested once the optical density at 600 
nm had reached approximately 1.0. The cultures were then centrifuged (15,000 x g, 10 
min, 4oC) and the supernatant was discarded and the pellets re-suspended with 40 mL 
buffer (50 mM Tris, pH 7.5). This was followed by another 10 min centrifugation and 
finally by an additional wash step. Cell pellets were then re-suspended in buffer to a final 
optical density of approximately 50. The concentrated cells were stored at -80oC until 
further use. 
Concentrated cells were thawed and phenylmethylsulfonylfluoride (PMSF) and 
dithiothreitol (DTT) were added to achieve final concentrations of 5 mM for each. The 
cells were then lysed by passage through a French Press (SLM Aminco, Urbana, IL) three 
times at 137 MPa. The broken cells were centrifuged (5,700 x g, 10 min, 4oC). The 
pellets were then discarded and the supernatant centrifuged (200,000 x g, 45 min, 4oC). 
The resulting membrane pellet was re-suspended in 10 mL of 10 mM Tris, pH 7.5 and 
this was centrifuged twice (200,000 x g, 45 min, 4oC). The washed pellets were finally 
re-suspended in 10 mM Tris, pH 7.5, to obtain a protein concentration of approximately 
6.4 mg/mL using the Lowry assay (80). Aliquots of re-suspended proteins were stored at 
-80oC until further use. 
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Sucrose Isopycnic Density Gradient Centrifugation 
In order to obtain a more defined membrane fraction for subsequent mass 
spectrometric analyses, the crude membranes from wild type and ethanol-adapted C. 
thermocellum were subjected to sucrose isopycnic density gradient centrifugation 
(SIDGC). The gradient was prepared by layering solutions of increasing sucrose 
percentages in 11 mL centrifuge tubes (bottom to top) as follows: one part 55%, two parts 
45%, two parts 40%, two parts 35%, three parts 30% and finally one part sample. The 
tubes were then centrifuged in a swinging bucket rotor (270,000 x g, 47 h, 4oC). Aliquots 
(0.5 mL) were removed and protein concentration was estimated by absorbance at 280 
nm. Fractions were pooled based on their absorbance and these pools were diluted 
approximately 3-fold with 10 mM Tris (pH 7.5). Membrane proteins were then collected 
by centrifugation (48,300 x g, 2 h, 4oC). The resultant pellets were washed twice with 10 
mM Tris (pH 7.5) and the final resuspension yielded a protein concentration between 11 
and 20 μg/μl. 
 
Bicine-dSDS-PAGE 
A previously developed Bicine-dSDS-PAGE approach (34) was used to separate 
membrane proteins. Large (20 cm x 20 cm) format gel experiments were performed with 
the PROTEAN II xi electrophoresis cell (Bio-Rad). Linear acrylamide gradients in the 
second dimension of dSDS-PAGE were generated using a Model 485 Gradient Former 
and all gels were run at 4oC. The first dimension of a dSDS-PAGE experiment consisted 
of a 4% acrylamide stacking gel and an 8 or 11% separating gel (1 mm thick). The two 
separating gel percentages provided enhanced resolution of different regions of the 
bacterial membrane proteome. The Laemmli protocol (19) was used to separate the 
proteins in the first dimension of Bicine-dSDS-PAGE and gels were run at 16 mA/gel for 
protein migration through the stacking gel. This was then increased to 24 mA/gel when 
the dye front entered the separating gel. Run times for large format 1D gels were 
typically 7 h. 
Membrane proteins were then further resolved in the second dimension by a 7-
12% linear acrylamide gradient gel of 1.5 mm thickness. After staining with Coomassie 
R-250 overnight, gel strips (approximately 5 mm wide) were excised from the first 
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dimension, swelled for 30 min in buffer (100 mM Tris, 150 mM HCl, approximately pH 
2), and then placed in between the glass plates and on top of the separating gel of the 
second dimension (17). Gaps between the excised gel lane and the spacers of the second 
dimension were filled with gel mixtures that contained 10% acrylamide, the same 
composition as in the 1D strip. Gel and running buffer preparation for the second 
dimension of Bicine-dSDS-PAGE were described previously (34). Running conditions 
for second dimensional gels were 90 V for 30 min and 120 V thereafter, with run times of 
approximately 24 h. All second dimension gels were stained with G-250 Colloidal 
Coomassie (23). 
 
Image Analyses 
Gel images were captured using a Bio-rad Versadoc Imaging System and analysis 
of 1D and 2D images was performed by Bio-Rad Quantity One and PDQuest software, 
respectively. Images shown in figures are Gaussian representations generated by the 
software. 
 
Protein Identification 
Tryptic digests of membrane proteins were examined in positive ion mode using a 
Bruker Autoflex MALDI-TOF or a Finnigan LCQ Classic quadrupole ion trap mass 
spectrometer. HCCA was used as the matrix for MALDI-TOF protein analyses. MALDI 
spectra were internally calibrated using peptides from trypsin autolysis (m/z 842.51 and 
2211.10). Peptide mass fingerprinting data (PMF) with monoisotopic peak mass lists 
were analyzed using the MASCOT algorithm and the C. thermocellum database (82). 
Protein spots that could not be identified by MALDI were subjected to LC-ESI-MS/MS. 
A Hewlett Packard LC system (1100 series) with a custom-made C18 capillary LC 
column was interfaced to the ion trap mass spectrometer for reversed phase LC-MS/MS 
analyses. A mobile phase mixture of water and acetonitrile (ACN), each containing 0.1% 
formic acid, was used in all experiments. Gradient elution was employed in these studies, 
as described in Chapter 1.2 of Part 1. LCQ data was also analyzed by the MASCOT 
algorithm and the C. thermocellum database. 
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Results 
 
The Bicine-dSDS-PAGE analysis provided a diagonal arrangement of C. 
thermocellum membrane protein spots and a total of 145 proteins were identified from 
crude and SIDGC membrane preparations using MALDI-TOF MS and MASCOT 
database searching. The MALDI-TOF mass spectrum of a histidine kinase identified 
from C. thermocellum membrane preparations is given in Figure 2.3.1. Analysis of crude 
membrane fractions revealed that 45% of all proteins identified from this fraction were 
cytosolic (based on the absence of protein transmembrane domains or TMDs). In 
contrast, the highly purified samples from SIDGC contained dramatically lower amounts 
(14%) of such proteins. Since the SIDGC fractions were more highly enriched with non-
cytosolic proteins, these samples were used in subsequent experiments. 
The Bicine-dSDS-PAGE analysis of highly purified membrane fractions revealed 
similar spot diversity for wild type and ethanol-adapted C. thermocellum in both the high 
and low molecular weight ranges. Gel experiments aimed at better resolution and 
representation of high molecular weight proteins (8% first dimension separating gel) 
resolved 76 spots in the wild type organism (Figure 2.3.2(A)) and 72 spots in the ethanol-
adapted strain (Figure 2.3.3(A)). For dSDS-PAGE experiments geared towards low 
molecular weight protein analysis (11% first dimension separating gel), wild type C. 
thermocellum membranes yielded 123 spots (Figure 2.3.2(B)) whereas the ethanol-
adapted organism provided 117 spots (Figure 2.3.3(B)). Despite the similarities in protein 
spot numbers between the two cultures, it was evident that many proteins were present at 
higher levels in wild type membranes compared to ethanol-adapted bacteria. Analysis of 
the relative expression values indicated a fairly even distribution of differentially 
expressed proteins throughout the molecular weight range under investigation (Table 
2.3.1). 
 Further examination of the proteins from the SIDGC fractions by measures of 
relative hydrophobicity can provide information on their propensity of being membrane-
associated. TMD analyses revealed that a majority of these proteins have two or more 
TMDs and nearly half had positive Grand Average of Hydropathicity (GRAVY) scores 
(Table 2.3.2). As a general trend, higher numbers of TMDs corresponded with more  
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Figure 2.3.1. MALDI-TOF mass spectrum of histidine kinase, HAMP region: bacterial 
chemotaxis sensory transducer (#32: gi 67874049). 
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(A) 
 
(B) 
 
Figure 2.3.2. Bicine-dSDS-PAGE of the wild type C. thermocellum membrane proteins: 
(A) 8% acrylamide and (B) 11% acrylamide 1D experiments were followed by a 9-12% 
2D acrylamide gradient gel separation. Highlighted proteins identified by mass 
spectrometry include glycoside hydrolase (#45: gi 67874975), SecA (#6: gi 67916795), 
chemotaxis sensory transducer (#37: gi 67873910), flagellar biosynthetic protein FlhB 
(#67: gi 67875429), Mg2+-transporter protein, CorA-like (#26: gi 67875293), divalent 
cation transporter (#61: gi 67916199), amino acid-binding ACT: MgtC/SapB transporter 
(#51: gi 67916179) and S-layer proteins (#18: gi 67917201 and #23: gi 67916324). 
kDa 
97.4 
66.2 
45.0 
31.0 
45 
6 
37 
61 
18 
23 
kDa 
97.4 
66.2 
45.0 
31.0 
21.5 
14.4 
67 
51 
26 
 191
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Figure. 2.3.3. Bicine-dSDS-PAGE of the ethanol-adapted C. thermocellum membrane 
proteins: (A) 8% acrylamide and (B) 11% acrylamide 1D experiments were followed by 
a 9-12% 2D acrylamide gradient gel separation. Highlighted proteins identified by mass 
spectrometry include glycoside hydrolase (#45: gi 67874975), SecA (#6: gi 67916795), 
chemotaxis sensory transducer (#37: gi 67873910), flagellar biosynthetic protein FlhB 
(#67: gi 67875429), Mg2+-transporter protein, CorA-like (#26: gi 67875293), divalent 
cation transporter (#61: gi 67916199), amino acid-binding ACT: MgtC/SapB transporter 
(#51: gi 67916179) and S-layer proteins (#18: gi 67917201 and #23: gi 67916324). 
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Table 2.3.1. Proteins identified from purified membrane fractions: gel analysis data. 
 
# gi Protein Name MW pI MOWSE Score 
Seq. 
cov. 
(%) 
Ratio* 
WT/EA 
1 67876078 Chaperonin Cpn60/TCP-1 57474 4.96 425 43 0.88 
2 67876077 Chaperonin Cpn10 10156 5.22 38 30 1.35 
3 67874556 AMP-dependent synthetase and ligase 64507 8.72 177 37 1.05 
4 67874931 Cysteine synthase K/M: Cysteine synthase K 33398 6.62 652 43 1.19 
5 67916452 Anthranilate synthase component I 56020 6.30 33 12 2.73 
6 67916795 SecA protein 104612 6.38 132 24 2.57 
7 67916027 H
+-transporting two-sector 
ATPase 65363 5.30 159 30 1.18 
8 67875538 NADH dehydrogenase (ubiquinone) 68124 6.55 102 22 1.23 
9 67916533 
Ferredoxin: 4Fe-4S ferredoxin, 
iron-sulfur binding domain: 
Iron hydrogenase, small 
subunit: Hydrogenase large 
subunit, C-terminal 
64013 6.25 34 11 1.78 
10 67916676 Acetate kinase 43966 7.12 34 14 1.39 
11 67916856 
Clostridium cellulosome 
enzyme, dockerin type I: 
Carbohydrate binding module, 
family 6 
105247 6.03 38 7 2.12 
12 67916907 
Glycoside hydrolase, family 5: 
Clostridium cellulosome 
enzyme, dockerin type I: 
Carbohydrate binding domain, 
family 11 
102415 5.61 33 6 1.18 
13 67874442 Polysaccharide deacetylase 36292 5.39 100 17 2.42 
14 67875254 
Glycoside hydrolase, family 9: 
Clostridium cellulosome 
enzyme, dockerin type I 
68642 5.57 32 6 3.21 
15 67875618 Conserved hypothetical protein 40466 5.64 32 5 2.54 
16 67917396 Periplasmic binding protein 34968 4.98 43 25 2.08 
17 67916519 
Peptide chain release factor 3: 
Small GTP-binding protein 
domain 
60641 5.95 32 9 1.18 
18 67917201 S-layer protein (SLH domain): Bacterial Ig-related 64851 4.50 354 12 3.78 
19 67875524 
Glycoside hydrolase, family 9: 
Clostridium cellulosome 
enzyme, dockerin type 1: 
Carbohydrate-binding, CenC-
like: Glycoside hydrolase 
family 9, N-terminal, Ig-like 
100621 5.29 32 5 2.20 
20 67874774 
Glycoside hydrolase, family 9: 
Bacterial type 3a cellulose-
binding domain: Clostridium 
82122 5.49 32 5 4.17 
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cellulosome enzyme, dockerin 
type 1 
21 67876088 Clostridium cellulosome enzyme, dockerin type I 55169 8.55 97 17 2.01 
22 67916212 
Putative esterase: Glycoside 
hydrolase, family 10: 
Clostridium cellulosome 
enzyme, dockerin type 1: 
Carbohydrate-binding, CenC-
like 
119664 5.45 33 3 2.76 
23 67916324 Similar to S-layer domain 89952 5.12 32 7 2.08 
24 67875819 Hypothetical protein CtheDRAFT_2053 17520 9.61 48 25 2.96 
25 67917091 
ATP-binding region, ATPase-
like: Histidine kinase A, N-
terminal 
39499 7.33 86 19 1.62 
26 67875293 Mg
2+ transporter protein, 
CorA-like 36590 4.91 73 25 0.44 
27 67916045 
CheW-like protein:ATP-
binding region, ATPase-like: 
Signal transducing histidine 
kinase, homodimeric domain: 
Hpt 
78305 4.94 95 5 0.40 
28 67916751 
Glycosyl transferase, group 1: 
Phospholipid/glycerol 
acyltransferase 
71359 9.80 36 6 2.35 
29 67916159 
Clostridium cellulosome 
enzyme, dockerin type I: 
Glycosyl hydrolase, BNR 
repeat 
92364 5.19 73 7 2.44 
30 67916443 Protein of unknown function DUF 1432 35303 8.73 253 56 2.95 
31 67916720 Glycosyl transferase, family 2 36155 8.69 48 13 2.76 
32 67874049 
Histidine kinase, HAMP 
region: Bacterial chemotaxis 
sensory transducer 
68286 5.02 46 21 0.50 
33 67916032 AAA ATPase, central region: Peptidase M41, FtsH 43874 8.82 132 24 1.32 
34 67875125 
Glycoside hydrolase, family 9: 
Bacterial type 3a cellulose-
binding domain: Clostridium 
cellulosome enzyme, dockerin 
type 1 
79810 5.23 51 10 2.22 
35 67873911 ABC1 64815 6.29 113 20 2.26 
36 67874822 MotA/TolQ/ExbB proton channel 30847 5.62 98 10 1.60 
37 67873910 Chemotaxis sensory transducer 45710 4.92 103 32 0.38 
38 67875410 Flagellar FliF M-ring protein 57822 4.90 41 8 0.43 
39 67876339 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 44383 7.80 112 10 0.99 
40 67916760 
ATP-binding region, ATPase-
like: Histidine kinase A, N-
terminal 
40280 5.46 83 15 1.65 
41 67874555 Serine-type D-Ala-D-Ala carboxypeptidase 47984 6.95 44 5 2.54 
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42 67916336 Chemotaxis sensory transducer 46229 4.99 33 6 0.25 
43 67876447 Serine-type D-Ala-D-Ala carboxypeptidase 46650 5.68 53 17 2.14 
44 67874093 Hypothetical protein CtheDRAFT_3149 30329 9.31 49 7 1.84 
45 67874975 Glycoside hydrolase, family 15 73680 5.52 32 7 2.29 
46 67916154 Conserved hypothetical protein 25138 9.09 74 26 1.86 
47 67876065 Peptidase C39, bacteriocin processing 33754 8.55 102 22 2.10 
48 67917031 
Putative sugar transport system 
permease ABC transporter 
protein 
18113 9.30 76 12 2.92 
49 67917112 ABC transporter, transmembrane region 29046 8.97 35 7 1.80 
50 67873242 Similar to Flp pilus assembly protein TadB 30626 5.42 55 9 0.49 
51 67916179 Amino acid-binding ACT: MgtC/SapB transporter 25495 9.04 50 10 0.35 
52 67916824 
Histidine kinase, HAMP 
region: Cache domain: 
Bacterial chemotaxis sensory 
transducer 
91309 5.06 32 13 0.91 
53 67875449 Holin, toxin secretion/phage lysis 14926 8.31 32 6 1.13 
54 67916023 H
+-transporting two-sector 
ATPase, C subunit 15977 6.62 48 13 1.45 
55 67915993 MscS Mechanosensitive ion channel 31354 8.80 42 9 0.47 
56 67916702 
ABC transporter, 
transmembrane region: ABC 
transporter 
71856 8.51 58 18 2.44 
57 67875027 Hedgehog/Intein hint domain, N-terminal 60427 6.41 98 19 0.73 
58 67916960 Lipopolysaccharide biosynthesis 47526 5.18 75 22 1.11 
59 67916966 Glycosyl transferase, family 2 44800 8.88 103 33 1.10 
60 67876364 
CDP-diacylglycerol-glycerol-
3-phosphate 3-
phosphatidyltransferase 
22566 9.59 27 2 2.30 
61 67916199 Divalent cation transporter 50239 5.03 48 8 0.24 
62 67916249 
Amino acid ABC transporter, 
permease protein, 3-TM 
region, His/Glu/Gln/Arg/opine 
24788 9.54 53 13 2.22 
63 67873370 GGDEF: Uncharacterized HDIG domain 60702 8.34 36 4 2.11 
64 67875548 Small basic protein 13797 9.27 77 12 2.08 
65 67874594 Permease 13024 9.60 42 11 3.02 
66 67916392 Cobalt transport protein 30127 9.36 44 15 0.59 
67 67875429 Flagellar biosynthetic protein FlhB 44294 9.52 49 13 0.50 
68 67875120 Hypothetical protein CtheDRAFT_2575 37170 9.00 55 10 1.85 
69 67875688 
ABC transporter, 
transmembrane region: ABC 
transporter 
70505 7.19 73 3 1.70 
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70 67873849 H
+-transporting two-sector 
ATPase, A subunit 28464 5.59 39 8 0.99 
71 67917176 Phosphatidate cytidylyltransferase 22273 9.14 61 9 2.06 
72 67873913 
Cation transporting ATPase, 
N-terminal: Haloacid 
dehalogenase-like hydrolase: 
Cation transport ATPase, C-
terminal: E1-E2 ATPase-
associated region 
93885 6.40 75 10 2.28 
* Spot density ratio 
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Table 2.3.2. Proteins identified from purified membrane fractions: Grand Average of 
Hydropathicity (GRAVY) and transmembrane domain (TMD) analysis. 
# gi Protein Name F. Class* GRAVY
† # TMDs‡ 
1 67876078 Chaperonin Cpn60/TCP-1 O -0.081 0 
2 67876077 Chaperonin Cpn10 O -0.068 0 
3 67874556 AMP-dependent synthetase and ligase I 0.193 0 
4 67874931 Cysteine synthase K/M: Cysteine synthase K E -0.129 0 
5 67916452 Anthranilate synthase component I EH -0.276 0 
6 67916795 SecA protein U -0.546 0 
7 67916027 H+-transporting two-sector ATPase C -0.228 0 
8 67875538 NADH dehydrogenase (ubiquinone) C -0.209 0 
9 67916533 
Ferredoxin: 4Fe-4S ferredoxin, iron-sulfur 
binding domain: Iron hydrogenase, small 
subunit: Hydrogenase large subunit, C-terminal 
C -0.202 0 
10 67916676 Acetate kinase C -0.089 0 
11 67916856 Clostridium cellulosome enzyme, dockerin type I: Carbohydrate binding module, family 6 G -0.238 1 
12 67916907 
Glycoside hydrolase, family 5: Clostridium 
cellulosome enzyme, dockerin type I: 
Carbohydrate binding domain, family 11 
G -0.456 1 
13 67874442 Polysaccharide deacetylase G -0.264 1 
14 67875254 Glycoside hydrolase, family 9: Clostridium cellulosome enzyme, dockerin type I G -0.445 1 
15 67875618 Conserved hypothetical protein S -0.639 1 
16 67917396 Periplasmic binding protein P -0.346 1 
17 67916519 Peptide chain release factor 3: Small GTP-binding protein domain O -0.319 1 
18 67917201 S-layer protein (SLH domain): Bacterial Ig-related V -0.208 1 
19 67875524 
Glycoside hydrolase, family 9: Clostridium 
cellulosome enzyme, dockerin type 1: 
Carbohydrate-binding, CenC-like: Glycoside 
hydrolase family 9, N-terminal, Ig-like 
G -0.532 1 
20 67874774 
Glycoside hydrolase, family 9: Bacterial type 
3a cellulose-binding domain: Clostridium 
cellulosome enzyme, dockerin type 1 
G -0.327 1 
21 67876088 Clostridium cellulosome enzyme, dockerin type I G -0.212 1 
22 67916212 
Putative esterase: Glycoside hydrolase, family 
10: Clostridium cellulosome enzyme, dockerin 
type 1: Carbohydrate-binding, CenC-like 
G -0.358 1 
23 67916324 Similar to S-layer domain V -0.190 2 
24 67875819 Hypothetical protein CtheDRAFT_2053 S 0.193 2 
25 67917091 ATP-binding region, ATPase-like: Histidine kinase A, N-terminal T -0.034 2 
26 67875293 Mg2+ transporter protein, CorA-like P 0.036 2 
27 67916045 
CheW-like protein: ATP-binding region, 
ATPase-like: Signal transducing histidine 
kinase, homodimeric domain: Hpt 
T -0.148 2 
28 67916751 Glycosyl transferase, group 1: Phospholipid/glycerol acyltransferase G -0.029 2 
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29 67916159 Clostridium cellulosome enzyme, dockerin type I: Glycosyl hydrolase, BNR repeat G -0.298 2 
30 67916443 Protein of unknown function DUF 1432 S 0.177 2 
31 67916720 Glycosyl transferase, family 2 G 0.130 2 
32 67874049 Histidine kinase, HAMP region: Bacterial chemotaxis sensory transducer T -0.284 2 
33 67916032 AAA ATPase, central region: Peptidase M41, FtsH O -0.151 2 
34 67875125 
Glycoside hydrolase, family 9: Bacterial type 
3a cellulose-binding domain: Clostridium 
cellulosome enzyme, dockerin type 1 
G -0.360 2 
35 67873911 ABC1 O -0.034 2 
36 67874822 MotA/TolQ/ExbB proton channel U 0.084 2 
37 67873910 Chemotaxis sensory transducer T -0.057 2 
38 67875410 Flagellar FliF M-ring protein N -0.403 2 
39 67876339 UDP-N-acetylglucosamine 1-carboxyvinyltransferase M 0.130 2 
40 67916760 ATP-binding region, ATPase-like: Histidine kinase A, N-terminal T -0.159 2 
41 67874555 Serine-type D-Ala-D-Ala carboxypeptidase O -0.054 2 
42 67916336 Chemotaxis sensory transducer T -0.179 2 
43 67876447 Serine-type D-Ala-D-Ala carboxypeptidase O 0.069 2 
44 67874093 Hypothetical protein CtheDRAFT_3149 S -0.140 2 
45 67874975 Glycoside hydrolase, family 15 G -0.335 3 
46 67916154 Conserved hypothetical protein S 0.657 3 
47 67876065 Peptidase C39, bacteriocin processing O 0.120 3 
48 67917031 Putative sugar transport system permease ABC transporter protein G 0.957 3 
49 67917112 ABC transporter, transmembrane region R 0.528 3 
50 67873242 Similar to Flp pilus assembly protein TadB N 0.217 3 
51 67916179 Amino acid-binding ACT: MgtC/SapB transporter E 0.356 3 
52 67916824 
Histidine kinase, HAMP region: Cache 
domain: Bacterial chemotaxis sensory 
transducer 
T -0.244 3 
53 67875449 Holin, toxin secretion/phage lysis V 0.635 3 
54 67916023 H+-transporting two-sector ATPase, C subunit C 1.126 3 
55 67915993 MscS Mechanosensitive ion channel V 0.223 3 
56 67916702 ABC transporter, transmembrane region: ABC transporter R 0.036 3 
57 67875027 Hedgehog/Intein hint domain, N-terminal T 0.044 3 
58 67916960 Lipopolysaccharide biosynthesis GI -0.239 3 
59 67916966 Glycosyl transferase, family 2 G -0.093 4 
60 67876364 CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase I 0.776 4 
61 67916199 Divalent cation transporter P 0.265 4 
62 67916249 Amino acid ABC transporter, permease protein, 3-TM region, His/Glu/Gln/Arg/opine E 0.793 4 
63 67873370 GGDEF: Uncharacterized HDIG domain FT 0.064 4 
64 67875548 Small basic protein S 0.791 4 
65 67874594 Permease R 1.046 4 
66 67916392 Cobalt transport protein P 0.619 4 
67 67875429 Flagellar biosynthetic protein FlhB N -0.011 4 
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68 67875120 Hypothetical protein CtheDRAFT_2575 S 0.416 4 
69 67875688 ABC transporter, transmembrane region: ABC transporter R 0.132 5 
70 67873849 H+-transporting two-sector ATPase, A subunit C 0.793 5 
71 67917176 Phosphatidate cytidylyltransferase F 1.005 5 
72 67873913 
Cation transporting ATPase, N-terminal: 
Haloacid dehalogenase-like hydrolase: Cation 
transport ATPase, C-terminal: E1-E2 ATPase-
associated region 
P 0.159 9 
* Function class of protein (see Appendix for function class names) 
†Grand Average of Hydropathicity (GRAVY) score 
‡Number of transmembrane domains (TMDs) 
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positive GRAVY values, indicating greater hydrophobicity of the protein. Overall, these 
results showed that the SIDGC fractions indeed were enriched with relatively 
hydrophobic proteins that are probably associated with the cell membrane. 
Approximately 60% of the identified proteins in the purified fraction were 
differentially expressed in the wild type and ethanol-adapted strains. Of these 
differentially expressed proteins, 74% were up-regulated by a factor of two or more in the 
wild type strain with the remaining 26% up-regulated in the ethanol-adapted bacterium. 
Approximately half of the up-regulated proteins in the wild type organism were involved 
with carbohydrate transport and metabolism. Some of the up-regulated proteins in the 
ethanol-adapted species were associated with chemotaxis and signal transduction. 
 
Discussion 
 
The C. thermocellum Membrane Proteome 
The 3214 putative proteins in the C. thermocellum proteome were interrogated for 
membrane proteins using the Sosui algorithm (87). This program predicts the number of 
TMDs in the amino acid sequences of proteins. Based on the analysis, 935 proteins 
(29.1% of the total proteome) were found to contain at least one TMD. Furthermore, 492 
proteins in the database contained at least two TMDs. Proteins containing such 
hydrophobic domains were considered as integral membrane proteins. A virtual 2D gel 
map of the C. thermocellum membrane proteome was generated using web-based JVirGel 
software (88), as shown in Figure 2.3.4. 
 
Membrane Proteome Analysis with Bicine-dSDS-PAGE 
The highly purified membrane protein fraction obtained through SIDGC enabled 
relative quantification of differentially expressed proteins in wild type and ethanol-
adapted C. thermocellum (Table 2.3.1). Many of these proteins were not observed in the 
crude fraction, perhaps because of their low abundance compared to other proteins in the 
sample, particularly cytosolic proteins. These experiments clearly demonstrated the 
benefits of employing sample purification procedures to enrich membrane proteins, as 
well as gel-based separation methods that are attentive to their physicochemical nature.  
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Figure 2.3.4. Theoretical 2D gel of the C. thermocellum membrane proteome. 
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The two-stage Bicine-dSDS-PAGE analyses of wild type (Figures 2.3.2(A) and 
(B)) and ethanol-adapted (Figures 2.3.3(A) and (B)) cells displayed similar protein spot 
representation in the high and low molecular weight range. The tendency of membrane 
proteins to have basic pI values is a significant contributor to their under-representation 
in traditional 2D-PAGE (13). However, as demonstrated by the data presented here, pI 
was not a limiting factor in the Bicine-dSDS-PAGE analyses (Table 2.3.1). In addition, 
the generally hydrophobic nature of membrane proteins further contributes to their low 
abundance in 2D gel maps. Here again,  Bicine-dSDS-PAGE analyses proved to be a 
suitable approach due to the fact that solubility issues of membrane proteins in the first 
dimension or isoelectric focusing step of 2D-PAGE are completely circumvented by 
applying molecular weight-based separations in both dimensions.  
 
TMD and GRAVY Analysis of Membrane Proteins 
The presence of hydrophobic domains in a majority of the proteins identified from 
the SIDG fractions supported the contention that these proteins are intimately associated 
with the cell membrane (Table 2.3.2). The membrane protein distribution as a function of 
the number of transmembrane domains (TMDs) in both the C. thermocellum database 
and the experimentally determined membrane proteins from SIDGC fractions revealed a 
marked decline in the number of proteins with high numbers of TMDs, particularly in the 
theoretical membrane population (Figures 2.3.5(A) and (B)). While the theoretical 
membrane population showed a substantially high proportion of proteins with only one 
TMD (47% of all predicted membrane proteins), this was not the case for the 
experimentally determined set (17% of proteins). It should be noted that a sizable fraction 
of proteins with only one TMD may not be true membrane proteins and the fact that this 
set was under-represented in the experimental population is a measure of the 
effectiveness of our sample preparation procedures in eliminating non-membrane protein 
components. The experimental set also differed from the theoretical membrane protein 
population in the representation of proteins with large numbers of TMDs. A possibility 
for the under-representation of these highly hydrophobic proteins is likely related to 
sample solubilization issues. Use of solubilizing detergents in the sample buffer in 
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Figure 2.3.5. Membrane protein distribution as a function of the number of 
transmembrane domains (TMDs) in (A) the C. thermocellum database and (B) the 
experimentally determined membrane proteins from SIDGC fractions. 
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conjunction with the first dimension of dSDS-PAGE could perhaps enhance the presence 
of such proteins in the gels. 
In a majority of the cases, proteins with a high number of TMDs corresponded 
with more positive GRAVY values. The GRAVY analysis of identified proteins should 
be considered with caution, however, as these scores represent the overall hydrophobicity 
of the entire protein and not just the regions of TMDs. Integral membrane proteins often 
have sizable hydrophilic sequences that are not embedded within the lipid bi-layer which 
can contribute to the overall reduction (more negative) of the GRAVY score. An example 
of such a protein is a glycosyl transferase (#59: gi 67916966). This protein had four 
TMDs but its GRAVY score was slightly negative (-0.093). On the opposite end, AMP-
dependent synthetase and ligase (#3: gi 67874556) was determined to have no TMDs but 
GRAVY analysis resulted in a very positive score (0.193). It is possible that such a 
protein is associated with the cell membrane through protein – protein interactions but is 
not necessarily an integral membrane protein. 
 
Differential Protein Expression in C. thermocellum Strains 
Herrero et al. (2) proposed that ethanol effects on membrane fluidity and the 
inhibition of certain membrane-bound enzymes associated with carbohydrate metabolism 
contributed to the ethanol sensitivity of the bacterium. Our results clearly demonstrated 
that a significant proportion of membrane-associated proteins involved with carbohydrate 
transport and metabolism, such as glycoside hydrolase (#45: gi 67874975), were present 
at over 2-fold lower concentrations in the ethanol-adapted strain, compared to the wild 
type organism. It is possible that these proteins are not being properly incorporated into 
the ethanol-challenged cell membrane.  
Studies have shown that in ethanol-challenged systems, membrane damage is 
manifested by the leakage of small, albeit significant, quantities of proteins (11). A 
survey of the proteins present in higher concentrations in the wild type strain showed that 
one of the members of this category is the protein SecA (#6: gi 67916795). This is a 
soluble protein, as demonstrated by the absence of TMDs and negative GRAVY score. 
However, it binds peripherally to membranes with high affinity and supports 
translocation of proteins across the cell membrane (89). Passive leakage of proteins 
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through the membrane lipid bi-layer can potentially account for the down-regulation of 
this protein observed in ethanol-adapted cells. 
Previous investigations have reported that ethanol-challenged cells are 
characterized by the acceleration of a diverse range of processes, including survival, 
chemotaxis, growth and spore germination, particularly at very low ethanol 
concentrations (89). While only a few of the analyzed proteins were found to be up-
regulated in the ethanol-adapted organisms, several of these proteins were observed to 
have signal transduction and/or chemotaxis function, such as the chemotaxis sensory 
transducer (#37: gi 67873910). Some proteins involved with cell motility, such as the 
flagellar biosynthetic protein FlhB (#67: gi 67875429), were also present at higher levels 
in the ethanol-adapted cell membrane. 
Some membrane-bound magnesium ion transporters were up-regulated in the 
ethanol-tolerant organism. These included the Mg2+-transporter protein, CorA-like (#26: 
gi 67875293) and the divalent cation transporter (#61: gi 67916199). Earlier 
investigations (11) have demonstrated that fermentation rates are closely related to 
cellular magnesium concentrations. Leaky membranes, as are characteristic of ethanol-
challenged organisms, can effect the loss of appreciable quantities of small, inorganic 
ions, such as magnesium. It is possible that when adapting to ethanol, the organism 
attempts to incorporate more magnesium ion transporters into the cell membrane, so as to 
counterbalance the passive loss of this ion through the lipid bi-layer. Another protein 
associated with magnesium transport that was up-regulated in ethanol-adapted strains was 
the amino acid-binding ACT: MgtC/SapB transporter (#51: gi 67916179). This protein is 
believed to act as an accessory protein for MgtB, thus mediating magnesium influx into 
the cytosol (89). 
 
Ethanol Exposure and the Membrane Proteome 
A closer look at the physiological effects of ethanol on cell membranes may offer 
explanations for the differential expression of membrane proteins observed in C. 
thermocellum strains under investigation. The hydrophobic interior of the membrane lipid 
bi-layer provides a barrier to the passive transport of polar molecules in and out of the 
cell. The primary physiological effect of an ethanolic environment is a general tightening 
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of the bi-layer as it becomes interspersed with ethanol molecules (11). The polarity of the 
hydrophobic core is increased and the cell responds through mechanisms that attempt to 
offset this increase in membrane rigidity. Ethanol-induced stress causes a reduction in the 
hydrophobic interactions among acyl side chains and hydrophobic domains of proteins. 
Increases in coulombic interactions stimulate a decrease in ionization and an elevation in 
the strength of charge repulsions between the polar heads of membrane phospholipids. 
The overall effect is an increase in surface area occupied per phospholipids molecule, 
reduction in membrane thickness and increases in membrane fluidity (3). Ethanol 
exposure clearly compromises lipid-lipid and lipid-protein interactions within the cell 
membrane. 
Roberts and co-workers (2) have shown that when ethanol is added to C. 
thermocellum cultures, changes in membrane composition occur after the period of 
growth arrest. They detected an increase in the proportion of normal and anteiso-
branched fatty acids (lower melting points) at the expense of iso-branched fatty acids 
(higher melting points), which causes fluidizing of the membrane. Studies have shown 
that key cellular targets for growth inhibition are hydrophobic in nature and that cessation 
of growth is directly proportional to the concentration of perturbing molecules that have 
partitioned into the hydrophobic milieu (2). It is evident that the cell membrane is an 
organelle most vulnerable to ethanol-induced changes. 
Hydrophobic interactions are the major driving force for the biological self-
assembly of membranes and both electrostatic and hydrophobic interactions are involved 
in preserving the spatial organization of membrane components, such as membrane-
associated and integral membrane proteins (11). The positioning of proteins within the 
lipid bi-layer is brought about through a complex balance of charge interactions and 
hydrophobic associations. While the physical principles of ethanol action would be 
similar for all proteins, both cytosolic and membrane-bound, the specific consequences 
for a given protein would clearly depend on the physicochemical properties, structure and 
immediate environment of that particular protein. Ethanol-induced changes in the 
mechanics and chemical environment of the cell membrane can significantly affect the 
tertiary and quaternary structure of membrane proteins, resulting in their inefficient 
assimilation and folding within the lipid bi-layer. Previous investigations from our 
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laboratory (78) have suggested that cell surface proteins, such as different S-layer 
components, could be accumulating at their site of manufacture (the cytosol), perhaps due 
to the failure of chaperones and protein folding agents to successfully incorporate 
membrane proteins into the cell membrane. It is worthwhile to mention that S-layer 
proteins (#18: gi 67917201 and #23: gi 67916324) were observed to be up-regulated in 
the wild-type organism in the investigations reported here. 
 
Conclusions 
 
Proteomics is a very powerful analytical tool for understanding how organisms 
respond to environmental stress, such as ethanol exposure and adaptation. Nevertheless, 
the use of proteomic techniques with C. thermocellum is limited. In fact, to our 
knowledge, this is the first study of the C. thermocellum membrane proteome using 
carefully designed proteomics approaches. In recent years, the realization that cellular 
proteomes are comprised of diverse sub-proteomes which often require different 
methodologies for effective characterization and analysis has brought about a marked 
increase in resources dedicated to methods development for membrane proteome 
analysis. The recently developed Bicine-dSDS-PAGE method was very well-suited for 
studying differential protein expression in wild type and ethanol-adapted C. 
thermocellum strains (34). Dramatic strides in membrane protein representation and 
reduction of cytosolic protein contaminants were achieved through sucrose isopycnic 
density gradient centrifugation techniques. This was corroborated by transmembrane 
domain (TMD) and hydropathy (GRAVY) analyses of identified proteins. 
 It is evident from these investigations that the membrane proteomes of wild type 
and ethanol-adapted species are dissimilar, with a majority of differentially expressed 
proteins being under-represented in the ethanol-adapted bacterium (90). A close 
investigation of differential protein expression can offer insights into the true nature of 
ethanol tolerance. It is probable that the under-represented proteins are being produced in 
lower quantities in the ethanol-adapted cells. Another possibility is that the organism 
simply fails to incorporate the proteins into the cell membrane. The latter option would 
perhaps result in a build-up of integral membrane and membrane-associated proteins in 
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the cytosol, hinting at an inadequate environment in the lipid bi-layer for proper protein 
assimilation and folding to occur. Investigations to determine which possibility is the 
more likely answer are definitely worthwhile in the interest of better understanding 
ethanol adaptation.  
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Chapter 2.4 
Conclusions 
 
Proteomics has emerged, in the wake of the genomics era, as a powerful 
analytical tool for the large-scale study of proteins in cells, the minute specks of universe 
termed living. While the genome is a rather constant, unchanging entity, the proteome 
differs from cell to cell and is frequently altered through biochemical interactions with 
the genome and the environment. An organism will have radically different protein 
expression patterns in different parts of the body, during different stages of the life cycle 
and in different types of environmental conditions. A host of environmental stressors, 
such as disease, climactic changes, fluctuations in nutrient levels and the presence of 
toxins can cause specific alterations in the cellular proteome that can be effectively 
studied using proteomics approaches. A survey of the diversity of living organisms and 
the ecological niches they occupy, ranging from hot sulfur springs to the polar ice caps, is 
a clear indication of the adaptability and versatility of life. It has long been known that 
fermenting organisms, such as yeast and certain thermophilic bacteria including 
Clostridium thermocellum, can be adapted to an environment of accumulating 
fermentation byproducts, such as ethanol. These organisms and their ability to generate 
ethanol have recently generated interest in bio-fuels research and development. This area 
of research has become increasingly important in the current geo-political climate, as the 
trend towards developing cleaner and more efficient fuels becomes critical. A study of 
differential protein expression can offer clues into how these organisms respond to an 
ethanolic environment in an effort to adjust and adapt to existing living conditions. 
Industrial-scale production of bio-ethanol has traditionally been the realm of 
yeast. However, this fungus has the significant drawback of only being able to ferment 
expensive simple sugars, such as maize starch, through multi-step mechanisms. The cost 
of generating large quantities of ethanol through yeast is a definite limitation in 
exploiting this organism for competing with, and ultimately replacing, fossil fuels as the 
chief energy source for human consumption. This is in contrast to anaerobic, cellulolytic, 
thermophilic bacteria, such as C. thermocellum, that can ferment cheap cellulose 
byproducts from the agricultural and forestry sectors via a single step process. Despite the 
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benefits, C. thermocellum is inhibited by low ethanol concentrations (< 2%) in its 
immediate environment, unlike yeast, which can tolerate high levels of ethanol (> 10%) 
in the media. Through sequential transfer procedures, C. thermocellum strains able to 
tolerate as high as 8% ethanol have been developed and preliminary proteomics 
investigations have clearly demonstrated that critical changes in the membrane proteome 
are brought about by ethanol adaptation. A closer look at the bacterial membrane protein 
expression could therefore provide insight into how ethanol tolerance is developed. 
With increasing research and development dedicated to understanding global 
protein expression and changes came the understanding that the cellular proteome is 
composed of many sub-proteomes that often require different experimental conditions for 
optimum analysis. One such sub-proteome that stands apart from other cellular protein 
components is the class of proteins in the cell membrane. These proteins are difficult to 
analyze using traditional gel-based approaches that are the cornerstone of proteomics 
investigations. This is largely due to their high hydrophobicity and solubility issues in the 
first dimension or isoelectric focusing step of 2D-PAGE. A solid understanding of 
differential protein expression in the C. thermocellum membrane proteome demands the 
design of suitable proteomic methodologies geared towards the analysis of membrane 
proteins. The newly developed Bicine-dSDS-PAGE method, described in Chapter 2.2, 
provided a more effective means of separating membrane proteins compared to other 
dSDS-PAGE and traditional 2D-PAGE approaches. This methodology featured 
molecular weight-based separations in both dimensions of SDS-PAGE and completely 
circumvented problems associated with pI-based separations (34). 
Orthogonality of separation in Bicine-dSDS-PAGE was achieved through 
manipulation of the parameter space for gel and electrophoresis buffer preparation. 
Hydrophobicity and the relatively high pI values commonly observed in C. thermocellum 
membrane proteins did not pose as a significant drawback in Bicine-dSDS-PAGE 
analyses, in contrast to traditional 2D-PAGE. A comparison of this technique with the 
established Glycine (Laemmli)- and Tricine-dSDS-PAGE protocols revealed significant 
improvements in membrane protein representation and abundance. These differences 
were explained to be the effect of differential electrophoretic migration of the trailing 
ions in the three dSDS-PAGE approaches: bicine for Bicine-dSDS-PAGE, tricine for 
 210
Tricine-dSDS-PAGE and glycine for Laemmli-dSDS-PAGE. While faster-moving tricine 
is well-suited for separation of small proteins and the slower glycine is appropriate for 
cytosolic proteins, intermediate mobility of bicine was adequate for effective separation 
and resolution of membrane proteins. 
The Bicine-dSDS-PAGE method was successfully applied towards the study of 
differential protein expression in wild type and ethanol-adapted C. thermocellum strains, 
as described in Chapter 2.3. To our knowledge, this is the first study of differential 
protein expression in wild type and ethanol-adapted C. thermocellum cells (90). Highly 
purified membrane fractions, obtained through sucrose isopycnic density gradient 
centrifugation procedures (SIDGC), were employed. Hydropathy (GRAVY) and 
transmembrane domain (TMD) analyses revealed substantial representation of membrane 
proteins and dramatically reduced cytosolic proteins, compared to crude membrane 
preparations. It was evident from these investigations that while protein spot 
representation was fairly similar between the two strains, there were dramatic differences 
in the abundance of several proteins. A majority of the proteins that were differentially 
expressed in these studies were observed to be up-regulated in the wild type strain, 
particularly those intimately involved with carbohydrate transport and metabolism. Of the 
few proteins that were present in higher abundance in the ethanol-challenged strain, 
several were associated with chemotaxis and sensory transduction. It is possible that the 
lower levels of different proteins in the ethanol-adapted organism is likely due to the 
failure of chaperones and protein folding agents to properly incorporate membrane 
proteins into the very fluid lipid bi-layer that is so characteristic of these cells. 
These investigations have clearly highlighted the importance of careful sample 
preparation and methods development in proteomics investigations. A solid 
understanding of the chemistry and biochemistry of the target analytes, such as 
membrane proteins, in the development of appropriate methodologies can substantially 
improve the quality of data obtained. The study of the C. thermocellum membrane 
proteome with specially designed gel-based technology provided a basic understanding of 
ethanol-induced changes. A closer look at these proteins, investigations into their 
metabolic pathways and whether or not they are under-produced or inefficiently 
incorporated into the cell membrane will no doubt significantly add to existing 
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knowledge about ethanol adaptation. These are the key initial steps towards the eventual 
design of more ethanol-resistant C. thermocellum strains and their exploitation as bio-
energy producers. 
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Appendix 
 
COG function classes of proteins and their abbreviations. 
 
C Energy production and conversion 
D Cell cycle control, cell division, chromosome partitioning 
E Amino acid transport and metabolism 
F Nucleotide transport and metabolism 
G Carbohydrate transport and metabolism 
H Coenzyme transport and metabolism 
I Lipid transport and metabolism 
J Translation, ribosomal structure and biogenesis 
K Transcription 
L Replication, recombination and repair 
M Cell wall/membrane/envelope biogenesis 
N Cell motility 
O Posttranslational modification, protein turnover, chaperones 
P Inorganic ion transport and metabolism 
Q Secondary metabolites biosynthesis, transport and catabolism 
R General function prediction only 
S Function unknown 
T Signal transduction mechanisms 
U Intracellular trafficking, secretion, and vesicular transport 
V Defense mechanisms 
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CONCLUSIONS 
 
 In the year 1803, when John Dalton proposed that matter was composed of small, 
indivisible particles called atoms, it was popularly believed that mankind was fast 
approaching the frontiers of what can be known about the fabric of the cosmos. Smashing 
the atom quickly dissipated such ideas as matter was probed at increasingly detailed 
levels to reveal a whole new universe of understanding in quantum mechanics. A major 
contributor to the power of mass spectrometry, particularly in the bioanalytical world, lies 
in its ability to deliver sensitive and selective quantitative and qualitative data at 
vanishingly lower detection levels, resulting in very accurate and detailed analysis. Full 
exploitation of such characteristics of this analytical tool is realized through careful 
methods development geared towards specific analytes. By repeatedly challenging the 
frontiers of mass spectrometry through instrument development and experimental design, 
it can be possible to broaden the scope of scientific analysis to even lower limits of 
detection and quantification. The ability to measure minute quantities of analytes, such as 
detection of subtle changes between diseased and control data sets, can vastly improve 
knowledge of the biological system under investigation, both in the realms of small and 
large molecule research. How low is low enough? The pioneers of string theory and M 
theory would probably say “as low as technologically possible and then lower”.  
 Discovery of biomarkers, which have traditionally been small organic molecules, 
in disease progression research would be of little use for the development of disease 
diagnostics and cures if those biomarkers could not be accurately detected and quantified. 
There are numerous diseases with poor diagnostic methods and treatments that claim 
untold lives every year. Of all the cancers that afflict women, ovarian cancer is one of the 
deadliest and by the time it is diagnosed, the odds of a cure have generally dropped to 
little more than 1 in 10. While there are many terminal diseases, such as AIDS, 
Alzheimer’s disease and several types of cancer, in many cases, early diagnosis renders 
the diseases treatable, if not curable, in a manner that can improve the quality of life 
during the lifetime of the afflicted individual. The ultimate goal of disease research 
should be the development of complete cures. However, in the interest of those who will 
succumb before such cures come to pass, an equally strong emphasis ought to be placed 
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on early detection and symptom alleviation. Human lives and the quality of life itself 
depend on the design of reliable, sensitive and accurate clinical diagnostics. 
 Retirement of the baby boom generation will place a significant fraction of the 
elderly populace, unmatched in history, in the hands of the geriatric physician. The aging 
population, particularly in the western world, will clearly demand greater medical and 
social attention for diseases of the elderly, such as Alzheimer’s disease. The first part of 
this dissertation described the development of MS-based sensitive, selective and accurate 
methodologies for the quantification of biogenic aldehydes, potential biomarkers for this 
debilitating illness. This was achieved through a solid understanding of the chemistry of 
these analytes, along with careful experimental design in HPLC separation and mass 
spectrometry. The reliability of biogenic aldehydes as AD biomarkers renders them well-
suited for exploitation as a clinical diagnostic, through analysis of human cerebrospinal 
fluid (CSF) samples, for instance. It can be possible to improve the quantitative power of 
this methodology through the use of radioactively labeled internal standards in isotope 
dilution mass spectrometry. Greater similarity between the physicochemical properties of 
internal standard and target analyte will produce a more effective and reliable analytical 
methodology. 
Application of the developed LC-MS method to measuring biogenic aldehydes in 
different regions of the human brain for individuals who displayed varying levels of AD 
pathology clearly demonstrated the power of MS-based methods development in disease 
progression research. The data confirmed that AD pathology appeared early in the 
disease, at the mild cognitive impairment (MCI) stage. To design reliable diagnostics and 
effect a cure for AD, it is imperative that research focus on the MCI stage. A sizable 
proportion of acrolein and HNE are known to be bound to proteins in the AD brain. 
Tapping into these reservoirs of biogenic aldehydes using similarly designed LC/MS 
methods can offer a clearer understanding of their prevalence in the brain. No doubt, one 
can also envision developing LC/MS techniques for the analysis of other possible AD 
biomarkers, such as isoprostanes. Metabolic and mutation studies coupled to LC/MS for 
detection of these compounds can further provide information on the circumstances of 
lipid peroxidation and AD occurrence. The possibilities of applying LC/MS-based 
methods for biomarker studies in other diseases are also very promising, especially in 
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view of the large parameter space of LC/MS experiments – ranging from LC column 
makeup to ion fragmentation techniques in MS – which can be manipulated to tailor 
experimental design towards the analyte of interest. 
The knowledge base for Alzheimer’s disease has grown significantly in the past 
decade and many believe that a viable clinical diagnostic lies within the foreseeable 
future. Understanding the etiology of the disease will pave the way to the discovery of 
effective biomarkers. The MCI stage is considered to be the earliest time when AD 
pathology appears. It is very likely that with improvements in the detection of AD 
pathology, a time even earlier than the MCI stage can be targeted in the development of 
clinical tests. Early detection is the key. A deeper understanding of AD biomarker 
generation, biochemistry, as well as careful evaluation of their relative abundance in the 
body (as demonstrated in Part 1 of this dissertation) can only strengthen the power of 
diagnostics based on these compounds. With the detection and quantification potential 
available in mass spectrometry, it is not difficult to see why an MS-based clinical 
diagnostic is a very practical and worthwhile avenue to pursue. 
 The power of mass spectrometry is such that it can be interfaced to a host of 
separation techniques, in no way limited to chromatography, for the analysis of a variety 
of compounds. While LC-based separations coupled to MS have had success in the area 
of large molecule research such as proteomics studies, the Laemmli protocol of 2D-SDS-
PAGE remains the gold standard for protein separations. But proteins are a diverse group 
of macromolecules which simply cannot be grouped together and effectively analyzed 
through a single gel-based separation approach. Such an assumption produced 
consistently low representation of cell membrane proteins in standard 2D gel maps. 
Closer scrutiny of these proteins revealed that their hydrophobicity, generally basic pI 
values and poor solubility in isoelectric focusing (first dimension of 2D-SDS-PAGE) 
buffers rendered them unsuitable for analysis using traditional 2D-SDS-PAGE. Since the 
membrane is the site of first contact of the cell with the exterior, membrane proteins play 
a critical role in cellular processes, especially during changes in the organism’s 
immediate environment. This was evident in ethanol tolerance studies of the 
thermophilic, anaerobic, cellulolytic bacterium Clostridium thermocellum. This organism 
has received attention in the area of bio-fuels research for its ability to ferment 
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inexpensive cellulose-based biomass to ethanol. With changing climactic conditions from 
burning of fossil fuels, national security issues, as well as predictions of an impending 
energy crisis, the development of alternative sources of energy for human consumption 
has become critical. 
 The second part of this dissertation focused on Clostridium thermocellum 
membrane proteome research in an effort to obtain a clear understanding of membrane 
protein expression patterns in wild type and ethanol-adapted strains. As with the AD 
investigations in Part 1, careful methods development in gel-based separations of 
membrane proteins proved to be highly beneficial in achieving desired goals. Bicine-
based electrophoresis buffers in conjunction with dSDS-PAGE approaches that 
circumvented solubility concerns encountered in the first dimension of 2D-SDS-PAGE 
were well-suited for low abundance membrane protein analysis. Greater protein spot 
representation was observed with Bicine-dSDS-PAGE, compared with conventional 
dSDS-PAGE techniques. The rationale for the applicability of bicine as a trailing ion in 
these investigations was explained through electrophoretic mobility studies using 
capillary electrophoresis experiments (CE). One can envision the careful selection of 
trailing ions through CE for specific analytes at hand to dramatically improve selectivity 
and separation efficiency of electrophoresis methods. Tailoring analysis to the target 
analyte, rather than employing generalized protocols for dissimilar classes of compounds, 
will ensure reliable data. Chromatography has enjoyed decades of analytical research 
culminating in a variety of mobile and stationary phases, as well as separation techniques. 
There is no reason why similar success in broadening the versatility and applications of 
gel electrophoretic methodologies should not be realized in the near future. 
 The Bicine-dSDS-PAGE method was successfully applied towards the analysis of 
differential protein expression in the wild type and ethanol-adapted C. thermocellum 
membrane proteomes. Definitive changes were observed, with a majority of differentially 
expressed proteins being present at higher concentrations in the wild-type organism. It 
was postulated that these proteins were either being under-produced by the ethanol-
adapted strain or the organism was unable to properly incorporate them into the 
membrane proteome. The latter possibility would imply that membrane protein build-up 
could be occurring at the site of manufacture (cytosol). While investigations presented 
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here offered a basic foundation for understanding ethanol tolerance at the membrane 
level, a closer examination of the biochemistry of differentially expressed proteins will 
surely provide a deeper appreciation of the underlying mechanisms for this phenomenon. 
Many proteins in the C. thermocellum cell membrane have been studied but a sizable 
fraction of the entire membrane proteome remains unexplored. One can envision using 
multi-dimensional chromatographic separation methods (MudPIT) coupled with isotope 
labeling to probe this class of proteins on a deeper level and obtain accurate relative 
quantification data. 
 The ethanol adapted C. thermocellum strain is considerably less robust than its 
wild type counterpart. Once a thorough understanding of differential protein expression 
of the entire C. thermocellum membrane proteome is obtained, mutation studies and 
metabolic experiments can shed light on which pathways are critical for ethanol 
adaptation to develop and which mechanisms contribute to the poor growth and overall 
health of the ethanol-adapted organism. Results from these investigations can definitely 
enable the production of specially designed, genetically engineered ethanol-adapted 
bacteria. These ‘super bugs’ would have certain genes with increased capabilities of up-
regulating ethanol production routes. Manipulation of other genes that effectively control 
metabolic pathways, rendering the bacteria more robust than their ethanol-challenged 
cousins, would also be beneficial. C. thermocellum strains with even as much ethanol 
tolerance as yeast, the current industrial bio-ethanol producer, would be a remarkable 
success. Unlike yeast which can only ferment expensive simple sugars, such bacterial 
strains would be able to effectively produce ethanol from inexpensive cellulose-based by-
products out of the agricultural and forestry sectors. With high demands on cleaner, more 
efficient fuel sources, along with increasing emphasis on recycling materials for human 
consumption, a bacterium able to mass-produce bio-ethanol from cellulose waste would 
be a highly promising outcome indeed. 
 The possibilities with methods development in MS investigations interfaced with 
separation technology in the biological arena are truly limitless. No matter what the 
analytes under investigation, be they small or large molecules, hydrophilic or 
hydrophobic, acidic or basic, reliable quantification is only achieved through careful 
consideration of analyte properties, as opposed to using generalized methodologies that 
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have little regard for the specific needs of target compounds. The versatility of various 
chromatographic and gel-based methods, coupled to the variety of ionization sources and 
mass analyzers available, culminate in a marriage of incredible analytical potential. In 
terms of biological systems that scientists desire to study and the permutations of 
separation-based MS methods available with which to study them, we are truly at the tip 
of a bioanalytical iceberg and the iceberg is growing every day. 
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